PARADIGM pathway analysis of mRNASeq expression data
Colon Adenocarcinoma (Primary solid tumor)
23 September 2013  |  analyses__2013_09_23
Maintainer Information
Citation Information
Maintained by Dan DiCara (Broad Institute)
Cite as Broad Institute TCGA Genome Data Analysis Center (2013): PARADIGM pathway analysis of mRNASeq expression data. Broad Institute of MIT and Harvard. doi:10.7908/C1FF3QNX
Overview
Introduction

PAthway Representation and Analysis by Direct Inference on Graphical Models (PARADIGM) predicts the activity of a diverse set of molecular concepts such as genes, complexes, and processes. The predicted activities are called Inferred Pathway Levels (IPLs) and are derived from a probabilistic belief propagation strategy that incorporates multimodal data such as copy number and gene expression estimates with a concept's pathway context.

Summary

There were 41 significant pathways identified in this analysis.

Table 1.  Get Full Table Top 10 out of 131 pathways in order of significance.

Pathway.Name Avg.Num.Perturbations
Syndecan-1-mediated signaling events 96
TCGA08_retinoblastoma 75
Reelin signaling pathway 70
Osteopontin-mediated events 49
Lissencephaly gene (LIS1) in neuronal migration and development 44
IL23-mediated signaling events 37
IL4-mediated signaling events 34
Glypican 1 network 34
FOXA2 and FOXA3 transcription factor networks 31
Signaling events mediated by the Hedgehog family 30
Results
Summary Table

The following list describes the columns found in Table 2.

  • Pathway.Name = Full pathway name of curated PARADIGM pathway

  • Significance.Ratio = (Ave.Num.Perturbations)/ (Cohort Size) where Cohort Size is 232 . Pathway is significant if Significance.Ratio > 0.05 .

  • Avg.Num.Perturbations = Average number of samples with perturbations across the pathway concepts determined by a background permutation model (>2 standard deviations away from the permuted distribution)

  • Total.Perturbations = Total number of perturbed concepts across all samples (>2 standard deviations away from the permuted distribution)

  • Num.Entities = Number of concepts that belong to the pathway

  • Min.Mean.Truth = Minimum IPL for concepts in the pathway among real samples

  • Max.Mean.Truth = Maximum IPL for concepts in the pathway among real samples

  • Min.Mean.Within = Minimum IPL for concepts in the pathway among null samples using "within permutation" (values are permuted across genes)

  • Max.Mean.Within = Maximum IPL for concepts in the pathway among null samples using "within permutation" (values are permuted across genes)

  • Min.Mean.Any = Minimum IPL for concepts in the pathway among null samples using "any permutation" (values are permuted across samples and genes)

  • Max.Mean.Any = Maximum IPL for concepts in the pathway among null samples using "any permutation" (values are permuted across samples and genes).

Table 2.  Get Full Table This summary table provides a report of cancer type specific pathway perturbations. Click on the links in the first column to display more detailed results for each pathway. A pathway is defined as significant (red number in Significance.Ratio column) if the Ave.Num.Perturbationsis > 5% of the cohort size ( 232 ).

Pathway.Name Significance.Ratio Avg.Num.Perturbations Total.Perturbations Num.Entities Min.Mean.Truth Max.Mean.Truth Min.Mean.Within Max.Mean.Within Min.Mean.Any Max.Mean.Within.1
Syndecan-1-mediated signaling events 0.4138 96 3285 34 -0.68 0.012 1000 -1000 -0.041 -1000
TCGA08_retinoblastoma 0.3233 75 605 8 -0.19 0.073 1000 -1000 -0.014 -1000
Reelin signaling pathway 0.3017 70 3932 56 -0.59 0.037 1000 -1000 -0.069 -1000
Osteopontin-mediated events 0.2112 49 1874 38 -0.34 0.019 1000 -1000 -0.068 -1000
Lissencephaly gene (LIS1) in neuronal migration and development 0.1897 44 2386 54 -0.59 0.023 1000 -1000 -0.086 -1000
IL23-mediated signaling events 0.1595 37 2220 60 -0.58 0.018 1000 -1000 -0.18 -1000
IL4-mediated signaling events 0.1466 34 3103 91 -0.8 0.63 1000 -1000 -0.18 -1000
Glypican 1 network 0.1466 34 1641 48 -0.36 0.023 1000 -1000 -0.031 -1000
FOXA2 and FOXA3 transcription factor networks 0.1336 31 1429 46 -0.62 0.018 1000 -1000 -0.13 -1000
Signaling events mediated by the Hedgehog family 0.1293 30 1561 52 -0.2 0.18 1000 -1000 -0.037 -1000
Caspase cascade in apoptosis 0.1121 26 1982 74 -0.18 0.092 1000 -1000 -0.04 -1000
Syndecan-4-mediated signaling events 0.1034 24 1653 67 -0.51 0.041 1000 -1000 -0.053 -1000
BCR signaling pathway 0.0905 21 2106 99 -0.16 0.018 1000 -1000 -0.074 -1000
Signaling events mediated by Stem cell factor receptor (c-Kit) 0.0905 21 1648 78 -0.13 0.041 1000 -1000 -0.072 -1000
Glucocorticoid receptor regulatory network 0.0862 20 2281 114 -0.59 0.29 1000 -1000 -0.063 -1000
Endothelins 0.0862 20 1994 96 -0.35 0.048 1000 -1000 -0.081 -1000
Ephrin B reverse signaling 0.0819 19 918 48 -0.15 0.063 1000 -1000 -0.056 -1000
BMP receptor signaling 0.0776 18 1492 81 -0.31 0.048 1000 -1000 -0.08 -1000
TCGA08_p53 0.0776 18 130 7 -0.14 0.072 1000 -1000 -0.01 -1000
HIF-1-alpha transcription factor network 0.0733 17 1315 76 -0.71 0.02 1000 -1000 -0.16 -1000
Canonical Wnt signaling pathway 0.0733 17 907 51 -0.38 0.18 1000 -1000 -0.054 -1000
Calcium signaling in the CD4+ TCR pathway 0.0733 17 544 31 -0.41 0.012 1000 -1000 -0.058 -1000
Nephrin/Neph1 signaling in the kidney podocyte 0.0690 16 547 34 -0.071 0.012 1000 -1000 -0.031 -1000
IL1-mediated signaling events 0.0690 16 1024 62 -0.29 0.053 1000 -1000 -0.085 -1000
Ephrin A reverse signaling 0.0647 15 111 7 -0.047 0 1000 -1000 -0.018 -1000
Syndecan-2-mediated signaling events 0.0647 15 1095 69 -0.4 0.036 1000 -1000 -0.034 -1000
Presenilin action in Notch and Wnt signaling 0.0647 15 972 61 -0.38 0.16 1000 -1000 -0.058 -1000
Fc-epsilon receptor I signaling in mast cells 0.0647 15 1524 97 -0.12 0.031 1000 -1000 -0.075 -1000
amb2 Integrin signaling 0.0647 15 1270 82 -0.16 0.022 1000 -1000 -0.053 -1000
Glypican 2 network 0.0647 15 60 4 -0.037 -0.028 1000 -1000 -0.011 -1000
Wnt signaling 0.0647 15 110 7 -0.13 0.012 1000 -1000 -0.029 -1000
Ras signaling in the CD4+ TCR pathway 0.0647 15 257 17 -0.062 0.025 1000 -1000 -0.035 -1000
Effects of Botulinum toxin 0.0603 14 377 26 -0.098 0.012 1000 -1000 -0.053 -1000
JNK signaling in the CD4+ TCR pathway 0.0560 13 223 17 -0.11 0.023 1000 -1000 -0.036 -1000
S1P1 pathway 0.0560 13 482 36 -0.13 0.013 1000 -1000 -0.049 -1000
Syndecan-3-mediated signaling events 0.0560 13 480 35 -0.4 0.037 1000 -1000 -0.043 -1000
Calcineurin-regulated NFAT-dependent transcription in lymphocytes 0.0560 13 887 68 -0.47 0.04 1000 -1000 -0.12 -1000
HIF-2-alpha transcription factor network 0.0517 12 527 43 -0.29 0.18 1000 -1000 -0.065 -1000
Signaling mediated by p38-alpha and p38-beta 0.0517 12 555 44 -0.048 0.012 1000 -1000 -0.032 -1000
EGFR-dependent Endothelin signaling events 0.0517 12 252 21 -0.093 0.019 1000 -1000 -0.063 -1000
Visual signal transduction: Rods 0.0517 12 647 52 -0.18 0.012 1000 -1000 -0.068 -1000
Aurora A signaling 0.0474 11 683 60 -0.4 0.03 1000 -1000 -0.036 -1000
p75(NTR)-mediated signaling 0.0474 11 1491 125 -0.74 0.037 1000 -1000 -0.083 -1000
Angiopoietin receptor Tie2-mediated signaling 0.0474 11 1016 88 -0.21 0.068 1000 -1000 -0.086 -1000
Sphingosine 1-phosphate (S1P) pathway 0.0431 10 297 28 -0.13 0.019 1000 -1000 -0.032 -1000
Noncanonical Wnt signaling pathway 0.0431 10 269 26 -0.13 0.012 1000 -1000 -0.047 -1000
S1P5 pathway 0.0431 10 175 17 -0.13 0.055 1000 -1000 -0.034 -1000
Retinoic acid receptors-mediated signaling 0.0431 10 624 58 -0.32 0.025 1000 -1000 -0.062 -1000
EPHB forward signaling 0.0431 10 897 85 -0.15 0.075 1000 -1000 -0.083 -1000
LPA receptor mediated events 0.0431 10 1105 102 -0.21 0.032 1000 -1000 -0.074 -1000
Signaling events regulated by Ret tyrosine kinase 0.0388 9 768 82 -0.1 0.012 1000 -1000 -0.073 -1000
TCR signaling in naïve CD8+ T cells 0.0388 9 919 93 -0.097 0.053 1000 -1000 -0.068 -1000
Plasma membrane estrogen receptor signaling 0.0388 9 843 86 -0.25 0.057 1000 -1000 -0.078 -1000
ErbB4 signaling events 0.0345 8 558 69 -0.34 0.063 1000 -1000 -0.08 -1000
Visual signal transduction: Cones 0.0345 8 317 38 -0.12 0.022 1000 -1000 -0.038 -1000
Nectin adhesion pathway 0.0345 8 555 63 -0.64 0.041 1000 -1000 -0.058 -1000
Integrins in angiogenesis 0.0345 8 673 84 -0.34 0.031 1000 -1000 -0.069 -1000
Nongenotropic Androgen signaling 0.0345 8 431 52 -0.13 0.024 1000 -1000 -0.047 -1000
S1P4 pathway 0.0345 8 207 25 -0.13 0.023 1000 -1000 -0.035 -1000
Thromboxane A2 receptor signaling 0.0302 7 803 105 -0.17 0.075 1000 -1000 -0.061 -1000
Signaling events mediated by PTP1B 0.0302 7 568 76 -0.38 0.061 1000 -1000 -0.071 -1000
Neurotrophic factor-mediated Trk receptor signaling 0.0302 7 851 120 -0.12 0.11 1000 -1000 -0.065 -1000
Signaling events mediated by PRL 0.0302 7 247 34 -0.12 0.032 1000 -1000 -0.035 -1000
IL12-mediated signaling events 0.0259 6 595 87 -0.18 0.038 1000 -1000 -0.14 -1000
PLK2 and PLK4 events 0.0259 6 18 3 -0.015 0.012 1000 -1000 -0.017 -1000
Arf6 signaling events 0.0259 6 393 62 -0.14 0.021 1000 -1000 -0.045 -1000
RXR and RAR heterodimerization with other nuclear receptor 0.0259 6 355 52 -0.14 0.029 1000 -1000 -0.044 -1000
IL27-mediated signaling events 0.0259 6 350 51 -0.16 0.027 1000 -1000 -0.071 -1000
S1P3 pathway 0.0259 6 258 42 -0.13 0.026 1000 -1000 -0.05 -1000
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha 0.0259 6 218 33 -0.19 0.037 1000 -1000 -0.034 -1000
Regulation of nuclear SMAD2/3 signaling 0.0216 5 766 136 -0.2 0.12 1000 -1000 -0.051 -1000
IFN-gamma pathway 0.0216 5 384 68 -0.079 0.032 1000 -1000 -0.087 -1000
Signaling mediated by p38-gamma and p38-delta 0.0216 5 75 15 -0.034 0.023 1000 -1000 -0.029 -1000
VEGFR1 specific signals 0.0216 5 284 56 -0.033 0.041 1000 -1000 -0.048 -1000
PDGFR-beta signaling pathway 0.0216 5 512 97 -0.2 0.041 1000 -1000 -0.069 -1000
Coregulation of Androgen receptor activity 0.0172 4 372 76 -0.24 0.05 1000 -1000 -0.03 -1000
PLK1 signaling events 0.0172 4 390 85 -0.09 0.027 1000 -1000 -0.038 -1000
Role of Calcineurin-dependent NFAT signaling in lymphocytes 0.0172 4 332 83 -0.32 0.071 1000 -1000 -0.057 -1000
Regulation of Telomerase 0.0172 4 472 102 -0.3 0.04 1000 -1000 -0.11 -1000
Regulation of Androgen receptor activity 0.0172 4 305 70 -0.24 0.026 1000 -1000 -0.055 -1000
Aurora B signaling 0.0172 4 314 67 -0.37 0.075 1000 -1000 -0.05 -1000
Paxillin-independent events mediated by a4b1 and a4b7 0.0129 3 144 37 -0.16 0.04 1000 -1000 -0.041 -1000
FAS signaling pathway (CD95) 0.0129 3 144 47 -0.027 0.025 1000 -1000 -0.044 -1000
Signaling events mediated by VEGFR1 and VEGFR2 0.0129 3 427 125 -0.031 0.058 1000 -1000 -0.086 -1000
Class I PI3K signaling events 0.0129 3 230 73 -0.12 0.035 1000 -1000 -0.052 -1000
E-cadherin signaling in keratinocytes 0.0129 3 134 43 -0.19 0.046 1000 -1000 -0.034 -1000
ErbB2/ErbB3 signaling events 0.0086 2 192 65 -0.06 0.042 1000 -1000 -0.06 -1000
a4b1 and a4b7 Integrin signaling 0.0086 2 11 5 0.003 0.016 1000 -1000 -0.016 -1000
Cellular roles of Anthrax toxin 0.0086 2 116 39 -0.063 0.013 1000 -1000 -0.016 -1000
Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met) 0.0086 2 209 85 -0.021 0.042 1000 -1000 -0.072 -1000
Hedgehog signaling events mediated by Gli proteins 0.0086 2 175 65 -0.13 0.048 1000 -1000 -0.054 -1000
Ceramide signaling pathway 0.0086 2 185 76 -0.093 0.046 1000 -1000 -0.038 -1000
Signaling events mediated by HDAC Class III 0.0086 2 104 40 -0.064 0.022 1000 -1000 -0.021 -1000
FoxO family signaling 0.0086 2 175 64 -0.12 0.086 1000 -1000 -0.082 -1000
Regulation of p38-alpha and p38-beta 0.0086 2 140 54 -0.12 0.032 1000 -1000 -0.056 -1000
TCGA08_rtk_signaling 0.0086 2 62 26 -0.028 0.039 1000 -1000 -0.017 -1000
IL6-mediated signaling events 0.0086 2 192 75 -0.047 0.051 1000 -1000 -0.078 -1000
Stabilization and expansion of the E-cadherin adherens junction 0.0086 2 202 74 -0.093 0.059 1000 -1000 -0.075 -1000
Rapid glucocorticoid signaling 0.0086 2 48 20 -0.006 0.015 1000 -1000 -0.015 -1000
FOXM1 transcription factor network 0.0086 2 144 51 -0.19 0.079 1000 -1000 -0.21 -1000
Canonical NF-kappaB pathway 0.0043 1 65 39 -0.067 0.054 1000 -1000 -0.075 -1000
Signaling events mediated by HDAC Class II 0.0043 1 79 75 -0.026 0.035 1000 -1000 -0.037 -1000
BARD1 signaling events 0.0043 1 66 57 -0.027 0.051 1000 -1000 -0.061 -1000
Arf6 downstream pathway 0.0043 1 57 43 -0.024 0.027 1000 -1000 -0.024 -1000
PDGFR-alpha signaling pathway 0.0043 1 81 44 -0.027 0.028 1000 -1000 -0.031 -1000
TRAIL signaling pathway 0.0043 1 76 48 -0.058 0.043 1000 -1000 -0.055 -1000
IL2 signaling events mediated by PI3K 0.0043 1 67 58 -0.068 0.054 1000 -1000 -0.082 -1000
IL2 signaling events mediated by STAT5 0.0043 1 39 22 -0.011 0.054 1000 -1000 -0.055 -1000
Arf6 trafficking events 0.0043 1 127 71 -0.047 0.036 1000 -1000 -0.057 -1000
IGF1 pathway 0.0043 1 88 57 -0.034 0.025 1000 -1000 -0.077 -1000
Insulin Pathway 0.0043 1 92 74 -0.056 0.032 1000 -1000 -0.077 -1000
p38 MAPK signaling pathway 0.0043 1 49 44 -0.049 0.033 1000 -1000 -0.063 -1000
LPA4-mediated signaling events 0.0000 0 6 12 -0.064 0.015 1000 -1000 -0.028 -1000
Regulation of cytoplasmic and nuclear SMAD2/3 signaling 0.0000 0 6 23 0.003 0.038 1000 -1000 -0.044 -1000
Circadian rhythm pathway 0.0000 0 20 22 -0.01 0.04 1000 -1000 -0.048 -1000
Aurora C signaling 0.0000 0 0 7 0 0.024 1000 -1000 -0.023 -1000
EPO signaling pathway 0.0000 0 43 55 -0.008 0.059 1000 -1000 -0.081 -1000
Insulin-mediated glucose transport 0.0000 0 1 32 0 0.038 1000 -1000 -0.045 -1000
mTOR signaling pathway 0.0000 0 11 53 0 0.033 1000 -1000 -0.051 -1000
Class I PI3K signaling events mediated by Akt 0.0000 0 11 68 -0.036 0.048 1000 -1000 -0.04 -1000
ceramide signaling pathway 0.0000 0 17 49 0 0.047 1000 -1000 -0.047 -1000
Signaling events mediated by HDAC Class I 0.0000 0 23 104 -0.025 0.047 1000 -1000 -0.049 -1000
Paxillin-dependent events mediated by a4b1 0.0000 0 13 36 -0.033 0.034 1000 -1000 -0.053 -1000
Atypical NF-kappaB pathway 0.0000 0 19 31 -0.012 0.036 1000 -1000 -0.036 -1000
HIV-1 Nef: Negative effector of Fas and TNF-alpha 0.0000 0 32 45 -0.007 0.06 1000 -1000 -0.081 -1000
E-cadherin signaling in the nascent adherens junction 0.0000 0 53 76 -0.015 0.051 1000 -1000 -0.069 -1000
Sumoylation by RanBP2 regulates transcriptional repression 0.0000 0 6 27 -0.001 0.032 1000 -1000 -0.043 -1000
Class IB PI3K non-lipid kinase events 0.0000 0 0 3 -0.012 0.012 1000 -1000 -0.009 -1000
E-cadherin signaling events 0.0000 0 0 5 0.012 0.025 1000 -1000 -0.015 -1000
Arf1 pathway 0.0000 0 2 54 0 0.028 1000 -1000 -0.022 -1000
Alternative NF-kappaB pathway 0.0000 0 0 13 0 0.037 1000 -1000 -0.022 -1000
Total NA 1346 75279 7203 -23 6.3 131000 -131000 -7.5 -131000
Syndecan-1-mediated signaling events

Figure S1.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S1.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.012 0 -9999 0 -10000 0 0
CCL5 -0.003 0.076 -9999 0 -0.34 10 10
SDCBP 0.012 0 -9999 0 -10000 0 0
FGFR/FGF2/Syndecan-1 -0.35 0.14 -9999 0 -0.42 165 165
mol:PI-4-5-P2 0 0 -9999 0 -10000 0 0
RP11-540L11.1 0 0 -9999 0 -10000 0 0
Syndecan-1/Laminin-5 -0.33 0.14 -9999 0 -0.4 165 165
Syndecan-1/Syntenin -0.33 0.14 -9999 0 -0.4 165 165
MAPK3 -0.29 0.12 -9999 0 -0.36 165 165
HGF/MET -0.014 0.12 -9999 0 -0.52 12 12
TGFB1/TGF beta receptor Type II 0.012 0 -9999 0 -10000 0 0
BSG 0.012 0 -9999 0 -10000 0 0
keratinocyte migration -0.32 0.13 -9999 0 -0.4 165 165
Syndecan-1/RANTES -0.33 0.14 -9999 0 -0.41 168 168
Syndecan-1/CD147 -0.31 0.13 -9999 0 -0.38 165 165
Syndecan-1/Syntenin/PIP2 -0.32 0.13 -9999 0 -0.39 165 165
LAMA5 0.012 0 -9999 0 -10000 0 0
positive regulation of cell-cell adhesion -0.31 0.13 -9999 0 -0.38 165 165
MMP7 -0.68 0.092 -9999 0 -0.7 228 228
HGF 0.003 0.065 -9999 0 -0.37 6 6
Syndecan-1/CASK -0.33 0.14 -9999 0 -0.41 165 165
Syndecan-1/HGF/MET -0.33 0.15 -9999 0 -0.41 169 169
regulation of cell adhesion -0.28 0.12 -9999 0 -0.35 162 162
HPSE 0.007 0.041 -9999 0 -0.3 4 4
positive regulation of cell migration -0.35 0.14 -9999 0 -0.42 165 165
SDC1 -0.35 0.14 -9999 0 -0.43 165 165
Syndecan-1/Collagen -0.35 0.14 -9999 0 -0.42 165 165
PPIB 0.012 0 -9999 0 -10000 0 0
MET -0.021 0.15 -9999 0 -0.7 11 11
PRKACA 0.012 0 -9999 0 -10000 0 0
MMP9 -0.15 0.3 -9999 0 -0.7 53 53
MAPK1 -0.29 0.12 -9999 0 -0.36 165 165
homophilic cell adhesion -0.34 0.14 -9999 0 -0.42 165 165
MMP1 -0.45 0.34 -9999 0 -0.7 152 152
TCGA08_retinoblastoma

Figure S2.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S2.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDKN2B -0.038 0.11 -10000 0 -0.27 43 43
CDKN2C 0.027 0.03 -10000 0 -10000 0 0
CDKN2A -0.19 0.32 -10000 0 -0.71 65 65
CCND2 0.069 0.084 0.16 99 -0.12 1 100
RB1 -0.068 0.096 -10000 0 -0.17 99 99
CDK4 0.073 0.1 0.18 100 -10000 0 100
CDK6 0.071 0.098 0.18 99 -10000 0 99
G1/S progression 0.068 0.096 0.17 99 -10000 0 99
Reelin signaling pathway

Figure S3.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S3.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDK5R1/CDK5 0.014 0.05 -9999 0 -0.52 2 2
VLDLR -0.009 0.079 -9999 0 -0.3 16 16
CRKL 0.012 0 -9999 0 -10000 0 0
LRPAP1 0.012 0 -9999 0 -10000 0 0
FYN 0.012 0 -9999 0 -10000 0 0
ITGA3 0.009 0.046 -9999 0 -0.7 1 1
RELN/VLDLR/Fyn -0.072 0.11 -9999 0 -0.32 15 15
MAPK8IP1/MKK7/MAP3K11/JNK1 0.037 0 -9999 0 -10000 0 0
AKT1 -0.081 0.12 -9999 0 -0.34 22 22
MAP2K7 0.012 0 -9999 0 -10000 0 0
RAPGEF1 0.012 0 -9999 0 -10000 0 0
DAB1 -0.042 0.18 -9999 0 -0.7 17 17
RELN/LRP8/DAB1 -0.44 0.2 -9999 0 -0.51 200 200
LRPAP1/LRP8 -0.44 0.19 -9999 0 -0.52 197 197
RELN/LRP8/DAB1/Fyn -0.41 0.19 -9999 0 -0.48 200 200
DAB1/alpha3/beta1 Integrin -0.39 0.18 -9999 0 -0.52 109 109
long-term memory -0.55 0.27 -9999 0 -0.61 207 207
DAB1/LIS1 -0.39 0.19 -9999 0 -0.46 200 200
DAB1/CRLK/C3G -0.38 0.18 -9999 0 -0.44 200 200
PIK3CA 0.012 0 -9999 0 -10000 0 0
DAB1/NCK2 -0.4 0.2 -9999 0 -0.46 200 200
ARHGEF2 0.012 0 -9999 0 -10000 0 0
mol:Src family inhibitors PP1 and PP2 0 0 -9999 0 -10000 0 0
GRIN2A -0.087 0.15 -9999 0 -0.31 70 70
CDK5R1 0.006 0.066 -9999 0 -0.7 2 2
RELN -0.14 0.16 -9999 0 -0.3 111 111
PIK3R1 0.012 0 -9999 0 -10000 0 0
RELN/LRP8/Fyn -0.45 0.19 -9999 0 -0.52 197 197
GRIN2A/RELN/LRP8/DAB1/Fyn -0.45 0.21 -9999 0 -0.52 200 200
MAPK8 0.012 0 -9999 0 -10000 0 0
RELN/VLDLR/DAB1 -0.096 0.15 -9999 0 -0.4 31 31
ITGB1 0.012 0 -9999 0 -10000 0 0
MAP1B -0.4 0.2 -9999 0 -0.46 200 200
RELN/LRP8 -0.45 0.19 -9999 0 -0.52 197 197
GRIN2B/RELN/LRP8/DAB1/Fyn -0.54 0.27 -9999 0 -0.6 207 207
PI3K 0.019 0 -9999 0 -10000 0 0
mol:PP2 0 0 -9999 0 -10000 0 0
alpha3/beta1 Integrin 0.016 0.035 -9999 0 -0.52 1 1
RAP1A -0.36 0.18 -9999 0 -0.49 109 109
PAFAH1B1 0.012 0 -9999 0 -10000 0 0
MAPK8IP1 0.012 0 -9999 0 -10000 0 0
CRLK/C3G 0.019 0 -9999 0 -10000 0 0
GRIN2B -0.23 0.34 -9999 0 -0.7 78 78
NCK2 0.012 0 -9999 0 -10000 0 0
neuron differentiation -0.21 0.12 -9999 0 -0.31 108 108
neuron adhesion -0.33 0.17 -9999 0 -0.46 109 109
LRP8 -0.59 0.25 -9999 0 -0.7 197 197
GSK3B -0.072 0.12 -9999 0 -0.32 22 22
RELN/VLDLR/DAB1/Fyn -0.084 0.14 -9999 0 -0.45 17 17
MAP3K11 0.012 0 -9999 0 -10000 0 0
RELN/VLDLR/DAB1/P13K -0.093 0.13 -9999 0 -0.36 22 22
CDK5 0.012 0 -9999 0 -10000 0 0
MAPT -0.047 0.12 -9999 0 -0.26 53 53
neuron migration -0.32 0.17 -9999 0 -0.46 110 110
RELN/LRP8/DAB1/Fyn/MAPK8IP1/MKK7/MAP3K11/JNK1 -0.21 0.12 -9999 0 -0.31 108 108
RELN/VLDLR -0.41 0.19 -9999 0 -0.48 197 197
Osteopontin-mediated events

Figure S4.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S4.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IKK alpha homodimer -0.18 0.22 -9999 0 -0.4 115 115
NF kappa B1 p50/RelA/I kappa B alpha -0.16 0.22 -9999 0 -0.46 47 47
alphaV/beta3 Integrin/Osteopontin/Src -0.25 0.28 -9999 0 -0.53 115 115
AP1 -0.15 0.22 -9999 0 -0.44 47 47
ILK -0.19 0.22 -9999 0 -0.41 115 115
bone resorption -0.14 0.19 -9999 0 -0.39 3 3
PTK2B 0.012 0 -9999 0 -10000 0 0
PYK2/p130Cas -0.16 0.21 -9999 0 -0.37 115 115
ITGAV 0.013 0.005 -9999 0 -10000 0 0
mol:GTP 0 0 -9999 0 -10000 0 0
CD44/Rho Family GTPase/ROCK2 0.019 0 -9999 0 -10000 0 0
alphaV/beta3 Integrin/Osteopontin -0.21 0.24 -9999 0 -0.46 115 115
MAP3K1 -0.19 0.22 -9999 0 -0.41 115 115
JUN 0.012 0.001 -9999 0 -10000 0 0
MAPK3 -0.19 0.23 -9999 0 -0.42 115 115
MAPK1 -0.19 0.23 -9999 0 -0.42 115 115
Rac1/GDP 0.009 0 -9999 0 -10000 0 0
NFKB1 0.012 0 -9999 0 -10000 0 0
MAPK8 -0.17 0.21 -9999 0 -0.39 115 115
ITGB3 0.006 0.045 -9999 0 -0.29 5 5
NFKBIA -0.18 0.23 -9999 0 -0.4 115 115
FOS 0.01 0.029 -9999 0 -0.3 2 2
CD44 0.012 0 -9999 0 -10000 0 0
CHUK 0.012 0 -9999 0 -10000 0 0
PLAU -0.23 0.32 -9999 0 -0.77 47 47
NF kappa B1 p50/RelA -0.19 0.2 -9999 0 -0.5 47 47
BCAR1 0.012 0 -9999 0 -10000 0 0
RELA 0.012 0 -9999 0 -10000 0 0
alphaV beta3 Integrin 0.015 0.031 -9999 0 -10000 0 0
mol:GDP 0 0 -9999 0 -10000 0 0
SYK -0.19 0.22 -9999 0 -0.41 115 115
VAV3 -0.19 0.22 -9999 0 -0.41 115 115
MAP3K14 -0.2 0.23 -9999 0 -0.43 115 115
ROCK2 0.012 0 -9999 0 -10000 0 0
SPP1 -0.34 0.36 -9999 0 -0.7 116 116
RAC1 0.012 0 -9999 0 -10000 0 0
Rac1/GTP -0.17 0.2 -9999 0 -0.41 62 62
MMP2 -0.12 0.19 -9999 0 -0.84 3 3
Lissencephaly gene (LIS1) in neuronal migration and development

Figure S5.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S5.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
DYNC1H1 0.012 0 -9999 0 -10000 0 0
VLDLR -0.009 0.079 -9999 0 -0.3 16 16
LRPAP1 0.012 0 -9999 0 -10000 0 0
NUDC 0.012 0 -9999 0 -10000 0 0
RELN/LRP8 -0.45 0.19 -9999 0 -0.52 197 197
CaM/Ca2+ 0.009 0 -9999 0 -10000 0 0
KATNA1 0.012 0 -9999 0 -10000 0 0
GO:0030286 0 0 -9999 0 -10000 0 0
ABL1 -0.4 0.18 -9999 0 -0.47 197 197
IQGAP1/CaM 0.019 0 -9999 0 -10000 0 0
DAB1 -0.042 0.18 -9999 0 -0.7 17 17
IQGAP1 0.012 0 -9999 0 -10000 0 0
PLA2G7 0.012 0 -9999 0 -10000 0 0
CALM1 0.012 0 -9999 0 -10000 0 0
DYNLT1 0.012 0 -9999 0 -10000 0 0
mol:Ca2+ 0 0 -9999 0 -10000 0 0
LRPAP1/LRP8 -0.44 0.19 -9999 0 -0.52 197 197
UniProt:Q4QZ09 0 0 -9999 0 -10000 0 0
CLIP1 0.012 0 -9999 0 -10000 0 0
CDK5R1 0.006 0.066 -9999 0 -0.7 2 2
LIS1/Poliovirus Protein 3A 0.014 0 -9999 0 -10000 0 0
CDK5R2 -0.034 0.13 -9999 0 -0.36 28 28
mol:PP1 0 0 -9999 0 -10000 0 0
RELN/VLDLR/DAB1 -0.11 0.16 -9999 0 -0.43 31 31
YWHAE 0.012 0 -9999 0 -10000 0 0
NDEL1/14-3-3 E -0.32 0.15 -9999 0 -0.44 112 112
MAP1B -0.006 0.034 -9999 0 -0.22 6 6
RAC1 0.018 0 -9999 0 -10000 0 0
p35/CDK5 -0.36 0.16 -9999 0 -0.41 198 198
RELN -0.14 0.16 -9999 0 -0.3 111 111
PAFAH/LIS1 0.023 0 -9999 0 -10000 0 0
LIS1/CLIP170 0.023 0 -9999 0 -10000 0 0
LIS1/NDEL1/Katanin 60/Dynein Light chain/Dynein heavy chain -0.26 0.11 -9999 0 -0.4 24 24
RELN/VLDLR/DAB1/LIS1/PAFAH1B2/PAFAH1B3 -0.088 0.14 -9999 0 -0.42 22 22
GO:0005869 0 0 -9999 0 -10000 0 0
NDEL1 -0.35 0.16 -9999 0 -0.4 197 197
LIS1/IQGAP1 0.023 0 -9999 0 -10000 0 0
RHOA 0.018 0 -9999 0 -10000 0 0
PAFAH1B1 0.019 0 -9999 0 -10000 0 0
PAFAH1B3 0.009 0.046 -9999 0 -0.7 1 1
PAFAH1B2 0.012 0 -9999 0 -10000 0 0
MAP1B/LIS1/Dynein heavy chain 0.019 0.023 -9999 0 -10000 0 0
NDEL1/Katanin 60/Dynein heavy chain -0.31 0.15 -9999 0 -0.42 112 112
LRP8 -0.59 0.25 -9999 0 -0.7 197 197
NDEL1/Katanin 60 -0.32 0.15 -9999 0 -0.44 112 112
P39/CDK5 -0.37 0.17 -9999 0 -0.43 198 198
LIS1/NudC/Dynein intermediate chain/microtubule organizing center 0.023 0 -9999 0 -10000 0 0
CDK5 -0.38 0.16 -9999 0 -0.44 197 197
PPP2R5D 0.012 0 -9999 0 -10000 0 0
LIS1/CLIP170/Dynein Complex/Dynactin Complex 0.02 0 -9999 0 -10000 0 0
CSNK2A1 0.012 0 -9999 0 -10000 0 0
RELN/VLDLR/DAB1/LIS1 -0.078 0.14 -9999 0 -0.45 17 17
RELN/VLDLR -0.41 0.19 -9999 0 -0.48 197 197
CDC42 0.018 0 -9999 0 -10000 0 0
IL23-mediated signaling events

Figure S6.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S6.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CCL2 -0.44 0.4 -10000 0 -0.98 58 58
IL23A -0.58 0.48 -10000 0 -1.1 73 73
NF kappa B1 p50/RelA/I kappa B alpha -0.51 0.4 -10000 0 -1 70 70
positive regulation of T cell mediated cytotoxicity -0.49 0.45 -10000 0 -1.1 62 62
ITGA3 -0.47 0.41 -10000 0 -1 60 60
IL17F -0.36 0.31 -10000 0 -0.74 61 61
IL12B -0.016 0.053 -10000 0 -0.72 1 1
STAT1 (dimer) -0.48 0.44 -10000 0 -1 63 63
CD4 -0.44 0.4 -10000 0 -0.97 58 58
IL23 -0.56 0.45 -10000 0 -1.1 72 72
IL23R -0.08 0.16 -10000 0 -1.3 3 3
IL1B -0.55 0.47 -10000 0 -1.1 76 76
T-helper cell lineage commitment 0 0 -10000 0 -10000 0 0
IL24 -0.54 0.46 -10000 0 -1.1 79 79
TYK2 -0.008 0.018 -10000 0 -10000 0 0
STAT4 0.011 0.021 -10000 0 -0.3 1 1
STAT3 0.012 0.002 -10000 0 -10000 0 0
IL18RAP -0.002 0.063 -10000 0 -0.3 10 10
IL12RB1 -0.022 0.085 -10000 0 -0.43 8 8
PIK3CA 0.012 0.002 -10000 0 -10000 0 0
IL12Rbeta1/TYK2 -0.019 0.065 -10000 0 -0.57 2 2
IL23R/JAK2 -0.089 0.16 -10000 0 -1.2 3 3
positive regulation of chronic inflammatory response -0.49 0.45 -10000 0 -1.1 62 62
natural killer cell activation 0.007 0.01 0.075 3 -10000 0 3
JAK2 -0.008 0.026 -10000 0 -10000 0 0
PIK3R1 0.012 0.002 -10000 0 -10000 0 0
NFKB1 0.008 0.003 -10000 0 -10000 0 0
RELA 0.008 0.003 -10000 0 -10000 0 0
positive regulation of dendritic cell antigen processing and presentation -0.53 0.43 -10000 0 -1 72 72
ALOX12B -0.44 0.4 -10000 0 -0.96 57 57
CXCL1 -0.55 0.46 -10000 0 -1 89 89
T cell proliferation -0.49 0.45 -10000 0 -1.1 62 62
NFKBIA 0.008 0.003 -10000 0 -10000 0 0
IL17A -0.34 0.27 -10000 0 -0.63 75 75
PI3K -0.49 0.4 -10000 0 -1 62 62
IFNG -0.021 0.033 0.14 1 -0.099 1 2
STAT3 (dimer) -0.49 0.4 -10000 0 -1 67 67
IL18R1 0.009 0.029 -10000 0 -0.3 2 2
IL23/IL23R/JAK2/TYK2/SOCS3 -0.26 0.23 -10000 0 -0.66 10 10
IL18/IL18R 0.018 0.043 -10000 0 -10000 0 0
macrophage activation -0.03 0.016 -10000 0 -0.044 78 78
TNF -0.52 0.44 -10000 0 -1 69 69
STAT3/STAT4 -0.48 0.4 -10000 0 -1 63 63
STAT4 (dimer) -0.47 0.44 -10000 0 -1 60 60
IL18 0.012 0.006 -10000 0 -10000 0 0
IL19 -0.44 0.4 -10000 0 -0.98 57 57
STAT5A (dimer) -0.47 0.44 -10000 0 -1 60 60
STAT1 0 0.092 -10000 0 -0.7 4 4
SOCS3 0.012 0 -10000 0 -10000 0 0
CXCL9 -0.51 0.44 -10000 0 -1 73 73
MPO -0.45 0.4 -10000 0 -0.97 61 61
positive regulation of humoral immune response -0.49 0.45 -10000 0 -1.1 62 62
IL23/IL23R/JAK2/TYK2 -0.51 0.48 -10000 0 -1.1 62 62
IL6 -0.49 0.44 -10000 0 -1.1 60 60
STAT5A 0.012 0 -10000 0 -10000 0 0
IL2 0.008 0.01 -10000 0 -10000 0 0
positive regulation of tyrosine phosphorylation of STAT protein 0.007 0.01 0.075 3 -10000 0 3
CD3E -0.46 0.43 -10000 0 -1 58 58
keratinocyte proliferation -0.49 0.45 -10000 0 -1.1 62 62
NOS2 -0.47 0.44 -10000 0 -1.1 65 65
IL4-mediated signaling events

Figure S7.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S7.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 -0.57 0.45 -10000 0 -1.1 62 62
STAT6 (cleaved dimer) -0.62 0.46 -10000 0 -1.1 89 89
IGHG1 -0.2 0.14 -10000 0 -0.55 1 1
IGHG3 -0.55 0.43 -10000 0 -1 78 78
AKT1 -0.29 0.24 -10000 0 -0.65 31 31
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHP1 -0.22 0.19 -10000 0 -0.53 25 25
IL4/IL4R/JAK1/IL2R gamma/JAK3/IRS1 -0.28 0.22 -10000 0 -0.62 16 16
THY1 -0.57 0.45 -10000 0 -1.1 61 61
MYB 0.012 0 -10000 0 -10000 0 0
HMGA1 0.003 0.08 -10000 0 -0.7 3 3
IL4/IL4R/JAK1/IL2R gamma/JAK3 -0.39 0.3 -10000 0 -0.79 57 57
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHIP -0.28 0.22 -10000 0 -0.61 19 19
SP1 0.015 0.015 -10000 0 -10000 0 0
INPP5D 0.012 0 -10000 0 -10000 0 0
SOCS5 0.034 0.017 -10000 0 -10000 0 0
STAT6 (dimer)/ETS1 -0.59 0.47 -10000 0 -1.1 81 81
SOCS1 -0.38 0.29 -10000 0 -0.75 47 47
SOCS3 -0.32 0.26 -10000 0 -0.72 32 32
FCER2 -0.72 0.57 -10000 0 -1.3 105 105
PARP14 0.008 0.011 -10000 0 -10000 0 0
CCL17 -0.58 0.46 -10000 0 -1.2 63 63
GRB2 0.012 0 -10000 0 -10000 0 0
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHC/SHIP -0.22 0.17 -10000 0 -0.6 3 3
T cell proliferation -0.57 0.47 -10000 0 -1.2 66 66
IL4R/JAK1 -0.57 0.45 -10000 0 -1.1 66 66
EGR2 -0.62 0.48 -10000 0 -1.2 73 73
JAK2 -0.022 0.025 -10000 0 -10000 0 0
JAK3 0 0.093 -10000 0 -0.7 4 4
PIK3R1 0.012 0 -10000 0 -10000 0 0
JAK1 0.003 0.009 -10000 0 -10000 0 0
COL1A2 -0.22 0.21 -10000 0 -0.75 21 21
CCL26 -0.63 0.47 -10000 0 -1.2 69 69
IL4R -0.61 0.48 -10000 0 -1.2 64 64
PTPN6 0.027 0.009 -10000 0 -10000 0 0
IL13RA2 -0.6 0.46 -10000 0 -1.2 66 66
IL13RA1 -0.022 0.025 -10000 0 -10000 0 0
IRF4 -0.41 0.57 -10000 0 -1.4 59 59
ARG1 -0.14 0.12 -10000 0 -0.59 2 2
CBL -0.36 0.29 -10000 0 -0.76 53 53
GTF3A -0.032 0.15 -10000 0 -0.72 10 10
PIK3CA 0.012 0 -10000 0 -10000 0 0
IL13RA1/JAK2 -0.029 0.034 -10000 0 -10000 0 0
IRF4/BCL6 -0.36 0.53 -10000 0 -1.2 59 59
CD40LG -0.017 0.093 -10000 0 -0.34 15 15
MAPK14 -0.36 0.29 -10000 0 -0.76 51 51
mitosis -0.28 0.23 -10000 0 -0.62 31 31
STAT6 -0.65 0.53 -10000 0 -1.3 74 74
SPI1 0.013 0.029 -10000 0 -0.3 2 2
RPS6KB1 -0.26 0.22 -10000 0 -0.6 26 26
STAT6 (dimer) -0.65 0.53 -10000 0 -1.3 74 74
STAT6 (dimer)/PARP14 -0.63 0.5 -10000 0 -1.2 76 76
mast cell activation 0.015 0.01 -10000 0 -10000 0 0
IL4/IL4R/JAK1/IL2R gamma/JAK3/DOK2 -0.28 0.22 -10000 0 -0.62 28 28
FRAP1 -0.29 0.24 -10000 0 -0.65 31 31
LTA -0.57 0.46 -10000 0 -1.2 61 61
FES 0.011 0.021 -10000 0 -0.3 1 1
T-helper 1 cell differentiation 0.63 0.51 1.2 74 -10000 0 74
CCL11 -0.62 0.51 -10000 0 -1.2 75 75
IL4/IL4R/JAK1/IL2R gamma/JAK3/FES -0.28 0.22 -10000 0 -0.62 29 29
IL2RG 0.011 0.023 -10000 0 -0.3 1 1
IL10 -0.6 0.48 -10000 0 -1.2 70 70
IRS1 0.012 0 -10000 0 -10000 0 0
IRS2 0.009 0.046 -10000 0 -0.7 1 1
IL4 -0.14 0.1 -10000 0 -10000 0 0
IL5 -0.57 0.45 -10000 0 -1.1 61 61
IL4/IL4R/JAK1/IL13RA1/JAK2 -0.46 0.34 -10000 0 -0.86 61 61
COL1A1 -0.37 0.29 -10000 0 -0.75 70 70
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
IL4/IL4R/JAK1 -0.57 0.46 -10000 0 -1.2 61 61
IL2R gamma/JAK3 0.003 0.073 -10000 0 -0.52 4 4
TFF3 -0.58 0.46 -10000 0 -1.2 63 63
ALOX15 -0.6 0.48 -10000 0 -1.2 64 64
MYBL1 0.009 0.046 -10000 0 -0.7 1 1
T-helper 2 cell differentiation -0.49 0.36 -10000 0 -0.91 66 66
SHC1 0.012 0 -10000 0 -10000 0 0
CEBPB 0.012 0.047 -10000 0 -0.7 1 1
IL4/IL4R/JAK1/IL2R gamma/JAK3/FES/IRS2 -0.27 0.21 -10000 0 -0.62 13 13
mol:PI-3-4-5-P3 -0.29 0.24 -10000 0 -0.65 31 31
PI3K -0.3 0.25 -10000 0 -0.69 31 31
DOK2 0.012 0 -10000 0 -10000 0 0
ETS1 0.028 0.011 -10000 0 -10000 0 0
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHC/SHIP/GRB2 -0.21 0.16 -10000 0 -0.58 3 3
ITGB3 -0.58 0.46 -10000 0 -1.2 62 62
PIGR -0.72 0.59 -10000 0 -1.3 93 93
IGHE 0.049 0.035 -10000 0 -10000 0 0
MAPKKK cascade -0.2 0.16 -10000 0 -0.57 3 3
BCL6 0.016 0.008 -10000 0 -10000 0 0
OPRM1 -0.57 0.45 -10000 0 -1.1 61 61
RETNLB -0.8 0.61 -10000 0 -1.4 111 111
SELP -0.67 0.55 -10000 0 -1.3 77 77
AICDA -0.56 0.44 -10000 0 -1.1 61 61
Glypican 1 network

Figure S8.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S8.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GPC1/FGF2 dimer/FGFR1 dimer 0.002 0.073 -10000 0 -0.38 4 4
fibroblast growth factor receptor signaling pathway 0.002 0.072 -10000 0 -0.38 4 4
LAMA1 -0.048 0.12 -10000 0 -0.3 45 45
PRNP 0.011 0.021 -10000 0 -0.3 1 1
GPC1/SLIT2 -0.051 0.11 -10000 0 -0.6 2 2
SMAD2 0.023 0.04 -10000 0 -0.4 2 2
GPC1/PrPc/Cu2+ 0.012 0.045 -10000 0 -0.45 2 2
GPC1/Laminin alpha1 -0.027 0.1 -10000 0 -0.6 2 2
TDGF1 -0.36 0.35 -10000 0 -0.68 124 124
CRIPTO/GPC1 -0.27 0.27 -10000 0 -0.53 118 118
APP/GPC1 0.014 0.05 -10000 0 -0.52 2 2
mol:NO 0 0 -10000 0 -10000 0 0
YES1 -0.22 0.24 -10000 0 -0.45 118 118
FLT1 0.012 0 -10000 0 -10000 0 0
GPC1/TGFB/TGFBR1/TGFBR2 0.021 0.044 -10000 0 -0.45 2 2
SERPINC1 0.005 0.047 -10000 0 -0.7 1 1
FYN -0.22 0.24 -10000 0 -0.45 118 118
FGR -0.23 0.24 -10000 0 -0.45 119 119
positive regulation of MAPKKK cascade -0.19 0.18 -10000 0 -0.35 125 125
SLIT2 -0.082 0.14 -10000 0 -0.3 70 70
GPC1/NRG -0.016 0.088 -10000 0 -0.52 2 2
NRG1 -0.031 0.11 -10000 0 -0.3 32 32
GPC1/VEGF165 homodimer/VEGFR1 homodimer -0.009 0.12 -10000 0 -0.45 17 17
LYN -0.22 0.24 -10000 0 -0.45 118 118
mol:Spermine 0.005 0.05 -10000 0 -0.53 2 2
cell growth 0.002 0.072 -10000 0 -0.38 4 4
BMP signaling pathway -0.006 0.065 0.7 2 -10000 0 2
SRC -0.22 0.24 -10000 0 -0.45 118 118
TGFBR1 0.012 0 -10000 0 -10000 0 0
mol:Cu2+ 0 0 -10000 0 -10000 0 0
PLA2G2A -0.087 0.16 -10000 0 -0.33 67 67
GPC1 0.006 0.066 -10000 0 -0.7 2 2
TGFBR1 (dimer) 0.012 0 -10000 0 -10000 0 0
VEGFA -0.033 0.17 -10000 0 -0.7 15 15
BLK -0.26 0.27 -10000 0 -0.52 119 119
HCK -0.22 0.24 -10000 0 -0.45 118 118
FGF2 -0.016 0.09 -10000 0 -0.3 21 21
FGFR1 0.007 0.041 -10000 0 -0.3 4 4
VEGFR1 homodimer 0.012 0 -10000 0 -10000 0 0
TGFBR2 0.012 0 -10000 0 -10000 0 0
cell death 0.014 0.05 -10000 0 -0.52 2 2
ATIII/GPC1 0.008 0.061 -10000 0 -0.52 3 3
PLA2G2A/GPC1 -0.055 0.13 -10000 0 -0.57 7 7
LCK -0.24 0.24 -10000 0 -0.45 126 126
neuron differentiation -0.016 0.087 -10000 0 -0.52 2 2
PrPc/Cu2+ 0.008 0.014 -10000 0 -0.2 1 1
APP 0.012 0 -10000 0 -10000 0 0
TGFBR2 (dimer) 0.012 0 -10000 0 -10000 0 0
FOXA2 and FOXA3 transcription factor networks

Figure S9.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S9.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ACADVL -0.42 0.32 -9999 0 -0.93 43 43
PCK1 -0.57 0.54 -9999 0 -1.2 87 87
HNF4A -0.47 0.36 -9999 0 -1 49 49
KCNJ11 -0.43 0.32 -9999 0 -0.95 44 44
AKT1 -0.2 0.12 -9999 0 -10000 0 0
response to starvation -0.012 0.022 -9999 0 -10000 0 0
DLK1 -0.44 0.32 -9999 0 -0.96 42 42
NKX2-1 -0.26 0.21 -9999 0 -0.73 26 26
ACADM -0.42 0.32 -9999 0 -0.93 43 43
TAT -0.46 0.48 -9999 0 -1.2 62 62
CEBPB -0.001 0.052 -9999 0 -0.7 1 1
CEBPA 0.002 0.036 -9999 0 -0.3 2 2
TTR -0.35 0.41 -9999 0 -1.1 51 51
PKLR -0.49 0.39 -9999 0 -1 64 64
APOA1 -0.49 0.36 -9999 0 -1.1 40 40
CPT1C -0.42 0.32 -9999 0 -0.94 41 41
ALAS1 -0.2 0.12 -9999 0 -10000 0 0
TFRC -0.32 0.21 -9999 0 -0.74 15 15
FOXF1 0.018 0.064 -9999 0 -0.3 6 6
NF1 0.018 0 -9999 0 -10000 0 0
HNF1A (dimer) -0.091 0.045 -9999 0 -0.25 1 1
CPT1A -0.42 0.32 -9999 0 -0.94 41 41
HMGCS1 -0.42 0.32 -9999 0 -0.94 42 42
NR3C1 -0.037 0.091 -9999 0 -0.31 11 11
CPT1B -0.42 0.32 -9999 0 -0.93 43 43
chromatin remodeling 0 0 -9999 0 -10000 0 0
SP1 -0.081 0.034 -9999 0 -10000 0 0
GCK -0.42 0.32 -9999 0 -0.96 41 41
CREB1 -0.041 0.072 -9999 0 -10000 0 0
IGFBP1 -0.27 0.23 -9999 0 -0.72 35 35
PDX1 -0.62 0.2 -9999 0 -0.72 160 160
UCP2 -0.42 0.32 -9999 0 -0.94 41 41
ALDOB -0.52 0.38 -9999 0 -1 65 65
AFP -0.043 0.095 -9999 0 -0.51 2 2
BDH1 -0.42 0.32 -9999 0 -0.94 42 42
HADH -0.42 0.32 -9999 0 -0.96 39 39
F2 -0.54 0.4 -9999 0 -1.1 57 57
HNF1A -0.091 0.045 -9999 0 -0.25 1 1
G6PC -0.19 0.33 -9999 0 -1.1 24 24
SLC2A2 -0.34 0.21 -9999 0 -0.95 13 13
INS 0.004 0.035 -9999 0 -10000 0 0
FOXA1 -0.001 0.089 -9999 0 -0.3 14 14
FOXA3 -0.077 0.11 -9999 0 -0.32 16 16
FOXA2 -0.5 0.35 -9999 0 -1 46 46
ABCC8 -0.5 0.38 -9999 0 -0.99 65 65
ALB -0.056 0.13 -9999 0 -0.47 14 14
Signaling events mediated by the Hedgehog family

Figure S10.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S10.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB2 0.021 0.14 -10000 0 -0.62 9 9
IHH 0.015 0.046 -10000 0 -0.42 2 2
SHH Np/Cholesterol/GAS1 -0.17 0.22 -10000 0 -0.43 95 95
LRPAP1 0.012 0 -10000 0 -10000 0 0
dorsoventral neural tube patterning 0.17 0.22 0.42 95 -10000 0 95
SMO/beta Arrestin2 -0.004 0.086 -10000 0 -0.47 2 2
SMO -0.01 0.09 -10000 0 -0.5 2 2
AKT1 0.014 0.045 -10000 0 -10000 0 0
ARRB2 0.012 0 -10000 0 -10000 0 0
BOC -0.028 0.1 -10000 0 -0.3 30 30
ADRBK1 0.012 0 -10000 0 -10000 0 0
heart looping -0.01 0.089 -10000 0 -0.49 2 2
STIL -0.12 0.19 -10000 0 -0.34 93 93
DHH N/PTCH2 0.004 0.06 -10000 0 -0.52 1 1
DHH N/PTCH1 0.018 0.077 -10000 0 -0.42 2 2
PIK3CA 0.012 0 -10000 0 -10000 0 0
DHH -0.006 0.072 -10000 0 -0.3 13 13
PTHLH 0.022 0.14 -10000 0 -0.58 9 9
determination of left/right symmetry -0.01 0.089 -10000 0 -0.49 2 2
PIK3R1 0.012 0 -10000 0 -10000 0 0
skeletal system development 0.022 0.14 -10000 0 -0.58 9 9
IHH N/Hhip -0.028 0.1 -10000 0 -0.34 5 5
DHH N/Hhip -0.033 0.098 -10000 0 -0.38 4 4
mol:Cholesterol 0 0 -10000 0 -10000 0 0
heart development -0.01 0.089 -10000 0 -0.49 2 2
pancreas development -0.046 0.12 -10000 0 -0.3 43 43
HHAT 0.011 0.021 -10000 0 -0.3 1 1
PI3K 0.019 0 -10000 0 -10000 0 0
EntrezGene:84976 0 0 -10000 0 -10000 0 0
GAS1 -0.031 0.13 -10000 0 -0.36 27 27
somite specification -0.01 0.089 -10000 0 -0.49 2 2
SHH Np/Cholesterol/PTCH1 -0.13 0.2 -10000 0 -0.37 92 92
SHH Np/Cholesterol/PTCH2 -0.15 0.21 -10000 0 -0.41 92 92
SHH Np/Cholesterol/Megalin -0.18 0.23 -10000 0 -0.43 101 101
SHH -0.2 0.26 -10000 0 -0.52 91 91
catabolic process 0.024 0.078 -10000 0 -0.48 2 2
SMO/Vitamin D3 -0.11 0.19 -10000 0 -0.33 93 93
SHH Np/Cholesterol/Hhip -0.18 0.22 -10000 0 -0.43 91 91
LRP2 -0.041 0.18 -10000 0 -0.7 16 16
receptor-mediated endocytosis -0.11 0.19 -10000 0 -0.53 10 10
SHH Np/Cholesterol/BOC -0.17 0.21 -10000 0 -0.42 92 92
SHH Np/Cholesterol/CDO -0.15 0.21 -10000 0 -0.41 91 91
mesenchymal cell differentiation 0.18 0.21 0.43 91 -10000 0 91
mol:Vitamin D3 -0.12 0.2 -10000 0 -0.36 92 92
IHH N/PTCH2 0.014 0.055 -10000 0 -0.43 2 2
CDON 0.012 0 -10000 0 -10000 0 0
IHH N/PTCH1 0.026 0.079 -10000 0 -0.48 2 2
Megalin/LRPAP1 -0.022 0.14 -10000 0 -0.52 16 16
PTCH2 0.009 0.046 -10000 0 -0.7 1 1
SHH Np/Cholesterol -0.16 0.21 -10000 0 -0.42 91 91
PTCH1 0.024 0.078 -10000 0 -0.48 2 2
HHIP -0.046 0.12 -10000 0 -0.3 43 43
Caspase cascade in apoptosis

Figure S11.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S11.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TOP1 -0.067 0.14 -10000 0 -0.26 74 74
ACTA1 -0.095 0.17 -10000 0 -0.33 74 74
NUMA1 -0.067 0.14 -10000 0 -0.26 74 74
SPTAN1 -0.093 0.17 -10000 0 -0.33 74 74
LIMK1 -0.093 0.17 -10000 0 -0.33 74 74
BIRC3 0.008 0.051 -10000 0 -0.5 2 2
BIRC2 0.012 0 -10000 0 -10000 0 0
BAX 0.012 0 -10000 0 -10000 0 0
CASP10 -0.13 0.23 -10000 0 -0.46 75 75
CRMA 0 0 -10000 0 -10000 0 0
XIAP 0.012 0 -10000 0 -10000 0 0
PTK2 -0.067 0.14 -10000 0 -0.26 74 74
DIABLO 0.012 0 -10000 0 -10000 0 0
apoptotic nuclear changes -0.092 0.16 -10000 0 -0.32 74 74
response to UV 0 0 -10000 0 -10000 0 0
CRADD 0.012 0 -10000 0 -10000 0 0
GSN -0.095 0.17 -10000 0 -0.33 74 74
MADD 0.012 0 -10000 0 -10000 0 0
TFAP2A -0.08 0.095 -10000 0 -0.26 4 4
BID -0.053 0.11 -10000 0 -0.21 75 75
MAP3K1 -0.03 0.064 -10000 0 -10000 0 0
TRADD 0.012 0 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
APAF-1/Pro-Caspase 9 0.019 0.001 -10000 0 -10000 0 0
mol:Activated DNA 0 0 -10000 0 -10000 0 0
ARHGDIB -0.093 0.17 -10000 0 -0.33 74 74
CASP9 0.013 0.001 -10000 0 -10000 0 0
DNA repair 0.024 0.048 -10000 0 -0.14 1 1
neuron apoptosis 0.009 0.021 -10000 0 -10000 0 0
mol:NAD 0 0 -10000 0 -10000 0 0
DNA fragmentation during apoptosis -0.082 0.16 -10000 0 -0.31 74 74
APAF1 0.013 0 -10000 0 -10000 0 0
CASP6 -0.023 0.082 -10000 0 -10000 0 0
TRAF2 0.012 0 -10000 0 -10000 0 0
ICAD/CAD -0.085 0.16 -10000 0 -0.31 74 74
CASP7 0.004 0.029 0.24 2 -10000 0 2
KRT18 0 0.033 -10000 0 -0.23 2 2
apoptosis -0.074 0.15 -10000 0 -0.51 3 3
DFFA -0.093 0.17 -10000 0 -0.33 74 74
DFFB -0.093 0.17 -10000 0 -0.33 74 74
PARP1 -0.024 0.048 0.14 1 -10000 0 1
actin filament polymerization 0.092 0.16 0.32 75 -10000 0 75
TNF 0.009 0.046 -10000 0 -0.7 1 1
CYCS -0.041 0.086 -10000 0 -0.16 74 74
SATB1 -0.019 0.08 -10000 0 -10000 0 0
SLK -0.093 0.17 -10000 0 -0.33 74 74
p15 BID/BAX -0.043 0.097 -10000 0 -0.3 4 4
CASP2 0.039 0.018 -10000 0 -10000 0 0
JNK cascade 0.03 0.063 -10000 0 -10000 0 0
CASP3 -0.1 0.18 -10000 0 -0.35 74 74
LMNB2 0.021 0.032 -10000 0 -10000 0 0
RIPK1 0.012 0 -10000 0 -10000 0 0
CASP4 0.012 0 -10000 0 -10000 0 0
Mammalian IAPs/DIABLO 0.029 0.03 -10000 0 -0.4 1 1
negative regulation of DNA binding -0.08 0.094 -10000 0 -0.26 4 4
stress fiber formation -0.092 0.16 -10000 0 -0.32 74 74
GZMB -0.16 0.26 -10000 0 -0.54 75 75
CASP1 0.014 0 -10000 0 -10000 0 0
LMNB1 0.021 0.032 -10000 0 -10000 0 0
APP 0.009 0.021 -10000 0 -10000 0 0
TNFRSF1A 0.012 0 -10000 0 -10000 0 0
response to stress 0 0 -10000 0 -10000 0 0
CASP8 0.009 0 -10000 0 -10000 0 0
VIM -0.077 0.15 -10000 0 -0.29 74 74
LMNA 0.021 0.032 -10000 0 -10000 0 0
TNF-alpha/TNFR1A/TRADD/MADD/cIAP2/RIP1/TRAF2/RAIDD/PIDD 0.036 0.019 -10000 0 -10000 0 0
LRDD 0.012 0 -10000 0 -10000 0 0
SREBF1 -0.093 0.17 -10000 0 -0.33 74 74
APAF-1/Caspase 9 -0.019 0.03 -10000 0 -10000 0 0
nuclear fragmentation during apoptosis -0.066 0.14 -10000 0 -0.26 74 74
CFL2 -0.095 0.17 -10000 0 -0.32 75 75
GAS2 -0.18 0.25 -10000 0 -0.44 97 97
positive regulation of apoptosis 0.026 0.03 -10000 0 -10000 0 0
PRF1 0.002 0.074 -10000 0 -0.46 5 5
Syndecan-4-mediated signaling events

Figure S12.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S12.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 -0.036 0.11 -9999 0 -0.35 25 25
Syndecan-4/Syndesmos -0.14 0.2 -9999 0 -0.51 31 31
positive regulation of JNK cascade -0.15 0.18 -9999 0 -0.44 44 44
Syndecan-4/ADAM12 -0.4 0.27 -9999 0 -0.61 116 116
CCL5 -0.003 0.076 -9999 0 -0.34 10 10
Rac1/GDP 0.009 0 -9999 0 -10000 0 0
DNM2 0.012 0 -9999 0 -10000 0 0
ITGA5 0.012 0 -9999 0 -10000 0 0
SDCBP 0.012 0 -9999 0 -10000 0 0
PLG 0.003 0.047 -9999 0 -0.69 1 1
ADAM12 -0.51 0.31 -9999 0 -0.7 170 170
mol:GTP 0 0 -9999 0 -10000 0 0
NUDT16L1 0.012 0 -9999 0 -10000 0 0
mol:PI-4-5-P2 0 0 -9999 0 -10000 0 0
Syndecan-4/PKC alpha -0.062 0.064 -9999 0 -0.18 2 2
Syndecan-4/Laminin alpha1 -0.15 0.2 -9999 0 -0.47 48 48
Syndecan-4/CXCL12/CXCR4 -0.16 0.2 -9999 0 -0.47 44 44
Syndecan-4/Laminin alpha3 -0.14 0.2 -9999 0 -0.51 33 33
MDK 0 0.092 -9999 0 -0.7 4 4
Syndecan-4/FZD7 -0.14 0.2 -9999 0 -0.51 31 31
Syndecan-4/Midkine -0.14 0.21 -9999 0 -0.53 33 33
FZD7 0.012 0 -9999 0 -10000 0 0
Syndecan-4/FGFR1/FGF -0.14 0.19 -9999 0 -0.48 31 31
THBS1 0.009 0.046 -9999 0 -0.7 1 1
integrin-mediated signaling pathway -0.14 0.21 -9999 0 -0.53 34 34
positive regulation of MAPKKK cascade -0.15 0.18 -9999 0 -0.44 44 44
Syndecan-4/TACI -0.18 0.22 -9999 0 -0.46 66 66
CXCR4 -0.009 0.12 -9999 0 -0.7 7 7
cell adhesion -0.001 0.082 -9999 0 -0.24 21 21
Syndecan-4/Dynamin -0.14 0.2 -9999 0 -0.51 31 31
Syndecan-4/TSP1 -0.14 0.2 -9999 0 -0.52 31 31
Syndecan-4/GIPC -0.14 0.2 -9999 0 -0.51 31 31
Syndecan-4/RANTES -0.14 0.2 -9999 0 -0.5 36 36
ITGB1 0.012 0 -9999 0 -10000 0 0
LAMA1 -0.048 0.12 -9999 0 -0.3 45 45
LAMA3 0.005 0.069 -9999 0 -0.56 3 3
RAC1 0.012 0 -9999 0 -10000 0 0
PRKCA 0.041 0.044 -9999 0 -10000 0 0
Syndecan-4/alpha-Actinin -0.14 0.2 -9999 0 -0.51 31 31
TFPI 0.009 0.046 -9999 0 -0.7 1 1
F2 -0.21 0.33 -9999 0 -0.7 71 71
alpha5/beta1 Integrin 0.019 0 -9999 0 -10000 0 0
positive regulation of cell adhesion -0.15 0.2 -9999 0 -0.46 48 48
ACTN1 0.012 0 -9999 0 -10000 0 0
TNC -0.013 0.12 -9999 0 -0.52 11 11
Syndecan-4/CXCL12 -0.15 0.2 -9999 0 -0.48 42 42
FGF6 0 0.002 -9999 0 -10000 0 0
RHOA 0.012 0 -9999 0 -10000 0 0
CXCL12 -0.035 0.11 -9999 0 -0.3 35 35
TNFRSF13B -0.12 0.15 -9999 0 -0.3 97 97
FGF2 -0.016 0.09 -9999 0 -0.3 21 21
FGFR1 0.007 0.041 -9999 0 -0.3 4 4
Syndecan-4/PI-4-5-P2 -0.14 0.19 -9999 0 -0.52 31 31
mol:GDP 0 0 -9999 0 -10000 0 0
FN1 -0.052 0.21 -9999 0 -0.63 25 25
cell migration -0.023 0.023 -9999 0 -10000 0 0
PRKCD 0.018 0.01 -9999 0 -10000 0 0
vasculogenesis -0.14 0.19 -9999 0 -0.5 31 31
SDC4 -0.15 0.2 -9999 0 -0.54 31 31
Syndecan-4/Tenascin C -0.15 0.22 -9999 0 -0.55 34 34
Syndecan-4/PI-4-5-P2/PKC alpha -0.049 0.05 -9999 0 -10000 0 0
Syndecan-4/Syntenin -0.14 0.2 -9999 0 -0.51 31 31
MMP9 -0.15 0.3 -9999 0 -0.7 53 53
Rac1/GTP -0.001 0.083 -9999 0 -0.25 21 21
cytoskeleton organization -0.13 0.19 -9999 0 -0.49 31 31
GIPC1 0.012 0 -9999 0 -10000 0 0
Syndecan-4/TFPI -0.14 0.2 -9999 0 -0.52 31 31
BCR signaling pathway

Figure S13.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S13.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
JUN -0.063 0.17 -9999 0 -0.42 33 33
IKBKB -0.031 0.087 -9999 0 -0.24 13 13
AKT1 -0.048 0.11 -9999 0 -0.24 36 36
IKBKG -0.032 0.093 -9999 0 -0.26 15 15
CALM1 -0.078 0.18 -9999 0 -0.43 39 39
PIK3CA 0.012 0 -9999 0 -10000 0 0
MAP3K1 -0.11 0.24 -9999 0 -0.59 39 39
MAP3K7 0.012 0 -9999 0 -10000 0 0
mol:Ca2+ -0.088 0.19 -9999 0 -0.46 40 40
DOK1 0.012 0 -9999 0 -10000 0 0
AP-1 -0.028 0.099 -9999 0 -0.24 32 32
LYN 0.012 0 -9999 0 -10000 0 0
BLNK 0.01 0.029 -9999 0 -0.3 2 2
SHC1 0.012 0 -9999 0 -10000 0 0
BCR complex -0.071 0.14 -9999 0 -0.38 30 30
CD22 -0.13 0.27 -9999 0 -0.56 54 54
CAMK2G -0.067 0.16 -9999 0 -0.41 36 36
CSNK2A1 0.012 0 -9999 0 -10000 0 0
INPP5D 0.012 0 -9999 0 -10000 0 0
SHC/GRB2/SOS1 -0.045 0.078 -9999 0 -10000 0 0
GO:0007205 -0.09 0.19 -9999 0 -0.46 40 40
SYK 0.012 0 -9999 0 -10000 0 0
ELK1 -0.079 0.18 -9999 0 -0.44 39 39
NFATC1 -0.099 0.2 -9999 0 -0.5 40 40
B-cell antigen/BCR complex -0.071 0.14 -9999 0 -0.38 30 30
PAG1/CSK 0.018 0 -9999 0 -10000 0 0
NFKBIB -0.002 0.031 -9999 0 -10000 0 0
HRAS -0.062 0.15 -9999 0 -0.39 32 32
NFKBIA -0.001 0.03 -9999 0 -10000 0 0
NF-kappa-B/RelA/I kappa B beta 0.005 0.025 -9999 0 -10000 0 0
RasGAP/Csk -0.047 0.13 -9999 0 -0.39 13 13
mol:GDP -0.085 0.18 -9999 0 -0.44 40 40
PTEN 0.011 0.021 -9999 0 -0.3 1 1
CD79B -0.031 0.11 -9999 0 -0.31 31 31
NF-kappa-B/RelA/I kappa B alpha 0.005 0.025 -9999 0 -10000 0 0
GRB2 0.012 0 -9999 0 -10000 0 0
PI3K/BCAP/CD19 -0.13 0.24 -9999 0 -0.51 58 58
PIK3R1 0.012 0 -9999 0 -10000 0 0
mol:IP3 -0.09 0.19 -9999 0 -0.47 40 40
CSK 0.012 0 -9999 0 -10000 0 0
FOS -0.07 0.17 -9999 0 -0.42 35 35
CHUK -0.032 0.093 -9999 0 -0.26 15 15
IBTK 0.012 0 -9999 0 -10000 0 0
CARD11/BCL10/MALT1/TAK1 -0.1 0.18 -9999 0 -0.51 25 25
PTPN6 -0.12 0.25 -9999 0 -0.53 54 54
RELA 0.012 0 -9999 0 -10000 0 0
BCL2A1 0.003 0.028 -9999 0 -0.11 8 8
VAV2 -0.13 0.27 -9999 0 -0.56 56 56
ubiquitin-dependent protein catabolic process 0.002 0.03 -9999 0 -10000 0 0
BTK -0.087 0.28 -9999 0 -1 19 19
CD19 -0.13 0.27 -9999 0 -0.56 55 55
MAP4K1 -0.02 0.095 -9999 0 -0.3 24 24
CD72 0.008 0.051 -9999 0 -0.5 2 2
PAG1 0.012 0 -9999 0 -10000 0 0
MAPK14 -0.083 0.2 -9999 0 -0.49 39 39
SH3BP5 0.012 0 -9999 0 -10000 0 0
PIK3AP1 -0.083 0.19 -9999 0 -0.46 39 39
B-cell antigen/BCR complex/Btk/LYN/SYK/BLNK/PLCgamma2/CD72 -0.098 0.22 -9999 0 -0.4 70 70
RAF1 -0.053 0.14 -9999 0 -0.37 32 32
RasGAP/p62DOK/SHIP -0.042 0.12 -9999 0 -0.37 13 13
CD79A -0.081 0.14 -9999 0 -0.3 69 69
re-entry into mitotic cell cycle -0.029 0.1 -9999 0 -0.24 32 32
RASA1 0.012 0 -9999 0 -10000 0 0
MAPK3 -0.034 0.12 -9999 0 -0.37 16 16
MAPK1 -0.034 0.12 -9999 0 -0.37 16 16
CD72/SHP1 -0.11 0.24 -9999 0 -0.58 40 40
NFKB1 0.012 0 -9999 0 -10000 0 0
MAPK8 -0.083 0.2 -9999 0 -0.49 39 39
actin cytoskeleton organization -0.11 0.23 -9999 0 -0.56 39 39
NF-kappa-B/RelA 0.014 0.048 -9999 0 -10000 0 0
Calcineurin -0.051 0.15 -9999 0 -0.48 18 18
PI3K -0.13 0.19 -9999 0 -0.48 44 44
B-cell antigen/BCR complex/Btk/LYN/SYK/BLNK/PLCgamma2 -0.09 0.2 -9999 0 -0.48 40 40
SOS1 0.012 0 -9999 0 -10000 0 0
Bam32/HPK1 -0.13 0.29 -9999 0 -0.78 34 34
DAPP1 -0.16 0.31 -9999 0 -0.87 33 33
cytokine secretion -0.092 0.19 -9999 0 -0.46 40 40
mol:DAG -0.09 0.19 -9999 0 -0.47 40 40
PLCG2 -0.008 0.077 -9999 0 -0.3 15 15
MAP2K1 -0.044 0.13 -9999 0 -0.4 18 18
B-cell antigen/BCR complex/FcgammaRIIB -0.072 0.15 -9999 0 -0.36 41 41
mol:PI-3-4-5-P3 -0.092 0.13 -9999 0 -0.34 38 38
ETS1 -0.056 0.15 -9999 0 -0.39 32 32
B-cell antigen/BCR complex/LYN/SYK/BLNK -0.03 0.11 -9999 0 -0.38 2 2
B-cell antigen/BCR complex/LYN -0.13 0.23 -9999 0 -0.65 34 34
MALT1 0.012 0 -9999 0 -10000 0 0
TRAF6 0.013 0 -9999 0 -10000 0 0
RAC1 -0.12 0.24 -9999 0 -0.61 39 39
B-cell antigen/BCR complex/LYN/SYK -0.13 0.22 -9999 0 -0.61 34 34
CARD11 -0.12 0.22 -9999 0 -0.46 56 56
FCGR2B -0.028 0.1 -9999 0 -0.3 30 30
PPP3CA 0.012 0 -9999 0 -10000 0 0
BCL10 0.012 0 -9999 0 -10000 0 0
IKK complex -0.006 0.038 -9999 0 -0.097 2 2
PTPRC -0.008 0.077 -9999 0 -0.3 15 15
PDPK1 -0.045 0.099 -9999 0 -0.24 31 31
PPP3CB 0.012 0 -9999 0 -10000 0 0
PPP3CC 0.012 0 -9999 0 -10000 0 0
POU2F2 0.007 0.021 -9999 0 -10000 0 0
Signaling events mediated by Stem cell factor receptor (c-Kit)

Figure S14.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S14.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MAP4K1 -0.026 0.15 -10000 0 -0.38 35 35
CRKL -0.027 0.15 -10000 0 -0.38 35 35
HRAS -0.007 0.14 -10000 0 -0.39 8 8
mol:PIP3 -0.035 0.14 -10000 0 -0.37 35 35
SPRED1 0.012 0 -10000 0 -10000 0 0
SPRED2 0.012 0 -10000 0 -10000 0 0
GAB1 -0.034 0.16 -10000 0 -0.41 35 35
FOXO3 -0.019 0.14 -10000 0 -0.35 35 35
AKT1 -0.027 0.15 -10000 0 -0.38 35 35
BAD -0.019 0.14 -10000 0 -0.35 35 35
megakaryocyte differentiation -0.071 0.19 -10000 0 -0.41 54 54
GSK3B -0.019 0.14 -10000 0 -0.35 35 35
RAF1 0.002 0.12 -10000 0 -0.32 6 6
SHC1 0.012 0 -10000 0 -10000 0 0
STAT3 -0.034 0.16 -10000 0 -0.41 35 35
STAT1 -0.096 0.35 -10000 0 -0.9 36 36
HRAS/SPRED1 0.001 0.12 -10000 0 -0.32 6 6
cell proliferation -0.033 0.16 -10000 0 -0.4 35 35
PIK3CA 0.012 0 -10000 0 -10000 0 0
TEC 0.012 0 -10000 0 -10000 0 0
RPS6KB1 -0.033 0.16 -10000 0 -0.4 35 35
HRAS/SPRED2 0.001 0.12 -10000 0 -0.32 6 6
LYN/TEC/p62DOK -0.02 0.15 -10000 0 -0.38 35 35
MAPK3 0.013 0.09 -10000 0 -0.27 1 1
STAP1 -0.052 0.19 -10000 0 -0.48 35 35
GRAP2 0.004 0.05 -10000 0 -0.3 6 6
JAK2 -0.076 0.3 -10000 0 -0.76 36 36
STAT1 (dimer) -0.092 0.34 -10000 0 -0.88 36 36
mol:Gleevec 0 0.006 -10000 0 -10000 0 0
GRB2/SOCS1/VAV1 -0.025 0.16 -10000 0 -0.39 36 36
actin filament polymerization -0.033 0.16 -10000 0 -0.4 35 35
LYN 0.012 0 -10000 0 -10000 0 0
STAP1/STAT5A (dimer) -0.063 0.24 -10000 0 -0.62 35 35
PIK3R1 0.012 0 -10000 0 -10000 0 0
CBL/CRKL/GRB2 -0.012 0.14 -10000 0 -0.34 35 35
PI3K -0.02 0.15 -10000 0 -0.38 35 35
PTEN 0.011 0.021 -10000 0 -0.3 1 1
SCF/KIT/EPO/EPOR -0.11 0.4 -10000 0 -1.1 35 35
MAPK8 -0.034 0.16 -10000 0 -0.41 35 35
STAT3 (dimer) -0.033 0.16 -10000 0 -0.4 35 35
positive regulation of transcription 0.015 0.076 -10000 0 -0.22 1 1
mol:GDP -0.012 0.14 -10000 0 -0.4 9 9
PIK3C2B -0.034 0.16 -10000 0 -0.41 35 35
CBL/CRKL -0.018 0.14 -10000 0 -0.36 35 35
FER -0.034 0.16 -10000 0 -0.41 35 35
SH2B3 -0.034 0.16 -10000 0 -0.41 35 35
PDPK1 -0.027 0.13 -10000 0 -0.34 35 35
SNAI2 -0.036 0.16 -10000 0 -0.4 36 36
positive regulation of cell proliferation -0.063 0.26 -10000 0 -0.67 36 36
KITLG 0.012 0.012 -10000 0 -10000 0 0
cell motility -0.063 0.26 -10000 0 -0.67 36 36
PTPN6 0.013 0.009 -10000 0 -10000 0 0
EPOR -0.001 0.11 -10000 0 -10000 0 0
STAT5A (dimer) -0.048 0.22 -10000 0 -0.56 35 35
SOCS1 0.009 0.046 -10000 0 -0.7 1 1
cell migration 0.041 0.16 0.42 36 -10000 0 36
SOS1 0.012 0 -10000 0 -10000 0 0
EPO 0.005 0.046 -10000 0 -0.69 1 1
VAV1 0.002 0.057 -10000 0 -0.3 8 8
GRB10 -0.034 0.16 -10000 0 -0.41 35 35
PTPN11 0.013 0.006 -10000 0 -10000 0 0
SCF/KIT -0.042 0.17 -10000 0 -0.43 35 35
GO:0007205 0.001 0.009 -10000 0 -10000 0 0
MAP2K1 0.01 0.097 -10000 0 -0.3 1 1
CBL 0.012 0 -10000 0 -10000 0 0
KIT -0.13 0.42 -10000 0 -1.1 35 35
MAP2K2 0.01 0.097 -10000 0 -0.3 1 1
SHC/Grb2/SOS1 -0.02 0.15 -10000 0 -0.38 35 35
STAT5A -0.05 0.23 -10000 0 -0.58 35 35
GRB2 0.012 0 -10000 0 -10000 0 0
response to radiation -0.035 0.16 -10000 0 -0.4 36 36
SHC/GRAP2 0.013 0.034 -10000 0 -10000 0 0
PTPRO -0.073 0.2 -10000 0 -0.42 54 54
SH2B2 -0.034 0.16 -10000 0 -0.41 35 35
DOK1 0.012 0 -10000 0 -10000 0 0
MATK -0.042 0.17 -10000 0 -0.43 36 36
CREBBP 0.016 0.042 -10000 0 -10000 0 0
BCL2 -0.016 0.2 -10000 0 -1.3 4 4
Glucocorticoid receptor regulatory network

Figure S15.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S15.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PCK2 0.014 0.064 0.3 3 -10000 0 3
SMARCC2 0.014 0.002 -10000 0 -10000 0 0
SMARCC1 0.014 0.003 -10000 0 -10000 0 0
TBX21 -0.11 0.16 -10000 0 -0.56 16 16
SUMO2 0.013 0.005 -10000 0 -10000 0 0
STAT1 (dimer) 0.008 0.092 -10000 0 -0.69 4 4
FKBP4 0.009 0.046 -10000 0 -0.7 1 1
FKBP5 0.012 0 -10000 0 -10000 0 0
GR alpha/HSP90/FKBP51/HSP90 0.11 0.088 0.32 9 -10000 0 9
PRL -0.097 0.17 -10000 0 -0.67 13 13
cortisol/GR alpha (dimer)/TIF2 0.26 0.2 0.5 58 -10000 0 58
RELA -0.065 0.079 -10000 0 -10000 0 0
FGG 0.16 0.22 0.48 21 -0.49 11 32
GR beta/TIF2 0.12 0.099 0.32 14 -10000 0 14
IFNG -0.34 0.29 -10000 0 -0.83 43 43
apoptosis 0.027 0.12 0.48 6 -0.49 2 8
CREB1 0.01 0.031 -10000 0 -10000 0 0
histone acetylation -0.062 0.095 -10000 0 -0.34 7 7
BGLAP -0.08 0.11 -10000 0 -0.45 4 4
GR/PKAc 0.099 0.097 0.31 8 -0.31 2 10
NF kappa B1 p50/RelA -0.12 0.14 -10000 0 -0.36 21 21
SMARCD1 0.014 0.003 -10000 0 -10000 0 0
MDM2 0.096 0.074 0.26 16 -10000 0 16
GATA3 0.006 0.074 -10000 0 -0.5 4 4
AKT1 0.006 0.001 -10000 0 -10000 0 0
CSF2 -0.21 0.23 -10000 0 -0.48 85 85
GSK3B 0.013 0.005 -10000 0 -10000 0 0
NR1I3 0.038 0.11 0.46 6 -10000 0 6
CSN2 0.16 0.14 0.41 16 -0.37 1 17
BRG1/BAF155/BAF170/BAF60A 0.038 0.009 -10000 0 -10000 0 0
NFATC1 0.01 0.029 -10000 0 -0.3 2 2
POU2F1 0.009 0.03 -10000 0 -10000 0 0
CDKN1A 0.029 0.011 -10000 0 -10000 0 0
response to stress 0 0 -10000 0 -10000 0 0
response to UV 0.001 0.006 -10000 0 -10000 0 0
SFN 0.012 0 -10000 0 -10000 0 0
GR alpha/HSP90/FKBP51/HSP90/14-3-3 0.12 0.082 0.32 7 -10000 0 7
prolactin receptor activity 0 0 -10000 0 -10000 0 0
EGR1 0.033 0.12 0.44 6 -0.79 1 7
JUN -0.25 0.16 -10000 0 -0.45 51 51
IL4 -0.097 0.11 -10000 0 -0.48 3 3
CDK5R1 0.007 0.065 -10000 0 -0.69 2 2
PRKACA 0.012 0 -10000 0 -10000 0 0
cortisol/GR alpha (monomer)/AP-1 -0.27 0.22 -10000 0 -0.5 71 71
GR alpha/HSP90/FKBP51/HSP90/PP5C 0.12 0.082 0.32 7 -10000 0 7
cortisol/GR alpha (monomer) 0.29 0.24 0.59 61 -0.37 1 62
NCOA2 0.012 0 -10000 0 -10000 0 0
response to hypoxia 0 0 -10000 0 -10000 0 0
FOS -0.089 0.054 -10000 0 -0.39 2 2
AP-1/NFAT1-c-4 -0.44 0.27 -10000 0 -0.65 109 109
AFP -0.17 0.11 -10000 0 -0.51 4 4
SUV420H1 0.012 0 -10000 0 -10000 0 0
IRF1 0.15 0.12 0.4 12 -10000 0 12
TP53 0.031 0 -10000 0 -10000 0 0
PPP5C 0.012 0 -10000 0 -10000 0 0
KRT17 -0.59 0.32 -10000 0 -0.72 181 181
KRT14 -0.13 0.16 0.39 1 -0.73 9 10
TBP 0.02 0 -10000 0 -10000 0 0
CREBBP 0.036 0.041 -10000 0 -10000 0 0
HDAC1 0.011 0.009 -10000 0 -10000 0 0
HDAC2 0.03 0.023 -10000 0 -10000 0 0
AP-1 -0.44 0.27 -10000 0 -0.65 110 110
MAPK14 0.013 0.005 -10000 0 -10000 0 0
MAPK10 -0.052 0.13 -10000 0 -0.3 48 48
MAPK11 0.013 0.005 -10000 0 -10000 0 0
KRT5 -0.35 0.3 -10000 0 -0.79 54 54
interleukin-1 receptor activity 0.017 0.024 -10000 0 -10000 0 0
NCOA1 0.015 0.001 -10000 0 -10000 0 0
STAT1 0.008 0.092 -10000 0 -0.69 4 4
CGA -0.1 0.14 -10000 0 -0.62 8 8
NF kappa B1 p50/RelA/Cbp/cortisol/GR alpha (monomer)/HDAC2 0.17 0.18 0.38 79 -0.4 1 80
MAPK3 0.013 0.006 -10000 0 -10000 0 0
MAPK1 0.013 0.005 -10000 0 -10000 0 0
ICAM1 -0.2 0.23 -10000 0 -0.62 30 30
NFKB1 -0.065 0.079 -10000 0 -10000 0 0
MAPK8 -0.19 0.14 -10000 0 -0.36 60 60
MAPK9 0.013 0.005 -10000 0 -10000 0 0
cortisol/GR alpha (dimer) 0.023 0.13 0.48 6 -0.52 2 8
BAX 0.029 0.011 -10000 0 -10000 0 0
POMC -0.16 0.26 -10000 0 -1.1 13 13
EP300 0.039 0.044 -10000 0 -10000 0 0
cortisol/GR alpha (dimer)/p53 0.27 0.2 0.52 56 -10000 0 56
proteasomal ubiquitin-dependent protein catabolic process 0.068 0.057 0.23 5 -10000 0 5
SGK1 0.085 0.1 -10000 0 -1.2 1 1
IL13 -0.24 0.2 -10000 0 -0.77 17 17
IL6 -0.23 0.26 -10000 0 -0.75 33 33
PRKACG 0.004 0.006 -10000 0 -10000 0 0
IL5 -0.2 0.16 -10000 0 -0.7 10 10
IL2 -0.3 0.21 -10000 0 -0.63 40 40
CDK5 0.013 0.003 -10000 0 -10000 0 0
PRKACB -0.008 0.077 -10000 0 -0.3 15 15
HSP90AA1 0.012 0 -10000 0 -10000 0 0
IL8 -0.41 0.35 -10000 0 -0.68 134 134
CDK5R1/CDK5 0.015 0.05 -10000 0 -0.52 2 2
NF kappa B1 p50/RelA/PKAc -0.074 0.11 -10000 0 -10000 0 0
cortisol/GR alpha (dimer)/Hsp90/FKBP52/HSP90 0.25 0.18 0.48 55 -10000 0 55
SMARCA4 0.014 0.002 -10000 0 -10000 0 0
chromatin remodeling 0.16 0.13 0.36 28 -0.57 1 29
NF kappa B1 p50/RelA/Cbp -0.045 0.12 -10000 0 -10000 0 0
JUN (dimer) -0.25 0.16 -10000 0 -0.45 51 51
YWHAH 0.012 0 -10000 0 -10000 0 0
VIPR1 -0.11 0.16 -10000 0 -0.52 17 17
NR3C1 0.16 0.15 0.41 32 -0.34 3 35
NR4A1 -0.025 0.17 -10000 0 -0.61 16 16
TIF2/SUV420H1 0.019 0 -10000 0 -10000 0 0
MAPKKK cascade 0.027 0.12 0.48 6 -0.49 2 8
cortisol/GR alpha (dimer)/Src-1 0.27 0.2 0.51 58 -10000 0 58
PBX1 0 0.061 -10000 0 -0.3 7 7
POU1F1 -0.004 0.063 -10000 0 -0.84 1 1
SELE -0.3 0.34 -10000 0 -0.76 71 71
cortisol/GR alpha/BRG1/BAF155/BAF170/BAF60A 0.16 0.13 0.37 26 -0.57 1 27
cortisol/GR alpha (monomer)/Hsp90/FKBP52/HSP90 0.25 0.18 0.48 55 -10000 0 55
mol:cortisol 0.16 0.14 0.33 68 -0.21 2 70
MMP1 -0.43 0.28 -10000 0 -0.62 152 152
Endothelins

Figure S16.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S16.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
AKT1 -0.028 0.25 -10000 0 -0.56 29 29
PTK2B 0.013 0.001 -10000 0 -10000 0 0
mol:Ca2+ 0.006 0.2 -10000 0 -0.88 8 8
EDN1 0.025 0.16 -10000 0 -0.52 7 7
EDN3 -0.13 0.16 -10000 0 -0.3 107 107
EDN2 -0.044 0.12 -10000 0 -0.3 42 42
HRAS/GDP -0.009 0.13 -10000 0 -0.44 3 3
ETA receptor/Endothelin-1/Gq/GTP/PLC beta 0.022 0.12 -10000 0 -0.29 13 13
ADCY4 -0.047 0.2 -10000 0 -0.53 22 22
ADCY5 -0.091 0.21 -10000 0 -0.5 31 31
ADCY6 -0.047 0.2 -10000 0 -0.53 22 22
ADCY7 -0.047 0.2 -10000 0 -0.53 22 22
ADCY1 -0.058 0.21 -10000 0 -0.52 28 28
ADCY2 -0.07 0.21 -10000 0 -0.49 32 32
ADCY3 -0.047 0.2 -10000 0 -0.53 22 22
ADCY8 -0.054 0.2 -10000 0 -0.48 28 28
ADCY9 -0.048 0.2 -10000 0 -0.53 22 22
arachidonic acid secretion -0.017 0.14 -10000 0 -0.39 9 9
ETB receptor/Endothelin-1/Gq/GTP 0.017 0.083 -10000 0 -0.29 6 6
GNAO1 -0.13 0.16 -10000 0 -0.3 103 103
HRAS 0.013 0 -10000 0 -10000 0 0
ETA receptor/Endothelin-1/G12/GTP 0.048 0.29 0.3 99 -0.52 29 128
ETA receptor/Endothelin-1/Gs/GTP 0.033 0.28 0.28 97 -0.5 30 127
mol:GTP 0.001 0.003 -10000 0 -10000 0 0
COL3A1 -0.063 0.33 -10000 0 -0.79 32 32
EDNRB 0.001 0.054 -10000 0 -0.3 6 6
response to oxidative stress 0 0 -10000 0 -10000 0 0
CYSLTR2 -0.046 0.27 -10000 0 -0.58 33 33
CYSLTR1 -0.056 0.28 -10000 0 -0.56 41 41
SLC9A1 0.007 0.13 -10000 0 -0.33 13 13
mol:GDP -0.017 0.14 -10000 0 -0.34 15 15
SLC9A3 -0.19 0.3 -10000 0 -0.56 70 70
RAF1 -0.019 0.12 -10000 0 -0.36 5 5
JUN 0.025 0.13 -10000 0 -0.52 2 2
JAK2 -0.028 0.25 -10000 0 -0.55 31 31
mol:IP3 0.02 0.1 -10000 0 -0.33 3 3
ETA receptor/Endothelin-1 0.038 0.35 0.35 101 -0.59 37 138
PLCB1 0.008 0.051 -10000 0 -0.5 2 2
PLCB2 0.013 0.002 -10000 0 -10000 0 0
ETA receptor/Endothelin-3 -0.12 0.22 -10000 0 -0.56 28 28
FOS -0.002 0.12 -10000 0 -0.85 2 2
Gai/GDP -0.25 0.32 -10000 0 -0.6 103 103
CRK 0.013 0.001 -10000 0 -10000 0 0
mol:Ca ++ -0.019 0.22 -10000 0 -0.59 20 20
BCAR1 0.013 0 -10000 0 -10000 0 0
PRKCB1 0.018 0.099 -10000 0 -0.3 4 4
GNAQ 0.014 0.003 -10000 0 -10000 0 0
GNAZ 0.007 0.041 -10000 0 -0.3 4 4
GNAL -0.006 0.075 -10000 0 -0.3 14 14
Gs family/GDP -0.051 0.11 -10000 0 -0.42 5 5
ETA receptor/Endothelin-1/Gq/GTP 0.015 0.14 -10000 0 -0.36 16 16
MAPK14 0.027 0.068 -10000 0 -0.29 2 2
TRPC6 0.003 0.21 -10000 0 -0.95 8 8
GNAI2 0.012 0 -10000 0 -10000 0 0
GNAI3 0.012 0 -10000 0 -10000 0 0
GNAI1 0.007 0.041 -10000 0 -0.3 4 4
ETB receptor/Endothelin-1/Gq/GTP/PLC beta 0.023 0.073 -10000 0 -0.29 3 3
ETB receptor/Endothelin-2 -0.028 0.088 -10000 0 -0.26 1 1
ETB receptor/Endothelin-3 -0.087 0.11 -10000 0 -0.38 4 4
ETB receptor/Endothelin-1 0.021 0.14 -10000 0 -0.48 6 6
MAPK3 -0.006 0.12 -10000 0 -0.73 2 2
MAPK1 -0.006 0.12 -10000 0 -0.73 2 2
Rac1/GDP -0.009 0.13 -10000 0 -0.41 4 4
cAMP biosynthetic process -0.088 0.19 -10000 0 -0.47 29 29
MAPK8 0.017 0.15 -10000 0 -0.46 8 8
SRC 0.012 0 -10000 0 -10000 0 0
ETB receptor/Endothelin-1/Gi/GTP -0.052 0.12 -10000 0 -0.34 15 15
p130Cas/CRK/Src/PYK2 -0.043 0.15 -10000 0 -0.49 9 9
mol:K + 0 0 -10000 0 -10000 0 0
G12/GDP -0.009 0.13 -10000 0 -0.41 4 4
COL1A2 -0.036 0.3 -10000 0 -0.73 29 29
EntrezGene:2778 0 0 -10000 0 -10000 0 0
ETA receptor/Endothelin-2 -0.052 0.22 -10000 0 -0.6 22 22
mol:DAG 0.02 0.1 -10000 0 -0.33 3 3
MAP2K2 -0.01 0.12 -10000 0 -0.53 2 2
MAP2K1 -0.01 0.12 -10000 0 -0.47 3 3
EDNRA -0.025 0.26 -10000 0 -0.8 19 19
positive regulation of muscle contraction -0.018 0.22 -10000 0 -0.57 21 21
Gq family/GDP -0.063 0.11 -10000 0 -0.47 8 8
HRAS/GTP -0.029 0.12 -10000 0 -0.34 6 6
PRKCH 0.023 0.099 -10000 0 -0.31 3 3
RAC1 0.012 0 -10000 0 -10000 0 0
PRKCA 0.023 0.099 -10000 0 -0.31 3 3
PRKCB -0.004 0.12 -10000 0 -0.36 5 5
PRKCE 0.025 0.098 -10000 0 -0.32 2 2
PRKCD 0.023 0.099 -10000 0 -0.31 3 3
PRKCG -0.15 0.22 -10000 0 -0.42 64 64
regulation of vascular smooth muscle contraction -0.004 0.14 -10000 0 -1 2 2
PRKCQ 0.017 0.11 -10000 0 -0.37 3 3
PLA2G4A -0.019 0.14 -10000 0 -0.4 10 10
GNA14 0.013 0.021 -10000 0 -0.3 1 1
GNA15 -0.029 0.17 -10000 0 -0.7 14 14
GNA12 0.012 0 -10000 0 -10000 0 0
GNA11 0.013 0.003 -10000 0 -10000 0 0
Rac1/GTP 0.048 0.29 0.3 99 -0.6 21 120
MMP1 -0.35 0.3 -10000 0 -0.56 152 152
Ephrin B reverse signaling

Figure S17.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S17.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EFNB2 0.012 0 -10000 0 -10000 0 0
EPHB2 0.009 0.046 -10000 0 -0.7 1 1
EFNB1 0.018 0.002 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
Rac1/GDP -0.065 0.17 -10000 0 -0.36 55 55
Ephrin B2/EPHB1-2 -0.079 0.18 -10000 0 -0.41 55 55
neuron projection morphogenesis -0.087 0.15 -10000 0 -0.35 55 55
Ephrin B1/EPHB1-2/Tiam1 -0.075 0.18 -10000 0 -0.39 55 55
DNM1 0.012 0.001 -10000 0 -10000 0 0
cell-cell signaling -0.001 0.002 -10000 0 -10000 0 0
MAP2K4 -0.008 0.094 -10000 0 -0.57 5 5
YES1 -0.023 0.12 -10000 0 -0.41 15 15
Ephrin B1/EPHB1-2/NCK2 -0.063 0.17 -10000 0 -0.37 55 55
PI3K -0.003 0.095 -10000 0 -0.58 5 5
mol:GDP -0.074 0.18 -10000 0 -0.39 55 55
ITGA2B -0.013 0.13 -10000 0 -0.7 8 8
endothelial cell proliferation 0.016 0.001 -10000 0 -10000 0 0
FYN -0.023 0.12 -10000 0 -0.41 15 15
MAP3K7 -0.016 0.099 -10000 0 -0.61 5 5
FGR -0.025 0.13 -10000 0 -0.42 15 15
TIAM1 -0.013 0.086 -10000 0 -0.3 19 19
PIK3R1 0.012 0 -10000 0 -10000 0 0
RGS3 0.012 0 -10000 0 -10000 0 0
cell adhesion -0.008 0.12 -10000 0 -0.49 12 12
LYN -0.023 0.12 -10000 0 -0.41 15 15
Ephrin B1/EPHB1-2/Src Family Kinases -0.023 0.11 -10000 0 -0.38 15 15
Ephrin B1/EPHB1-2 -0.027 0.1 -10000 0 -0.38 15 15
SRC -0.024 0.12 -10000 0 -0.42 15 15
ITGB3 0.006 0.045 -10000 0 -0.3 5 5
EPHB1 -0.15 0.3 -10000 0 -0.69 55 55
EPHB4 0.012 0 -10000 0 -10000 0 0
RAC1 0.012 0 -10000 0 -10000 0 0
Ephrin B2/EPHB4 0.017 0.001 -10000 0 -10000 0 0
alphaIIb/beta3 Integrin -0.006 0.1 -10000 0 -0.52 8 8
BLK -0.091 0.14 -10000 0 -0.49 15 15
HCK -0.028 0.12 -10000 0 -0.42 15 15
regulation of stress fiber formation 0.063 0.17 0.37 55 -10000 0 55
MAPK8 -0.002 0.09 -10000 0 -0.54 5 5
Ephrin B1/EPHB1-2/RGS3 -0.063 0.17 -10000 0 -0.37 55 55
endothelial cell migration -0.011 0.085 -10000 0 -0.51 5 5
NCK2 0.012 0 -10000 0 -10000 0 0
PTPN13 -0.023 0.15 -10000 0 -0.57 15 15
regulation of focal adhesion formation 0.063 0.17 0.37 55 -10000 0 55
chemotaxis 0.063 0.17 0.37 55 -10000 0 55
PIK3CA 0.012 0 -10000 0 -10000 0 0
Rac1/GTP -0.067 0.16 -10000 0 -0.36 55 55
angiogenesis -0.027 0.1 -10000 0 -0.37 15 15
LCK -0.027 0.13 -10000 0 -0.42 15 15
BMP receptor signaling

Figure S18.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S18.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BMP7/BMPR2/BMPR1A-1B/FS -0.18 0.22 -9999 0 -0.4 109 109
SMAD6-7/SMURF1 0.025 0 -9999 0 -10000 0 0
NOG 0.007 0.047 -9999 0 -0.7 1 1
SMAD9 -0.043 0.15 -9999 0 -0.52 17 17
SMAD4 0.012 0 -9999 0 -10000 0 0
SMAD5 -0.025 0.093 -9999 0 -0.32 6 6
BMP7/USAG1 -0.26 0.27 -9999 0 -0.55 104 104
SMAD5/SKI -0.017 0.09 -9999 0 -0.3 5 5
SMAD1 0.034 0.017 -9999 0 -10000 0 0
BMP2 -0.004 0.069 -9999 0 -0.3 12 12
SMAD1/SMAD1/SMAD4 0 0.002 -9999 0 -10000 0 0
BMPR1A 0.012 0 -9999 0 -10000 0 0
BMPR1B -0.028 0.15 -9999 0 -0.5 18 18
BMPR1A-1B/BAMBI -0.065 0.18 -9999 0 -0.45 41 41
AHSG -0.019 0.14 -9999 0 -0.7 9 9
CER1 -0.031 0.16 -9999 0 -0.7 12 12
BMP2-4/CER1 -0.058 0.18 -9999 0 -0.47 33 33
BMP2-4/BMPR2/BMPR1A-1B/RGM/ENDOFIN/GADD34/PP1CA -0.045 0.12 -9999 0 -0.32 11 11
BMP2-4 (homodimer) -0.044 0.17 -9999 0 -0.54 22 22
RGMB 0.012 0 -9999 0 -10000 0 0
BMP6/BMPR2/BMPR1A-1B 0.007 0.09 -9999 0 -0.4 9 9
RGMA -0.085 0.14 -9999 0 -0.3 72 72
SMURF1 0.012 0 -9999 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM/XIAP -0.053 0.12 -9999 0 -0.31 26 26
BMP2-4/USAG1 -0.064 0.16 -9999 0 -0.46 25 25
SMAD6/SMURF1/SMAD5 -0.017 0.09 -9999 0 -0.3 5 5
SOSTDC1 -0.05 0.12 -9999 0 -0.3 46 46
BMP7/BMPR2/BMPR1A-1B -0.18 0.23 -9999 0 -0.42 108 108
SKI 0.012 0 -9999 0 -10000 0 0
BMP6 (homodimer) 0.01 0.029 -9999 0 -0.3 2 2
HFE2 0.003 0.005 -9999 0 -10000 0 0
ZFYVE16 0.012 0 -9999 0 -10000 0 0
MAP3K7 0.012 0 -9999 0 -10000 0 0
BMP2-4/CHRD -0.032 0.15 -9999 0 -0.46 23 23
SMAD5/SMAD5/SMAD4 -0.017 0.09 -9999 0 -0.3 5 5
MAPK1 0.012 0 -9999 0 -10000 0 0
TAK1/TAB family -0.059 0.085 -9999 0 -0.42 2 2
BMP7 (homodimer) -0.3 0.35 -9999 0 -0.67 108 108
NUP214 0.012 0 -9999 0 -10000 0 0
BMP6/FETUA -0.007 0.1 -9999 0 -0.52 9 9
SMAD1/SKI 0.04 0.016 -9999 0 -10000 0 0
SMAD6 0.012 0 -9999 0 -10000 0 0
CTDSP2 0.012 0 -9999 0 -10000 0 0
BMP2-4/FETUA -0.05 0.17 -9999 0 -0.46 31 31
MAP3K7IP1 0 0 -9999 0 -10000 0 0
GREM1 -0.032 0.16 -9999 0 -0.5 20 20
BMPR2 (homodimer) 0.012 0 -9999 0 -10000 0 0
GADD34/PP1CA 0.025 0 -9999 0 -10000 0 0
BMPR1A-1B (homodimer) -0.011 0.11 -9999 0 -0.52 9 9
CHRDL1 -0.15 0.16 -9999 0 -0.3 118 118
ENDOFIN/SMAD1 0.04 0.016 -9999 0 -10000 0 0
SMAD6-7/SMURF1/SMAD1 0.048 0.015 -9999 0 -10000 0 0
SMAD6/SMURF1 0.012 0 -9999 0 -10000 0 0
BAMBI -0.085 0.24 -9999 0 -0.7 32 32
SMURF2 0.009 0.046 -9999 0 -0.7 1 1
BMP2-4/CHRDL1 -0.12 0.17 -9999 0 -0.51 27 27
BMP2-4/GREM1 -0.057 0.17 -9999 0 -0.46 32 32
SMAD7 0.012 0 -9999 0 -10000 0 0
SMAD8A/SMAD8A/SMAD4 -0.034 0.14 -9999 0 -0.5 16 16
SMAD1/SMAD6 0.04 0.016 -9999 0 -10000 0 0
TAK1/SMAD6 0.019 0 -9999 0 -10000 0 0
BMP7 -0.31 0.35 -9999 0 -0.67 108 108
BMP6 0.01 0.029 -9999 0 -0.3 2 2
MAP3K7IP2 0 0 -9999 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM/SMAD7/SMURF1 -0.045 0.11 -9999 0 -0.28 26 26
PPM1A 0.012 0 -9999 0 -10000 0 0
SMAD1/SMURF2 0.038 0.029 -9999 0 -0.34 1 1
SMAD7/SMURF1 0.019 0 -9999 0 -10000 0 0
CTDSPL 0.012 0 -9999 0 -10000 0 0
PPP1CA 0.012 0 -9999 0 -10000 0 0
XIAP 0.012 0 -9999 0 -10000 0 0
CTDSP1 0.012 0 -9999 0 -10000 0 0
PPP1R15A 0.012 0 -9999 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM/FS -0.075 0.16 -9999 0 -0.41 30 30
CHRD 0.007 0.041 -9999 0 -0.3 4 4
BMPR2 0.012 0 -9999 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM -0.061 0.12 -9999 0 -0.33 26 26
BMP4 -0.056 0.21 -9999 0 -0.68 23 23
FST -0.011 0.096 -9999 0 -0.35 15 15
BMP2-4/NOG -0.032 0.15 -9999 0 -0.47 23 23
BMP7/BMPR2/BMPR1A-1B/SMAD6/SMURF1 -0.17 0.21 -9999 0 -0.39 108 108
TCGA08_p53

Figure S19.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S19.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDKN2A -0.14 0.24 -10000 0 -0.53 65 65
TP53 -0.038 0.061 -10000 0 -10000 0 0
Senescence -0.038 0.061 -10000 0 -10000 0 0
Apoptosis -0.038 0.061 -10000 0 -10000 0 0
Activated_Oncogenes 0 0 -10000 0 -10000 0 0
MDM2 0.072 0.12 0.26 65 -10000 0 65
MDM4 0.012 0 -10000 0 -10000 0 0
HIF-1-alpha transcription factor network

Figure S20.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S20.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PKM2 -0.4 0.32 -9999 0 -0.97 23 23
HDAC7 0.011 0.006 -9999 0 -10000 0 0
HIF1A/ARNT/Cbp/p300/Src-1 -0.31 0.27 -9999 0 -0.85 13 13
SMAD4 0.013 0 -9999 0 -10000 0 0
ID2 -0.4 0.32 -9999 0 -0.99 21 21
AP1 0.018 0.02 -9999 0 -10000 0 0
ABCG2 -0.49 0.35 -9999 0 -0.94 53 53
HIF1A -0.065 0.049 -9999 0 -10000 0 0
TFF3 -0.4 0.33 -9999 0 -1 22 22
GATA2 0.005 0.05 -9999 0 -0.3 6 6
AKT1 -0.062 0.054 -9999 0 -10000 0 0
response to hypoxia -0.079 0.055 -9999 0 -0.23 1 1
MCL1 -0.4 0.32 -9999 0 -0.99 21 21
NDRG1 -0.4 0.32 -9999 0 -0.98 22 22
SERPINE1 -0.49 0.4 -9999 0 -1.1 53 53
FECH -0.4 0.32 -9999 0 -0.98 22 22
FURIN -0.4 0.32 -9999 0 -0.99 21 21
NCOA2 0.013 0.001 -9999 0 -10000 0 0
EP300 -0.061 0.071 -9999 0 -0.34 4 4
HMOX1 -0.4 0.32 -9999 0 -1 19 19
BHLHE40 -0.4 0.33 -9999 0 -1 25 25
BHLHE41 -0.4 0.32 -9999 0 -0.98 23 23
HIF1A/ARNT/SMAD3/SMAD4/SP1 -0.053 0.063 -9999 0 -10000 0 0
ENG -0.041 0.063 -9999 0 -10000 0 0
JUN 0.013 0.002 -9999 0 -10000 0 0
RORA -0.4 0.32 -9999 0 -0.98 22 22
ABCB1 -0.24 0.36 -9999 0 -1 39 39
TFRC -0.4 0.32 -9999 0 -1 19 19
CXCR4 -0.41 0.34 -9999 0 -1 21 21
TF -0.42 0.34 -9999 0 -0.98 30 30
CITED2 -0.4 0.32 -9999 0 -0.99 21 21
HIF1A/ARNT -0.44 0.37 -9999 0 -1.1 23 23
LDHA -0.052 0.042 -9999 0 -10000 0 0
ETS1 -0.4 0.32 -9999 0 -0.99 21 21
PGK1 -0.4 0.32 -9999 0 -0.99 21 21
NOS2 -0.42 0.35 -9999 0 -1 30 30
ITGB2 -0.4 0.32 -9999 0 -0.98 24 24
ALDOA -0.4 0.32 -9999 0 -0.97 23 23
Cbp/p300/CITED2 -0.39 0.33 -9999 0 -1.1 18 18
FOS 0.01 0.029 -9999 0 -0.3 2 2
HK2 -0.4 0.32 -9999 0 -0.99 21 21
SP1 0.012 0.023 -9999 0 -10000 0 0
GCK -0.099 0.18 -9999 0 -1.3 4 4
HK1 -0.4 0.32 -9999 0 -0.99 21 21
NPM1 -0.4 0.32 -9999 0 -0.99 21 21
EGLN1 -0.4 0.32 -9999 0 -1 19 19
CREB1 0.019 0 -9999 0 -10000 0 0
PGM1 -0.4 0.32 -9999 0 -0.99 21 21
SMAD3 0.013 0 -9999 0 -10000 0 0
EDN1 -0.047 0.11 -9999 0 -0.59 4 4
IGFBP1 -0.45 0.37 -9999 0 -1.1 37 37
VEGFA -0.3 0.3 -9999 0 -0.89 25 25
HIF1A/JAB1 -0.032 0.03 -9999 0 -10000 0 0
CP -0.46 0.34 -9999 0 -0.96 41 41
CXCL12 -0.42 0.34 -9999 0 -0.98 30 30
COPS5 0.013 0.001 -9999 0 -10000 0 0
SMAD3/SMAD4 0.02 0 -9999 0 -10000 0 0
BNIP3 -0.4 0.33 -9999 0 -0.98 26 26
EGLN3 -0.4 0.32 -9999 0 -0.99 21 21
CA9 -0.71 0.36 -9999 0 -1.1 90 90
TERT -0.44 0.36 -9999 0 -1.1 30 30
ENO1 -0.4 0.32 -9999 0 -0.98 22 22
PFKL -0.4 0.32 -9999 0 -0.99 21 21
NCOA1 0.013 0 -9999 0 -10000 0 0
ADM -0.4 0.32 -9999 0 -0.99 21 21
ARNT -0.065 0.049 -9999 0 -10000 0 0
HNF4A 0.014 0.01 -9999 0 -10000 0 0
ADFP -0.4 0.32 -9999 0 -0.94 28 28
SLC2A1 -0.32 0.31 -9999 0 -0.89 34 34
LEP -0.42 0.35 -9999 0 -1 30 30
HIF1A/ARNT/Cbp/p300 -0.32 0.28 -9999 0 -0.87 15 15
EPO -0.21 0.19 -9999 0 -0.64 1 1
CREBBP -0.061 0.071 -9999 0 -0.34 4 4
HIF1A/ARNT/Cbp/p300/HDAC7 -0.33 0.3 -9999 0 -0.89 24 24
PFKFB3 -0.4 0.32 -9999 0 -1 19 19
NT5E -0.4 0.32 -9999 0 -1 22 22
Canonical Wnt signaling pathway

Figure S21.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S21.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.026 0.024 -10000 0 -10000 0 0
AES 0.024 0.02 -10000 0 -10000 0 0
FBXW11 0.012 0 -10000 0 -10000 0 0
mol:GTP 0.001 0.001 -10000 0 -10000 0 0
LRP6/FZD1 0.019 0.001 -10000 0 -10000 0 0
SMAD4 0.012 0 -10000 0 -10000 0 0
DKK2 -0.085 0.24 -10000 0 -0.67 33 33
TLE1 0.023 0.019 -10000 0 -10000 0 0
MACF1 0.013 0.001 -10000 0 -10000 0 0
CTNNB1 0.069 0.099 0.23 32 -0.29 1 33
WIF1 -0.14 0.29 -10000 0 -0.7 49 49
beta catenin/RanBP3 0.1 0.16 0.34 45 -10000 0 45
KREMEN2 -0.088 0.25 -10000 0 -0.7 33 33
DKK1 -0.14 0.29 -10000 0 -0.7 50 50
beta catenin/beta TrCP1 0.072 0.093 0.23 22 -10000 0 22
FZD1 0.013 0.001 -10000 0 -10000 0 0
AXIN2 -0.17 0.26 -10000 0 -0.51 83 83
AXIN1 0.013 0.001 -10000 0 -10000 0 0
RAN 0.013 0.001 -10000 0 -10000 0 0
Axin1/APC/GSK3/beta catenin 0.04 0.037 -10000 0 -10000 0 0
beta catenin/TCF/CtBP/CBP/TLE1/AES/SMAD4 0.026 0.097 -10000 0 -10000 0 0
Axin1/APC/GSK3 0.097 0.061 0.19 29 -10000 0 29
Axin1/APC/GSK3/beta catenin/Macf1 0.061 0.048 -10000 0 -0.3 1 1
HNF1A 0.024 0.02 -10000 0 -10000 0 0
CTBP1 0.024 0.02 -10000 0 -10000 0 0
MYC -0.041 0.13 -10000 0 -0.57 11 11
RANBP3 0.013 0.001 -10000 0 -10000 0 0
DKK2/LRP6/Kremen 2 -0.1 0.23 -10000 0 -0.48 59 59
NKD1 -0.38 0.35 -10000 0 -0.7 130 130
TCF4 0.024 0.021 -10000 0 -10000 0 0
TCF3 0.024 0.02 -10000 0 -10000 0 0
WNT1/LRP6/FZD1/Axin1 0.029 0.04 -10000 0 -0.4 2 2
Ran/GTP 0.011 0.002 -10000 0 -10000 0 0
CtBP/CBP/TCF/TLE1/AES 0.072 0.16 0.51 5 -10000 0 5
LEF1 -0.17 0.32 -10000 0 -0.68 64 64
DVL1 0.05 0.035 -10000 0 -10000 0 0
CSNK2A1 0.013 0 -10000 0 -10000 0 0
beta catenin/TCF/CtBP/CBP/TLE1/AES -0.018 0.1 -10000 0 -10000 0 0
DKK1/LRP6/Kremen 2 -0.14 0.26 -10000 0 -0.51 71 71
LRP6 0.013 0.001 -10000 0 -10000 0 0
CSNK1A1 0.026 0.024 -10000 0 -10000 0 0
NLK 0.01 0.005 -10000 0 -10000 0 0
CCND1 -0.03 0.094 -10000 0 -0.52 4 4
WNT1 0.003 0.065 -10000 0 -0.7 2 2
GSK3A 0.013 0.001 -10000 0 -10000 0 0
GSK3B 0.012 0.001 -10000 0 -10000 0 0
FRAT1 0.012 0.001 -10000 0 -10000 0 0
PPP2R5D 0.18 0.15 0.31 130 -10000 0 130
APC 0.029 0.038 -10000 0 -0.37 2 2
WNT1/LRP6/FZD1 0.066 0.08 0.22 49 -10000 0 49
CREBBP 0.024 0.02 -10000 0 -10000 0 0
Calcium signaling in the CD4+ TCR pathway

Figure S22.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S22.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC1 -0.007 0.037 -9999 0 -10000 0 0
NFATC2 -0.011 0.048 -9999 0 -0.23 2 2
NFATC3 -0.006 0.033 -9999 0 -10000 0 0
CD40LG -0.12 0.23 -9999 0 -0.55 32 32
PTGS2 -0.12 0.25 -9999 0 -0.62 29 29
JUNB 0.012 0 -9999 0 -10000 0 0
CaM/Ca2+/Calcineurin A alpha-beta B1 -0.005 0.02 -9999 0 -10000 0 0
CaM/Ca2+ -0.005 0.02 -9999 0 -10000 0 0
CALM1 0.005 0.011 -9999 0 -10000 0 0
JUN 0.007 0.011 -9999 0 -10000 0 0
mol:Ca2+ -0.01 0.013 -9999 0 -10000 0 0
Calcineurin A alpha-beta B1/FKBP12/FK506 0.004 0.007 -9999 0 -10000 0 0
FOSL1 -0.41 0.35 -9999 0 -0.7 138 138
CREM 0.012 0 -9999 0 -10000 0 0
Jun/NFAT1-c-4/p21SNFT -0.06 0.15 -9999 0 -0.57 6 6
FOS 0.004 0.031 -9999 0 -0.31 2 2
IFNG -0.15 0.28 -9999 0 -0.66 41 41
AP-1/NFAT1-c-4 -0.13 0.26 -9999 0 -0.63 28 28
FASLG -0.11 0.23 -9999 0 -0.56 28 28
NFAT1-c-4/ICER1 -0.026 0.086 -9999 0 -0.42 1 1
IL2RA -0.11 0.23 -9999 0 -0.56 28 28
FKBP12/FK506 0.009 0 -9999 0 -10000 0 0
CSF2 -0.24 0.35 -9999 0 -0.63 94 94
JunB/Fra1/NFAT1-c-4 -0.24 0.21 -9999 0 -0.46 82 82
IL4 -0.11 0.22 -9999 0 -0.54 28 28
IL2 -0.006 0.011 -9999 0 -10000 0 0
IL3 -0.016 0.018 -9999 0 -10000 0 0
FKBP1A 0.012 0 -9999 0 -10000 0 0
BATF3 -0.003 0.1 -9999 0 -0.7 5 5
mol:FK506 0 0 -9999 0 -10000 0 0
POU2F1 0.012 0.001 -9999 0 -10000 0 0
Nephrin/Neph1 signaling in the kidney podocyte

Figure S23.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S23.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
positive regulation of NF-kappaB transcription factor activity 0.048 0.17 0.52 27 -10000 0 27
KIRREL 0.005 0.02 -10000 0 -10000 0 0
Nephrin/NEPH1Par3/Par6/Atypical PKCs -0.048 0.17 -10000 0 -0.52 27 27
PLCG1 0.012 0 -10000 0 -10000 0 0
ARRB2 0.012 0 -10000 0 -10000 0 0
WASL 0.012 0 -10000 0 -10000 0 0
Nephrin/NEPH1/podocin/CD2AP -0.028 0.14 -10000 0 -0.39 29 29
ChemicalAbstracts:57-88-5 0 0 -10000 0 -10000 0 0
Nephrin/NEPH1/podocin/NCK1-2/N-WASP -0.005 0.085 -10000 0 -0.45 1 1
FYN -0.029 0.12 -10000 0 -0.35 29 29
mol:Ca2+ -0.029 0.14 -10000 0 -0.39 29 29
mol:DAG -0.028 0.14 -10000 0 -0.39 29 29
NPHS2 -0.01 0.083 -10000 0 -0.71 3 3
mol:IP3 -0.028 0.14 -10000 0 -0.39 29 29
regulation of endocytosis -0.018 0.12 -10000 0 -0.32 29 29
Nephrin/NEPH1/podocin/Cholesterol -0.036 0.14 -10000 0 -0.4 29 29
establishment of cell polarity -0.048 0.17 -10000 0 -0.52 27 27
Nephrin/NEPH1/podocin/NCK1-2 -0.018 0.13 -10000 0 -0.35 29 29
Nephrin/NEPH1/beta Arrestin2 -0.018 0.12 -10000 0 -0.33 29 29
NPHS1 -0.071 0.23 -10000 0 -0.69 27 27
Nephrin/NEPH1/podocin -0.027 0.12 -10000 0 -0.35 29 29
TJP1 0.012 0 -10000 0 -10000 0 0
NCK1 0.012 0 -10000 0 -10000 0 0
NCK2 0.012 0 -10000 0 -10000 0 0
heterophilic cell adhesion 0 0 -10000 0 -10000 0 0
Nephrin/NEPH1/podocin/PLCgamma1 -0.028 0.14 -10000 0 -0.39 29 29
CD2AP 0.012 0 -10000 0 -10000 0 0
Nephrin/NEPH1/podocin/GRB2 -0.028 0.14 -10000 0 -0.39 29 29
GRB2 0.012 0 -10000 0 -10000 0 0
homophilic cell adhesion 0 0 -10000 0 -10000 0 0
TRPC6 -0.029 0.13 -10000 0 -0.36 30 30
cytoskeleton organization -0.009 0.11 -10000 0 -0.39 3 3
Nephrin/NEPH1 -0.033 0.13 -10000 0 -0.38 27 27
Nephrin/NEPH1/ZO-1 -0.03 0.14 -10000 0 -0.42 27 27
IL1-mediated signaling events

Figure S24.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S24.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
UBC13/UEV1A 0.014 0.005 -9999 0 -10000 0 0
PRKCZ 0.012 0 -9999 0 -10000 0 0
MAP3K7IP2 0 0 -9999 0 -10000 0 0
ERC1 0.012 0 -9999 0 -10000 0 0
IL1 beta fragment/IL1R1/IL1RAP/MYD88/IRAK4 -0.012 0.08 -9999 0 -10000 0 0
IRAK/TOLLIP 0.025 0.003 -9999 0 -10000 0 0
IKBKB 0.009 0.046 -9999 0 -0.7 1 1
IKBKG 0.012 0 -9999 0 -10000 0 0
IL1 alpha/IL1R2 -0.25 0.26 -9999 0 -0.53 98 98
IL1A -0.29 0.35 -9999 0 -0.7 98 98
IL1B -0.082 0.21 -9999 0 -0.52 43 43
IRAK/TRAF6/p62/Atypical PKCs 0.04 0.002 -9999 0 -10000 0 0
IL1R2 -0.044 0.12 -9999 0 -0.3 42 42
IL1R1 0.008 0.035 -9999 0 -0.3 3 3
IL1 beta fragment/IL1R1/IL1RAP/MYD88/IRAK4/IRAK/TOLLIP -0.001 0.071 -9999 0 -10000 0 0
TOLLIP 0.012 0 -9999 0 -10000 0 0
TICAM2 0.009 0.029 -9999 0 -0.3 2 2
MAP3K3 0.012 0 -9999 0 -10000 0 0
TAK1/TAB1/TAB2 0.008 0 -9999 0 -10000 0 0
IKK complex/ELKS 0.053 0.015 -9999 0 -10000 0 0
JUN 0.034 0.003 -9999 0 -10000 0 0
MAP3K7 0.012 0 -9999 0 -10000 0 0
IL1 beta fragment/IL1R1/IL1RAP/PI3K -0.035 0.15 -9999 0 -0.36 43 43
IL1 alpha/IL1R1/IL1RAP/MYD88 -0.15 0.22 -9999 0 -0.4 98 98
PIK3R1 0.012 0 -9999 0 -10000 0 0
IL1 alpha/IL1R1/IL1RAP/MYD88/IRAK4 -0.14 0.2 -9999 0 -0.38 98 98
IL1 beta fragment/IL1R1/IL1RAP -0.053 0.17 -9999 0 -0.4 43 43
NFKB1 0.012 0 -9999 0 -10000 0 0
MAPK8 0.031 0.003 -9999 0 -10000 0 0
IRAK1 0.019 0.004 -9999 0 -10000 0 0
IL1RN/IL1R1 -0.12 0.24 -9999 0 -0.52 60 60
IRAK4 0.012 0 -9999 0 -10000 0 0
PRKCI 0.012 0 -9999 0 -10000 0 0
TRAF6 0.012 0 -9999 0 -10000 0 0
PI3K 0.019 0 -9999 0 -10000 0 0
IL1 beta fragment/IL1R1/IL1RAP/MYD88/IRAK4/TOLLIP -0.01 0.088 -9999 0 -10000 0 0
CHUK 0.012 0 -9999 0 -10000 0 0
IL1 beta fragment/IL1R1/IL1RAP/MYD88s -0.053 0.17 -9999 0 -0.4 43 43
IL1 beta/IL1R2 -0.096 0.18 -9999 0 -0.44 44 44
IRAK/TRAF6/TAK1/TAB1/TAB2 0.027 0.002 -9999 0 -10000 0 0
NF kappa B1 p50/RelA -0.061 0.12 -9999 0 -10000 0 0
IRAK3 0.01 0.029 -9999 0 -0.3 2 2
IL1 beta fragment/IL1R1/IL1RAP/TICAM2/IRAK4 -0.037 0.15 -9999 0 -0.36 43 43
IL1 alpha/IL1R1/IL1RAP/MYD88/IRAK4/TOLLIP -0.072 0.12 -9999 0 -0.38 1 1
IL1 alpha/IL1R1/IL1RAP -0.18 0.23 -9999 0 -0.45 98 98
RELA 0.012 0 -9999 0 -10000 0 0
MAP3K7IP1 0 0 -9999 0 -10000 0 0
SQSTM1 0.012 0 -9999 0 -10000 0 0
MYD88 0.012 0 -9999 0 -10000 0 0
IRAK/TRAF6/MEKK3 0.032 0.003 -9999 0 -10000 0 0
IL1RAP 0.012 0 -9999 0 -10000 0 0
UBE2N 0.012 0 -9999 0 -10000 0 0
IRAK/TRAF6 -0.057 0.12 -9999 0 -10000 0 0
CASP1 0.012 0 -9999 0 -10000 0 0
IL1RN/IL1R2 -0.16 0.23 -9999 0 -0.53 60 60
IL1 beta fragment/IL1R1/IL1RAP/MYD88 -0.043 0.16 -9999 0 -0.38 43 43
TMEM189-UBE2V1 0.006 0.006 -9999 0 -10000 0 0
IL1 alpha/IL1R1/IL1RAP/MYD88/IRAK4/IRAK/TOLLIP -0.043 0.094 -9999 0 -0.41 1 1
PIK3CA 0.012 0 -9999 0 -10000 0 0
IL1RN -0.17 0.31 -9999 0 -0.7 60 60
TRAF6/TAK1/TAB1/TAB2 0.021 0.003 -9999 0 -10000 0 0
MAP2K6 0.027 0.003 -9999 0 -10000 0 0
Ephrin A reverse signaling

Figure S25.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S25.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MAPKKK cascade -0.046 0.094 -9999 0 -0.32 8 8
EFNA5 -0.039 0.12 -9999 0 -0.3 38 38
FYN -0.035 0.084 -9999 0 -0.28 8 8
neuron projection morphogenesis -0.046 0.094 -9999 0 -0.32 8 8
cell-cell signaling 0 0 -9999 0 -10000 0 0
Ephrin A5/EPHA5 -0.046 0.094 -9999 0 -0.32 8 8
EPHA5 -0.047 0.12 -9999 0 -0.3 41 41
Syndecan-2-mediated signaling events

Figure S26.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S26.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Syndecan-2/Fibronectin -0.024 0.14 -9999 0 -0.44 22 22
EPHB2 0.009 0.046 -9999 0 -0.7 1 1
Syndecan-2/TACI -0.054 0.088 -9999 0 -0.32 1 1
LAMA1 -0.048 0.12 -9999 0 -0.3 45 45
Syndecan-2/alpha2 ITGB1 0.018 0.095 -9999 0 -0.48 7 7
HRAS 0.012 0 -9999 0 -10000 0 0
Syndecan-2/CASK 0.012 0.011 -9999 0 -10000 0 0
ITGA5 0.012 0 -9999 0 -10000 0 0
BAX 0.032 0.002 -9999 0 -10000 0 0
EPB41 0.012 0 -9999 0 -10000 0 0
positive regulation of cell-cell adhesion 0.019 0.01 -9999 0 -10000 0 0
LAMA3 0.005 0.069 -9999 0 -0.56 3 3
EZR 0.012 0 -9999 0 -10000 0 0
mol:PI-4-5-P2 0 0 -9999 0 -10000 0 0
CAV2 0.009 0.046 -9999 0 -0.7 1 1
Syndecan-2/MMP2 0.015 0.054 -9999 0 -0.45 3 3
RP11-540L11.1 0 0 -9999 0 -10000 0 0
alpha2 ITGB1 0.002 0.092 -9999 0 -0.52 7 7
dendrite morphogenesis 0.019 0.033 -9999 0 -0.44 1 1
Syndecan-2/GM-CSF -0.16 0.23 -9999 0 -0.45 92 92
determination of left/right symmetry 0.016 0.014 -9999 0 -10000 0 0
Syndecan-2/PKC delta 0.021 0.011 -9999 0 -10000 0 0
GNB2L1 0.012 0 -9999 0 -10000 0 0
MAPK3 -0.14 0.21 -9999 0 -0.4 92 92
MAPK1 -0.14 0.21 -9999 0 -0.4 92 92
Syndecan-2/RACK1 0.026 0.01 -9999 0 -10000 0 0
NF1 0.012 0 -9999 0 -10000 0 0
FGFR/FGF/Syndecan-2 0.016 0.014 -9999 0 -10000 0 0
ITGA2 -0.009 0.12 -9999 0 -0.7 7 7
MAPK8 0.027 0.002 -9999 0 -10000 0 0
Syndecan-2/alpha2/beta1 Integrin -0.008 0.091 -9999 0 -0.4 7 7
Syndecan-2/Kininogen -0.024 0.079 -9999 0 -0.45 1 1
ITGB1 0.012 0 -9999 0 -10000 0 0
SRC 0.029 0.009 -9999 0 -10000 0 0
Syndecan-2/CASK/Protein 4.1 0.019 0.01 -9999 0 -10000 0 0
extracellular matrix organization 0.021 0.011 -9999 0 -10000 0 0
actin cytoskeleton reorganization -0.024 0.14 -9999 0 -0.44 22 22
Syndecan-2/Caveolin-2/Ras 0.026 0.03 -9999 0 -0.4 1 1
Syndecan-2/Laminin alpha3 0.016 0.046 -9999 0 -0.45 2 2
Syndecan-2/RasGAP 0.032 0.009 -9999 0 -10000 0 0
alpha5/beta1 Integrin 0.019 0 -9999 0 -10000 0 0
PRKCD 0.012 0 -9999 0 -10000 0 0
Syndecan-2 dimer 0.019 0.033 -9999 0 -0.45 1 1
GO:0007205 0.003 0 -9999 0 -10000 0 0
DNA mediated transformation 0 0 -9999 0 -10000 0 0
Syndecan-2/RasGAP/Src 0.036 0.009 -9999 0 -10000 0 0
RHOA 0.012 0 -9999 0 -10000 0 0
SDCBP 0.012 0 -9999 0 -10000 0 0
TNFRSF13B -0.12 0.15 -9999 0 -0.3 97 97
RASA1 0.012 0 -9999 0 -10000 0 0
alpha2/beta1 Integrin 0.002 0.092 -9999 0 -0.52 7 7
Syndecan-2/Synbindin 0.021 0.011 -9999 0 -10000 0 0
TGFB1 0.012 0 -9999 0 -10000 0 0
CASP3 0.026 0.01 -9999 0 -10000 0 0
FN1 -0.057 0.21 -9999 0 -0.63 25 25
Syndecan-2/IL8 -0.25 0.23 -9999 0 -0.45 136 136
SDC2 0.016 0.014 -9999 0 -10000 0 0
KNG1 -0.065 0.14 -9999 0 -0.31 54 54
Syndecan-2/Neurofibromin 0.021 0.011 -9999 0 -10000 0 0
TRAPPC4 0.012 0 -9999 0 -10000 0 0
CSF2 -0.27 0.35 -9999 0 -0.7 92 92
Syndecan-2/TGFB1 0.021 0.011 -9999 0 -10000 0 0
Syndecan-2/Syntenin/PI-4-5-P2 0.019 0.01 -9999 0 -10000 0 0
Syndecan-2/Ezrin 0.028 0.01 -9999 0 -10000 0 0
PRKACA 0.026 0.01 -9999 0 -10000 0 0
angiogenesis -0.25 0.23 -9999 0 -0.45 136 136
MMP2 0.003 0.08 -9999 0 -0.7 3 3
IL8 -0.4 0.35 -9999 0 -0.7 136 136
calcineurin-NFAT signaling pathway -0.054 0.087 -9999 0 -0.31 1 1
Presenilin action in Notch and Wnt signaling

Figure S27.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S27.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Delta 1/NOTCH/NOTCH(cleaved) 0 0.026 -10000 0 -0.37 1 1
HDAC1 0.01 0.006 -10000 0 -10000 0 0
AES 0.012 0.001 -10000 0 -10000 0 0
FBXW11 0.012 0 -10000 0 -10000 0 0
DTX1 0.007 0.055 -10000 0 -0.43 3 3
LRP6/FZD1 0.019 0 -10000 0 -10000 0 0
TLE1 0.012 0.001 -10000 0 -10000 0 0
AP1 -0.12 0.13 -10000 0 -0.24 129 129
NCSTN 0.012 0 -10000 0 -10000 0 0
ADAM10 0.012 0 -10000 0 -10000 0 0
Beta Catenin/TCF1/CtBP/CBP/TLE1/AES/SMAD4 0.047 0.043 -10000 0 -10000 0 0
NICD/RBPSUH 0.03 0.001 -10000 0 -10000 0 0
WIF1 -0.14 0.29 -10000 0 -0.7 49 49
NOTCH1 0.001 0.006 -10000 0 -10000 0 0
PSENEN 0.012 0 -10000 0 -10000 0 0
KREMEN2 -0.088 0.25 -10000 0 -0.7 33 33
DKK1 -0.14 0.29 -10000 0 -0.7 50 50
beta catenin/beta TrCP1 0.11 0.078 -10000 0 -10000 0 0
APH1B 0.012 0 -10000 0 -10000 0 0
APH1A 0.012 0 -10000 0 -10000 0 0
AXIN1 -0.032 0.034 -10000 0 -10000 0 0
CtBP/CBP/TCF1/TLE1/AES 0.024 0.023 -10000 0 -10000 0 0
PSEN1 0.012 0 -10000 0 -10000 0 0
FOS 0.01 0.029 -10000 0 -0.3 2 2
JUN 0.012 0 -10000 0 -10000 0 0
MAP3K7 0.012 0.003 -10000 0 -10000 0 0
CTNNB1 0.11 0.084 0.19 80 -10000 0 80
MAPK3 0.012 0 -10000 0 -10000 0 0
DKK2/LRP6/Kremen 2 -0.1 0.23 -10000 0 -0.48 59 59
HNF1A 0.012 0.001 -10000 0 -10000 0 0
CTBP1 0.012 0.001 -10000 0 -10000 0 0
MYC -0.001 0.11 -10000 0 -0.51 11 11
NKD1 -0.38 0.35 -10000 0 -0.69 130 130
FZD1 0.012 0 -10000 0 -10000 0 0
NOTCH1 precursor/Deltex homolog 1 0.028 0.026 -10000 0 -0.37 1 1
apoptosis -0.12 0.13 -10000 0 -0.24 129 129
Delta 1/NOTCHprecursor 0.028 0.026 -10000 0 -0.37 1 1
DLL1 0.008 0.051 -10000 0 -0.5 2 2
PPARD 0.021 0.016 -10000 0 -10000 0 0
Gamma Secretase 0.037 0.001 -10000 0 -10000 0 0
APC -0.032 0.034 -10000 0 -10000 0 0
DVL1 0.008 0.037 -10000 0 -10000 0 0
CSNK2A1 0.013 0.001 -10000 0 -10000 0 0
MAP3K7IP1 -0.001 0.003 -10000 0 -10000 0 0
DKK1/LRP6/Kremen 2 -0.14 0.26 -10000 0 -0.51 71 71
LRP6 0.012 0 -10000 0 -10000 0 0
CSNK1A1 0.013 0.001 -10000 0 -10000 0 0
NLK 0.012 0.007 -10000 0 -10000 0 0
CCND1 0.013 0.071 -10000 0 -0.51 4 4
WNT1 0.003 0.065 -10000 0 -0.7 2 2
Axin1/APC/beta catenin 0.062 0.037 -10000 0 -10000 0 0
DKK2 -0.085 0.24 -10000 0 -0.67 33 33
NOTCH1 precursor/DVL1 -0.004 0.014 -10000 0 -10000 0 0
GSK3B 0.012 0.001 -10000 0 -10000 0 0
FRAT1 0.012 0.002 -10000 0 -10000 0 0
NOTCH/Deltex homolog 1 -0.001 0.027 -10000 0 -0.37 1 1
PPP2R5D 0.16 0.15 0.3 130 -10000 0 130
MAPK1 0.012 0 -10000 0 -10000 0 0
WNT1/LRP6/FZD1 -0.068 0.18 -10000 0 -0.4 51 51
RBPJ 0.012 0 -10000 0 -10000 0 0
CREBBP 0.014 0.004 -10000 0 -10000 0 0
Fc-epsilon receptor I signaling in mast cells

Figure S28.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S28.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PPAP2A 0.011 0.021 -9999 0 -0.3 1 1
LAT2 -0.064 0.13 -9999 0 -0.31 33 33
AP1 -0.072 0.18 -9999 0 -0.54 20 20
mol:PIP3 -0.072 0.16 -9999 0 -0.37 36 36
IKBKB -0.051 0.12 -9999 0 -0.27 32 32
AKT1 -0.019 0.085 -9999 0 -10000 0 0
IKBKG -0.05 0.12 -9999 0 -0.27 31 31
MS4A2 -0.075 0.14 -9999 0 -0.3 64 64
mol:Sphingosine-1-phosphate 0 0 -9999 0 -10000 0 0
PIK3CA 0.012 0.001 -9999 0 -10000 0 0
MAP3K1 -0.054 0.14 -9999 0 -0.4 17 17
mol:Ca2+ -0.053 0.13 -9999 0 -0.29 36 36
LYN 0.013 0.002 -9999 0 -10000 0 0
CBLB -0.063 0.12 -9999 0 -0.31 33 33
SHC1 0.012 0 -9999 0 -10000 0 0
RasGAP/p62DOK 0.024 0 -9999 0 -10000 0 0
positive regulation of cell migration 0 0 -9999 0 -10000 0 0
INPP5D 0.012 0 -9999 0 -10000 0 0
PLD2 -0.045 0.097 -9999 0 -0.35 1 1
PTPN13 -0.086 0.16 -9999 0 -0.35 44 44
PTPN11 0.009 0.007 -9999 0 -10000 0 0
GO:0007205 0 0 -9999 0 -10000 0 0
regulation of mast cell degranulation -0.025 0.1 -9999 0 -0.33 1 1
SYK 0.013 0.002 -9999 0 -10000 0 0
GRB2 0.012 0.001 -9999 0 -10000 0 0
LAT/PLCgamma1/GRB2/SLP76/GADs -0.1 0.14 -9999 0 -0.38 40 40
LAT -0.063 0.12 -9999 0 -0.31 33 33
PAK2 -0.066 0.16 -9999 0 -0.45 18 18
NFATC2 -0.043 0.097 -9999 0 -0.52 8 8
HRAS -0.077 0.17 -9999 0 -0.39 41 41
GAB2 0.012 0 -9999 0 -10000 0 0
PLA2G1B 0.031 0.017 -9999 0 -10000 0 0
Fc epsilon R1 -0.076 0.12 -9999 0 -0.31 33 33
Antigen/IgE/Fc epsilon R1 -0.065 0.11 -9999 0 -0.28 33 33
mol:GDP -0.091 0.19 -9999 0 -0.44 41 41
JUN 0.012 0 -9999 0 -10000 0 0
mol:Ca++ 0 0 -9999 0 -10000 0 0
PIK3R1 0.012 0.001 -9999 0 -10000 0 0
FOS 0.01 0.029 -9999 0 -0.3 2 2
Antigen/IgE/Fc epsilon R1/LYN/SYK -0.072 0.13 -9999 0 -0.33 33 33
CHUK -0.05 0.12 -9999 0 -0.27 31 31
KLRG1 -0.042 0.11 -9999 0 -0.27 33 33
VAV1 -0.067 0.13 -9999 0 -0.32 36 36
calcium-dependent protein kinase C activity 0 0 -9999 0 -10000 0 0
CBL -0.063 0.12 -9999 0 -0.31 33 33
negative regulation of mast cell degranulation -0.046 0.1 -9999 0 -0.37 2 2
BTK -0.1 0.21 -9999 0 -0.5 41 41
Fc epsilon R1/FcgammaRIIB/SHIP/RasGAP/p62DOK -0.099 0.18 -9999 0 -0.42 46 46
GAB2/PI3K/SHP2 -0.051 0.07 -9999 0 -10000 0 0
Antigen/IgE/Fc epsilon R1/LYN/SYK/WIP -0.068 0.13 -9999 0 -0.34 33 33
RAF1 0.023 0.021 -9999 0 -10000 0 0
Fc epsilon R1/FcgammaRIIB/SHIP -0.066 0.13 -9999 0 -0.38 16 16
FCER1G 0.015 0.023 -9999 0 -0.31 1 1
FCER1A -0.087 0.15 -9999 0 -0.31 71 71
Antigen/IgE/Fc epsilon R1/Fyn -0.053 0.1 -9999 0 -0.37 1 1
MAPK3 0.03 0.018 -9999 0 -10000 0 0
MAPK1 0.03 0.018 -9999 0 -10000 0 0
NFKB1 0.012 0 -9999 0 -10000 0 0
MAPK8 -0.008 0.062 -9999 0 -0.47 1 1
DUSP1 0.012 0 -9999 0 -10000 0 0
NF-kappa-B/RelA -0.045 0.058 -9999 0 -0.21 1 1
actin cytoskeleton reorganization -0.075 0.15 -9999 0 -0.36 33 33
mol:Glucocorticoid Dexamethasone 0 0 -9999 0 -10000 0 0
PI3K -0.086 0.12 -9999 0 -0.41 14 14
FER -0.063 0.12 -9999 0 -0.31 33 33
RELA 0.012 0 -9999 0 -10000 0 0
ITK -0.022 0.08 -9999 0 -0.34 11 11
SOS1 0.012 0 -9999 0 -10000 0 0
PLCG1 -0.086 0.19 -9999 0 -0.43 41 41
cytokine secretion -0.033 0.042 -9999 0 -10000 0 0
SPHK1 -0.12 0.17 -9999 0 -0.35 65 65
PTK2 -0.078 0.15 -9999 0 -0.37 33 33
NTAL/PLCgamma1/GRB2/SLP76/GADs -0.11 0.15 -9999 0 -0.39 37 37
EDG1 0 0 -9999 0 -10000 0 0
mol:DAG -0.069 0.16 -9999 0 -0.37 36 36
MAP2K2 0.027 0.018 -9999 0 -10000 0 0
MAP2K1 0.027 0.018 -9999 0 -10000 0 0
MAP2K7 0.012 0 -9999 0 -10000 0 0
KLRG1/SHP2 -0.044 0.097 -9999 0 -0.36 2 2
MAP2K4 0.011 0.058 -9999 0 -0.86 1 1
Fc epsilon R1/FcgammaRIIB -0.078 0.14 -9999 0 -0.42 16 16
mol:Choline -0.045 0.096 -9999 0 -0.34 1 1
SHC/Grb2/SOS1 -0.048 0.12 -9999 0 -0.4 2 2
FYN 0.012 0 -9999 0 -10000 0 0
DOK1 0.012 0 -9999 0 -10000 0 0
PXN -0.068 0.14 -9999 0 -0.34 33 33
HCLS1 -0.063 0.13 -9999 0 -0.31 33 33
PRKCB -0.078 0.16 -9999 0 -0.34 48 48
FCGR2B -0.028 0.1 -9999 0 -0.3 30 30
IGHE -0.001 0.003 -9999 0 -10000 0 0
KLRG1/SHIP -0.046 0.11 -9999 0 -0.38 2 2
LCP2 0.012 0.001 -9999 0 -10000 0 0
PLA2G4A -0.076 0.14 -9999 0 -0.31 49 49
RASA1 0.012 0 -9999 0 -10000 0 0
mol:Phosphatidic acid -0.045 0.096 -9999 0 -0.34 1 1
IKK complex -0.028 0.092 -9999 0 -0.2 26 26
WIPF1 0.012 0 -9999 0 -10000 0 0
amb2 Integrin signaling

Figure S29.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S29.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
alphaM/beta2 Integrin/proMMP-2 0.009 0.082 -9999 0 -0.51 4 4
alphaM/beta2 Integrin/GPIbA 0.01 0.062 -9999 0 -0.4 3 3
alphaM/beta2 Integrin/proMMP-9 -0.092 0.2 -9999 0 -0.45 54 54
PLAUR 0.009 0.046 -9999 0 -0.7 1 1
HMGB1 0.011 0.012 -9999 0 -10000 0 0
alphaM/beta2 Integrin/Talin 0.015 0.051 -9999 0 -0.38 2 2
AGER 0.008 0.051 -9999 0 -0.74 1 1
RAP1A 0.012 0 -9999 0 -10000 0 0
SELPLG 0.012 0 -9999 0 -10000 0 0
mol:LDL 0 0 -9999 0 -10000 0 0
alphaM/beta2 Integrin/RAGE/HMGB1 0.018 0.078 -9999 0 -0.48 2 2
mol:GTP 0 0 -9999 0 -10000 0 0
MMP9 -0.15 0.3 -9999 0 -0.7 53 53
CYR61 0.009 0.046 -9999 0 -0.7 1 1
TLN1 0.012 0 -9999 0 -10000 0 0
Rap1/GTP -0.057 0.088 -9999 0 -0.31 14 14
RHOA 0.012 0 -9999 0 -10000 0 0
P-selectin oligomer -0.044 0.12 -9999 0 -0.3 42 42
MYH2 -0.06 0.13 -9999 0 -0.39 19 19
MST1R 0.012 0 -9999 0 -10000 0 0
leukocyte activation during inflammatory response -0.034 0.11 -9999 0 -0.38 16 16
APOB -0.074 0.18 -9999 0 -0.38 49 49
mol:GDP 0 0 -9999 0 -10000 0 0
complement component iC3b receptor activity 0 0 -9999 0 -10000 0 0
MMP2 0.003 0.08 -9999 0 -0.7 3 3
JAM3 0.012 0 -9999 0 -10000 0 0
GP1BA 0.006 0.055 -9999 0 -0.43 3 3
alphaM/beta2 Integrin/CTGF 0.004 0.085 -9999 0 -0.43 7 7
alphaM/beta2 Integrin -0.054 0.12 -9999 0 -0.33 23 23
JAM3 homodimer 0.012 0 -9999 0 -10000 0 0
ICAM2 0.012 0 -9999 0 -10000 0 0
ICAM1 -0.003 0.1 -9999 0 -0.7 5 5
phagocytosis triggered by activation of immune response cell surface activating receptor -0.054 0.12 -9999 0 -0.33 23 23
cell adhesion 0.01 0.061 -9999 0 -0.4 3 3
NFKB1 0.017 0.1 -9999 0 -0.5 2 2
THY1 0.006 0.066 -9999 0 -0.7 2 2
RhoA/GDP 0.009 0 -9999 0 -10000 0 0
Lipoprotein(a) -0.045 0.12 -9999 0 -0.46 13 13
alphaM/beta2 Integrin/LRP/tPA 0.022 0.047 -9999 0 -0.4 1 1
IL6 -0.003 0.17 -9999 0 -0.55 20 20
ITGB2 0.005 0.055 -9999 0 -0.43 3 3
elevation of cytosolic calcium ion concentration -0.082 0.19 -9999 0 -0.41 57 57
alphaM/beta2 Integrin/JAM2/JAM3 -0.019 0.088 -9999 0 -0.41 2 2
JAM2 -0.067 0.14 -9999 0 -0.3 59 59
alphaM/beta2 Integrin/ICAM1 -0.066 0.18 -9999 0 -0.38 54 54
alphaM/beta2 Integrin/uPA/Plg -0.088 0.19 -9999 0 -0.42 57 57
RhoA/GTP -0.065 0.14 -9999 0 -0.42 19 19
positive regulation of phagocytosis -0.037 0.092 -9999 0 -0.37 7 7
Ron/MSP -0.093 0.22 -9999 0 -0.52 48 48
alphaM/beta2 Integrin/uPAR/uPA -0.082 0.19 -9999 0 -0.41 57 57
alphaM/beta2 Integrin/uPAR 0.012 0.059 -9999 0 -0.4 3 3
PLAU -0.16 0.3 -9999 0 -0.7 55 55
PLAT 0.012 0 -9999 0 -10000 0 0
actin filament polymerization -0.058 0.13 -9999 0 -0.38 19 19
MST1 -0.13 0.29 -9999 0 -0.7 48 48
alphaM/beta2 Integrin/lipoprotein(a) -0.033 0.11 -9999 0 -0.38 16 16
TNF 0.021 0.1 -9999 0 -0.56 2 2
RAP1B 0.012 0 -9999 0 -10000 0 0
alphaM/beta2 Integrin/uPA -0.096 0.21 -9999 0 -0.46 56 56
fibrinolysis -0.088 0.19 -9999 0 -0.42 57 57
HCK 0.01 0.029 -9999 0 -0.3 2 2
dendritic cell antigen processing and presentation -0.054 0.12 -9999 0 -0.33 23 23
VTN -0.013 0.13 -9999 0 -0.7 8 8
alphaM/beta2 Integrin/CYR61 0.013 0.061 -9999 0 -0.41 3 3
LPA -0.002 0.08 -9999 0 -0.7 3 3
LRP1 0.012 0 -9999 0 -10000 0 0
cell migration -0.083 0.2 -9999 0 -0.43 53 53
FN1 -0.057 0.21 -9999 0 -0.63 25 25
alphaM/beta2 Integrin/Thy1 0.01 0.066 -9999 0 -0.41 4 4
MPO -0.019 0.14 -9999 0 -0.7 10 10
KNG1 -0.065 0.14 -9999 0 -0.31 54 54
RAP1/GDP 0.017 0 -9999 0 -10000 0 0
ROCK1 -0.056 0.13 -9999 0 -0.39 19 19
ELA2 0 0 -9999 0 -10000 0 0
PLG -0.001 0.046 -9999 0 -0.7 1 1
CTGF -0.003 0.1 -9999 0 -0.7 5 5
alphaM/beta2 Integrin/Hck 0.013 0.059 -9999 0 -0.4 3 3
ITGAM 0 0.057 -9999 0 -0.3 8 8
alphaM/beta2 Integrin/P-Selectin/PSGL1 -0.007 0.082 -9999 0 -0.41 2 2
HP -0.045 0.19 -9999 0 -0.7 18 18
leukocyte adhesion -0.011 0.096 -9999 0 -0.41 2 2
SELP -0.044 0.12 -9999 0 -0.3 42 42
Glypican 2 network

Figure S30.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S30.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MDK 0 0.092 -9999 0 -0.7 4 4
GPC2 -0.037 0.18 -9999 0 -0.7 16 16
GPC2/Midkine -0.028 0.15 -9999 0 -0.52 20 20
neuron projection morphogenesis -0.028 0.15 -9999 0 -0.52 20 20
Wnt signaling

Figure S31.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S31.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Noncanonical Wnts/FZD -0.063 0.13 -9999 0 -0.41 13 13
FZD6 0.012 0 -9999 0 -10000 0 0
WNT6 -0.035 0.14 -9999 0 -0.41 25 25
WNT4 -0.003 0.084 -9999 0 -0.39 9 9
FZD3 0 0.092 -9999 0 -0.7 4 4
WNT5A -0.021 0.15 -9999 0 -0.7 11 11
WNT11 -0.13 0.28 -9999 0 -0.67 48 48
Ras signaling in the CD4+ TCR pathway

Figure S32.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S32.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ERK1-2/ELK1 -0.005 0.11 -9999 0 -0.4 6 6
MAP3K8 0.013 0 -9999 0 -10000 0 0
FOS -0.015 0.1 -9999 0 -0.38 6 6
PRKCA 0.013 0.001 -9999 0 -10000 0 0
PTPN7 -0.016 0.14 -9999 0 -0.62 11 11
HRAS 0.013 0 -9999 0 -10000 0 0
PRKCB -0.062 0.13 -9999 0 -0.3 56 56
NRAS 0.013 0 -9999 0 -10000 0 0
RAS family/GTP 0.025 0.002 -9999 0 -10000 0 0
MAPK3 -0.01 0.083 -9999 0 -0.39 4 4
MAP2K1 -0.042 0.14 -9999 0 -0.29 56 56
ELK1 0.013 0.001 -9999 0 -10000 0 0
BRAF -0.048 0.14 -9999 0 -0.29 56 56
mol:GTP 0 0 -9999 0 -0.004 2 2
MAPK1 -0.01 0.083 -9999 0 -0.39 4 4
RAF1 -0.048 0.14 -9999 0 -0.29 56 56
KRAS 0.013 0 -9999 0 -10000 0 0
Effects of Botulinum toxin

Figure S33.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S33.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
STX1A -0.007 0.092 -9999 0 -0.53 7 7
UniProt:P19321 0 0 -9999 0 -10000 0 0
RIMS1/UNC13B -0.001 0.092 -9999 0 -0.52 7 7
STXBP1 0.006 0.066 -9999 0 -0.7 2 2
ACh/CHRNA1 -0.031 0.061 -9999 0 -0.24 10 10
RAB3GAP2/RIMS1/UNC13B 0.008 0.08 -9999 0 -0.45 7 7
mol:Ca2+ 0 0 -9999 0 -10000 0 0
UniProt:P30996 0 0 -9999 0 -10000 0 0
UniProt:Q60393 0 0 -9999 0 -10000 0 0
CST086 0 0 -9999 0 -10000 0 0
RIMS1 -0.013 0.12 -9999 0 -0.7 7 7
mol:ACh -0.041 0.051 -9999 0 -0.093 113 113
RAB3GAP2 0.012 0 -9999 0 -10000 0 0
STX1A/SNAP25/VAMP2 -0.063 0.089 -9999 0 -0.35 16 16
UniProt:P10844 0 0 -9999 0 -10000 0 0
muscle contraction -0.031 0.061 -9999 0 -0.24 10 10
UNC13B 0.012 0 -9999 0 -10000 0 0
CHRNA1 -0.008 0.085 -9999 0 -0.33 14 14
UniProt:P10845 0 0 -9999 0 -10000 0 0
ACh/Synaptotagmin 1 -0.039 0.073 -9999 0 -0.23 23 23
SNAP25 -0.098 0.11 -9999 0 -0.22 109 109
VAMP2 0.006 0 -9999 0 -10000 0 0
SYT1 -0.024 0.1 -9999 0 -0.3 27 27
UniProt:Q00496 0 0 -9999 0 -10000 0 0
STXIA/STXBP1 -0.002 0.09 -9999 0 -0.45 9 9
STX1A/SNAP25 fragment 1/VAMP2 -0.063 0.089 -9999 0 -0.35 16 16
JNK signaling in the CD4+ TCR pathway

Figure S34.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S34.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
LAT/GRAP2/SLP76/HPK1 0.011 0.063 -9999 0 -0.28 5 5
MAP4K1 -0.02 0.095 -9999 0 -0.3 24 24
MAP3K8 0.012 0 -9999 0 -10000 0 0
PRKCB -0.063 0.13 -9999 0 -0.3 56 56
DBNL 0.012 0 -9999 0 -10000 0 0
CRKL 0.012 0 -9999 0 -10000 0 0
MAP3K1 0.017 0.063 -9999 0 -0.28 5 5
JUN -0.096 0.23 -9999 0 -0.5 56 56
MAP3K7 0.017 0.063 -9999 0 -0.28 5 5
GRAP2 0.004 0.05 -9999 0 -0.3 6 6
CRK 0.012 0 -9999 0 -10000 0 0
MAP2K4 0.023 0.063 -9999 0 -0.28 5 5
LAT 0.012 0 -9999 0 -10000 0 0
LCP2 0.012 0 -9999 0 -10000 0 0
MAPK8 -0.11 0.24 -9999 0 -0.53 56 56
LAT/GRAP2/SLP76/HPK1/HIP-55/CRK family 0.012 0.067 -9999 0 -0.31 5 5
LAT/GRAP2/SLP76/HPK1/HIP-55 0.017 0.059 -9999 0 -10000 0 0
S1P1 pathway

Figure S35.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S35.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR2 homodimer/VEGFA homodimer -0.015 0.13 -9999 0 -0.52 15 15
PDGFRB -0.001 0.093 -9999 0 -0.7 4 4
SPHK1 -0.04 0.075 -9999 0 -0.27 4 4
mol:S1P -0.039 0.072 -9999 0 -0.28 3 3
S1P1/S1P/Gi -0.097 0.16 -9999 0 -0.37 36 36
GNAO1 -0.13 0.16 -9999 0 -0.3 103 103
PDGFB-D/PDGFRB/PLCgamma1 -0.08 0.14 -9999 0 -0.45 13 13
PLCG1 -0.086 0.15 -9999 0 -0.36 29 29
mol:GTP 0 0 -9999 0 -10000 0 0
PDGFB-D/PDGFRB -0.001 0.092 -9999 0 -0.7 4 4
GNAI2 0.013 0.004 -9999 0 -10000 0 0
GNAI3 0.011 0.003 -9999 0 -10000 0 0
GNAI1 0.006 0.041 -9999 0 -0.31 4 4
mol:GDP 0 0 -9999 0 -10000 0 0
EDG1 -0.013 0.11 -9999 0 -0.44 15 15
S1P1/S1P -0.028 0.12 -9999 0 -0.36 18 18
negative regulation of cAMP metabolic process -0.095 0.15 -9999 0 -0.36 36 36
MAPK3 -0.093 0.17 -9999 0 -0.47 21 21
calcium-dependent phospholipase C activity -0.001 0.002 -9999 0 -10000 0 0
Rac1/GDP 0.009 0 -9999 0 -10000 0 0
RhoA/GDP 0.009 0 -9999 0 -10000 0 0
KDR 0.013 0.002 -9999 0 -10000 0 0
PLCB2 -0.021 0.11 -9999 0 -0.33 16 16
RAC1 0.012 0 -9999 0 -10000 0 0
RhoA/GTP -0.037 0.096 -9999 0 -0.32 16 16
receptor internalization -0.041 0.11 -9999 0 -0.34 18 18
PTGS2 -0.096 0.21 -9999 0 -0.74 15 15
Rac1/GTP -0.037 0.096 -9999 0 -0.32 16 16
RHOA 0.012 0 -9999 0 -10000 0 0
VEGFA -0.033 0.17 -9999 0 -0.7 15 15
negative regulation of T cell proliferation -0.095 0.15 -9999 0 -0.36 36 36
GO:0007205 0 0 -9999 0 -10000 0 0
GNAZ 0.006 0.041 -9999 0 -0.3 4 4
MAPK1 -0.093 0.17 -9999 0 -0.47 21 21
S1P1/S1P/PDGFB-D/PDGFRB -0.028 0.14 -9999 0 -0.4 20 20
ABCC1 0.011 0.002 -9999 0 -10000 0 0
Syndecan-3-mediated signaling events

Figure S36.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S36.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CTTN 0.012 0 -9999 0 -10000 0 0
Syndecan-3/Src/Cortactin 0.009 0.054 -9999 0 -10000 0 0
Syndecan-3/Neurocan 0.012 0.028 -9999 0 -0.37 1 1
POMC -0.003 0.076 -9999 0 -0.34 10 10
EGFR 0.012 0 -9999 0 -10000 0 0
Syndecan-3/EGFR 0.023 0 -9999 0 -10000 0 0
AGRP 0.005 0.006 -9999 0 -10000 0 0
NCSTN 0.012 0 -9999 0 -10000 0 0
PSENEN 0.012 0 -9999 0 -10000 0 0
RP11-540L11.1 0 0 -9999 0 -10000 0 0
APH1B 0.012 0 -9999 0 -10000 0 0
APH1A 0.012 0 -9999 0 -10000 0 0
NCAN 0.005 0.047 -9999 0 -0.7 1 1
long-term memory 0.029 0 -9999 0 -10000 0 0
Syndecan-3/IL8 -0.21 0.2 -9999 0 -0.37 136 136
PSEN1 0.012 0 -9999 0 -10000 0 0
Src/Cortactin 0.019 0 -9999 0 -10000 0 0
FYN 0.012 0 -9999 0 -10000 0 0
limb bud formation 0 0 -9999 0 -10000 0 0
MC4R -0.011 0.1 -9999 0 -0.7 5 5
SRC 0.012 0 -9999 0 -10000 0 0
PTN -0.047 0.12 -9999 0 -0.3 44 44
FGFR/FGF/Syndecan-3 0 0 -9999 0 -10000 0 0
neuron projection morphogenesis -0.001 0.054 -9999 0 -0.33 1 1
Syndecan-3/AgRP 0.008 0.011 -9999 0 -10000 0 0
Syndecan-3/AgRP/MC4R 0.004 0.055 -9999 0 -0.36 5 5
Fyn/Cortactin 0.019 0 -9999 0 -10000 0 0
SDC3 0 0 -9999 0 -10000 0 0
GO:0007205 0 0 -9999 0 -10000 0 0
positive regulation of leukocyte migration -0.21 0.19 -9999 0 -0.37 136 136
IL8 -0.4 0.35 -9999 0 -0.7 136 136
Syndecan-3/Fyn/Cortactin 0.029 0 -9999 0 -10000 0 0
Syndecan-3/CASK 0 0 -9999 0 -10000 0 0
alpha-MSH/MC4R -0.01 0.1 -9999 0 -0.61 5 5
Gamma Secretase 0.037 0 -9999 0 -10000 0 0
Calcineurin-regulated NFAT-dependent transcription in lymphocytes

Figure S37.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S37.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
FOXP3 -0.083 0.25 -10000 0 -0.75 28 28
NFATC2 0.009 0.12 -10000 0 -0.65 2 2
NFATC3 -0.021 0.056 -10000 0 -10000 0 0
CD40LG -0.28 0.33 -10000 0 -0.87 26 26
ITCH 0.039 0.001 -10000 0 -10000 0 0
CBLB 0.039 0.001 -10000 0 -10000 0 0
CD4-positive CD25-positive alpha-beta regulatory T cell lineage commitment -0.18 0.28 -10000 0 -0.84 23 23
JUNB 0.012 0 -10000 0 -10000 0 0
CaM/Ca2+/Calcineurin A alpha-beta B1 0.034 0.001 -10000 0 -10000 0 0
T cell anergy 0.04 0.034 -10000 0 -10000 0 0
TLE4 0.019 0.088 -10000 0 -0.48 3 3
Jun/NFAT1-c-4/p21SNFT -0.13 0.22 -10000 0 -0.8 7 7
AP-1/NFAT1-c-4 -0.3 0.37 -10000 0 -0.89 34 34
IKZF1 0.001 0.14 -10000 0 -0.53 13 13
T-helper 2 cell differentiation -0.068 0.15 -10000 0 -0.85 4 4
AP-1/NFAT1 -0.055 0.11 -10000 0 -0.43 2 2
CALM1 0.025 0 -10000 0 -10000 0 0
EGR2 -0.034 0.19 -10000 0 -1.1 3 3
EGR3 -0.042 0.21 -10000 0 -0.99 5 5
NFAT1/FOXP3 -0.063 0.24 -10000 0 -0.61 30 30
EGR1 0.009 0.051 -10000 0 -0.5 2 2
JUN -0.027 0.035 -10000 0 -10000 0 0
EGR4 -0.14 0.29 -10000 0 -0.7 51 51
mol:Ca2+ 0.013 0 -10000 0 -10000 0 0
GBP3 0.003 0.14 -10000 0 -0.53 11 11
FOSL1 -0.41 0.35 -10000 0 -0.7 138 138
NFAT1-c-4/MAF/IRF4 -0.078 0.19 -10000 0 -0.99 3 3
DGKA 0.021 0.081 -10000 0 -0.46 2 2
CREM 0.012 0 -10000 0 -10000 0 0
NFAT1-c-4/PPARG -0.05 0.18 -10000 0 -0.93 3 3
CTLA4 -0.079 0.27 -10000 0 -0.62 39 39
NFAT1-c-4 (dimer)/EGR1 -0.05 0.18 -10000 0 -0.93 3 3
NFAT1-c-4 (dimer)/EGR4 -0.14 0.25 -10000 0 -0.85 7 7
FOS -0.03 0.045 -10000 0 -0.34 2 2
IFNG -0.1 0.22 -10000 0 -0.62 23 23
T cell activation -0.069 0.13 -10000 0 -0.68 1 1
MAF 0.011 0.021 -10000 0 -0.3 1 1
T-helper 2 cell lineage commitment 0 0 -10000 0 -10000 0 0
activation-induced cell death of T cells 0.04 0.17 1.1 3 -10000 0 3
TNF -0.11 0.21 -10000 0 -0.76 6 6
FASLG -0.084 0.28 -10000 0 -1.1 12 12
TBX21 -0.008 0.081 -10000 0 -0.35 9 9
BATF3 -0.003 0.1 -10000 0 -0.7 5 5
PRKCQ -0.001 0.098 -10000 0 -0.63 5 5
PTPN1 0.021 0.081 -10000 0 -0.46 2 2
NFAT1-c-4/ICER1 -0.051 0.18 -10000 0 -0.93 3 3
GATA3 0.004 0.071 -10000 0 -0.5 4 4
T-helper 1 cell differentiation -0.096 0.22 -10000 0 -0.61 23 23
IL2RA -0.19 0.23 -10000 0 -0.73 21 21
T-helper 1 cell lineage commitment 0 0 -10000 0 -10000 0 0
CASP3 0.021 0.081 -10000 0 -0.46 2 2
E2F1 0.006 0.092 -10000 0 -0.69 4 4
PPARG 0.013 0 -10000 0 -10000 0 0
SLC3A2 0.021 0.081 -10000 0 -0.46 2 2
IRF4 -0.064 0.14 -10000 0 -0.3 57 57
PTGS2 -0.28 0.34 -10000 0 -0.9 27 27
CSF2 -0.4 0.45 -10000 0 -0.92 89 89
JunB/Fra1/NFAT1-c-4 -0.28 0.26 -10000 0 -0.79 16 16
IL4 -0.07 0.16 -10000 0 -0.9 4 4
IL5 -0.28 0.33 -10000 0 -0.88 22 22
IL2 -0.069 0.13 -10000 0 -0.69 1 1
IL3 -0.059 0.049 -10000 0 -10000 0 0
RNF128 0.039 0.001 -10000 0 -10000 0 0
NFATC1 -0.04 0.17 -10000 0 -1.1 3 3
CDK4 0.025 0.11 0.64 2 -10000 0 2
PTPRK 0.021 0.081 -10000 0 -0.46 2 2
IL8 -0.47 0.45 -10000 0 -0.91 97 97
POU2F1 0.012 0.001 -10000 0 -10000 0 0
HIF-2-alpha transcription factor network

Figure S38.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S38.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MMP14 -0.031 0.12 -10000 0 -0.59 9 9
oxygen homeostasis -0.011 0.015 -10000 0 -10000 0 0
TCEB2 0.012 0 -10000 0 -10000 0 0
TCEB1 0.012 0 -10000 0 -10000 0 0
VHL/Elongin B/Elongin C/HIF2A -0.032 0.06 -10000 0 -10000 0 0
EPO -0.13 0.23 -10000 0 -0.61 19 19
FIH (dimer) 0.003 0.013 -10000 0 -10000 0 0
APEX1 -0.003 0.017 -10000 0 -10000 0 0
SERPINE1 -0.24 0.37 -10000 0 -0.8 56 56
FLT1 -0.007 0.028 -10000 0 -10000 0 0
ADORA2A -0.15 0.26 -10000 0 -0.68 27 27
germ cell development -0.15 0.27 -10000 0 -0.68 31 31
SLC11A2 -0.16 0.27 -10000 0 -0.7 30 30
BHLHE40 -0.16 0.28 -10000 0 -0.72 31 31
HIF1AN 0.004 0.013 -10000 0 -10000 0 0
HIF2A/ARNT/SIRT1 -0.065 0.14 -10000 0 -0.4 2 2
ETS1 0.025 0 -10000 0 -10000 0 0
CITED2 -0.01 0.027 -10000 0 -10000 0 0
KDR -0.007 0.028 -10000 0 -10000 0 0
PGK1 -0.15 0.27 -10000 0 -0.7 29 29
SIRT1 0.013 0 -10000 0 -10000 0 0
response to hypoxia 0 0.001 -10000 0 -10000 0 0
HIF2A/ARNT -0.18 0.33 -10000 0 -0.84 29 29
EPAS1 -0.038 0.091 -10000 0 -10000 0 0
SP1 0.018 0.004 -10000 0 -10000 0 0
ABCG2 -0.29 0.31 -10000 0 -0.85 29 29
EFNA1 -0.16 0.27 -10000 0 -0.69 30 30
FXN -0.15 0.26 -10000 0 -0.67 29 29
POU5F1 -0.16 0.28 -10000 0 -0.71 31 31
neuron apoptosis 0.18 0.31 0.81 29 -10000 0 29
EP300 0.012 0 -10000 0 -10000 0 0
EGLN3 0.004 0.013 -10000 0 -10000 0 0
EGLN2 0.003 0.013 -10000 0 -10000 0 0
EGLN1 0.004 0.013 -10000 0 -10000 0 0
VHL/Elongin B/Elongin C 0.025 0 -10000 0 -10000 0 0
VHL 0.012 0 -10000 0 -10000 0 0
ARNT -0.003 0.017 -10000 0 -10000 0 0
SLC2A1 -0.18 0.31 -10000 0 -0.73 41 41
TWIST1 -0.18 0.32 -10000 0 -0.8 38 38
ELK1 0.019 0 -10000 0 -10000 0 0
HIF2A/ARNT/Cbp/p300 -0.061 0.14 -10000 0 -10000 0 0
VEGFA -0.17 0.3 -10000 0 -0.74 37 37
CREBBP 0.012 0 -10000 0 -10000 0 0
Signaling mediated by p38-alpha and p38-beta

Figure S39.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S39.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTGS2 -0.029 0.19 -9999 0 -0.66 15 15
MKNK1 0.012 0 -9999 0 -10000 0 0
MAPK14 -0.011 0.093 -9999 0 -0.25 20 20
ATF2/c-Jun 0.008 0.071 -9999 0 -10000 0 0
MAPK11 -0.011 0.093 -9999 0 -0.36 1 1
MITF -0.012 0.12 -9999 0 -0.32 21 21
MAPKAPK5 -0.004 0.11 -9999 0 -0.3 20 20
KRT8 -0.004 0.11 -9999 0 -0.3 20 20
MAPKAPK3 0.012 0 -9999 0 -10000 0 0
MAPKAPK2 0.012 0 -9999 0 -10000 0 0
p38alpha-beta/CK2 -0.015 0.13 -9999 0 -0.36 20 20
CEBPB -0.006 0.11 -9999 0 -0.31 21 21
SLC9A1 -0.006 0.11 -9999 0 -0.31 20 20
mol:GDP 0 0 -9999 0 -10000 0 0
ATF2 0 0.11 -9999 0 -0.29 20 20
p38alpha-beta/MNK1 0 0.11 -9999 0 -0.44 1 1
JUN 0.008 0.071 -9999 0 -10000 0 0
PPARGC1A -0.031 0.15 -9999 0 -0.38 22 22
USF1 -0.004 0.11 -9999 0 -0.3 20 20
RAB5/GDP/GDI1 0 0.077 -9999 0 -0.3 1 1
NOS2 -0.048 0.24 -9999 0 -0.71 23 23
DDIT3 -0.004 0.11 -9999 0 -0.3 20 20
RAB5A 0.012 0 -9999 0 -10000 0 0
HSPB1 0.003 0.088 -9999 0 -0.24 20 20
p38alpha-beta/HBP1 0 0.11 -9999 0 -0.44 1 1
CREB1 -0.003 0.12 -9999 0 -0.32 20 20
RAB5/GDP 0.009 0 -9999 0 -10000 0 0
EIF4E 0.002 0.091 -9999 0 -0.39 1 1
RPS6KA4 -0.004 0.11 -9999 0 -0.3 20 20
PLA2G4A -0.003 0.094 -9999 0 -0.38 3 3
GDI1 -0.004 0.11 -9999 0 -0.3 20 20
TP53 -0.011 0.13 -9999 0 -0.36 20 20
RPS6KA5 -0.004 0.11 -9999 0 -0.3 20 20
ESR1 -0.027 0.15 -9999 0 -0.4 22 22
HBP1 0.012 0 -9999 0 -10000 0 0
MEF2C -0.008 0.11 -9999 0 -0.31 21 21
MEF2A -0.004 0.11 -9999 0 -0.3 20 20
EIF4EBP1 -0.003 0.12 -9999 0 -0.32 20 20
KRT19 -0.004 0.11 -9999 0 -0.3 20 20
ELK4 -0.004 0.11 -9999 0 -0.3 20 20
ATF6 -0.004 0.11 -9999 0 -0.3 20 20
ATF1 -0.003 0.12 -9999 0 -0.32 20 20
p38alpha-beta/MAPKAPK2 0 0.11 -9999 0 -0.44 1 1
p38alpha-beta/MAPKAPK3 0 0.11 -9999 0 -0.44 1 1
EGFR-dependent Endothelin signaling events

Figure S40.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S40.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HRAS 0.012 0 -9999 0 -10000 0 0
EGFR 0.012 0 -9999 0 -10000 0 0
EGF/EGFR -0.066 0.16 -9999 0 -0.4 37 37
EGF/EGFR dimer/SHC/GRB2/SOS1 -0.019 0.11 -9999 0 -0.38 16 16
mol:GTP 0 0 -9999 0 -10000 0 0
EDNRA -0.046 0.19 -9999 0 -0.7 19 19
response to oxidative stress 0 0 -9999 0 -10000 0 0
EGF -0.093 0.2 -9999 0 -0.41 57 57
EGF/EGFR dimer/SHC -0.039 0.13 -9999 0 -0.45 16 16
mol:GDP -0.021 0.11 -9999 0 -0.37 16 16
mol:Ca2+ 0 0 -9999 0 -10000 0 0
EDN1 0 0.092 -9999 0 -0.7 4 4
GRB2/SOS1 0.019 0 -9999 0 -10000 0 0
HRAS/GTP -0.042 0.09 -9999 0 -0.34 16 16
SHC1 0.012 0 -9999 0 -10000 0 0
HRAS/GDP -0.042 0.092 -9999 0 -0.35 16 16
FRAP1 -0.024 0.1 -9999 0 -0.36 16 16
EGF/EGFR dimer -0.057 0.15 -9999 0 -0.52 16 16
SOS1 0.012 0 -9999 0 -10000 0 0
GRB2 0.012 0 -9999 0 -10000 0 0
ETA receptor/Endothelin-1 -0.035 0.16 -9999 0 -0.52 23 23
Visual signal transduction: Rods

Figure S41.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S41.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
mol:K + 0.012 0 -9999 0 -10000 0 0
GNAT1/GTP 0 0 -9999 0 -10000 0 0
Metarhodopsin II/Arrestin 0.001 0.03 -9999 0 -0.45 1 1
PDE6G/GNAT1/GTP 0.002 0.034 -9999 0 -10000 0 0
mol:GTP 0 0 -9999 0 -10000 0 0
absorption of light 0 0 -9999 0 -10000 0 0
GNAT1 0 0 -9999 0 -10000 0 0
GRK1 -0.004 0.065 -9999 0 -0.7 2 2
CNG Channel -0.11 0.094 -9999 0 -0.37 6 6
mol:Na + -0.073 0.15 -9999 0 -0.44 27 27
mol:ADP -0.004 0.065 -9999 0 -0.7 2 2
RGS9-1/Gbeta5/R9AP -0.014 0.074 -9999 0 -10000 0 0
mol:GDP 0 0 -9999 0 -10000 0 0
cGMP/CNG Channel -0.06 0.16 -9999 0 -0.46 27 27
CNGB1 -0.058 0.12 -9999 0 -0.3 48 48
RDH5 -0.004 0.069 -9999 0 -0.3 12 12
SAG 0.003 0.005 -9999 0 -10000 0 0
mol:Ca2+ -0.05 0.15 -9999 0 -0.51 15 15
Na + (4 Units) -0.068 0.14 -9999 0 -0.49 15 15
RGS9 -0.055 0.13 -9999 0 -0.3 50 50
GNB1/GNGT1 -0.041 0.16 -9999 0 -0.52 24 24
GNAT1/GDP -0.011 0.062 -9999 0 -10000 0 0
GUCY2D -0.022 0.14 -9999 0 -0.7 10 10
GNGT1 -0.066 0.21 -9999 0 -0.7 24 24
GUCY2F 0.001 0.003 -9999 0 -10000 0 0
GNB5 0.012 0 -9999 0 -10000 0 0
mol:GMP (4 units) -0.082 0.088 -9999 0 -0.28 15 15
mol:11-cis-retinal -0.004 0.069 -9999 0 -0.3 12 12
mol:cGMP -0.035 0.16 -9999 0 -0.44 27 27
GNB1 0.012 0 -9999 0 -10000 0 0
Rhodopsin -0.003 0.058 -9999 0 -0.52 1 1
SLC24A1 0.012 0 -9999 0 -10000 0 0
CNGA1 -0.001 0.064 -9999 0 -0.3 10 10
Metarhodopsin II -0.003 0.048 -9999 0 -0.42 3 3
mol:Ca ++ 0 0 -9999 0 -10000 0 0
GC1/GCAP Family -0.037 0.16 -9999 0 -0.47 27 27
RGS9BP 0.012 0.003 -9999 0 -10000 0 0
Metarhodopsin II/Transducin -0.017 0.073 -9999 0 -0.23 25 25
GCAP Family/Ca ++ -0.024 0.12 -9999 0 -0.42 21 21
PDE6A/B -0.12 0.11 -9999 0 -0.38 8 8
mol:Pi -0.014 0.074 -9999 0 -10000 0 0
mol:all-trans-retinal 0 0 -9999 0 -10000 0 0
Transducin -0.032 0.13 -9999 0 -0.42 24 24
PDE6B -0.001 0.064 -9999 0 -0.3 10 10
PDE6A -0.18 0.15 -9999 0 -0.3 141 141
PDE6G 0 0.06 -9999 0 -0.3 9 9
RHO -0.002 0.046 -9999 0 -0.7 1 1
PDE6 -0.091 0.11 -9999 0 -0.39 8 8
GUCA1A -0.048 0.19 -9999 0 -0.7 19 19
GC2/GCAP Family -0.024 0.12 -9999 0 -0.41 21 21
GUCA1C 0 0 -9999 0 -10000 0 0
GUCA1B 0.006 0.066 -9999 0 -0.7 2 2
Aurora A signaling

Figure S42.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S42.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Aurora A/GADD45A 0.016 0.041 -9999 0 -0.24 5 5
BIRC5 0.009 0.046 -9999 0 -0.7 1 1
NFKBIA 0.017 0.041 -9999 0 -10000 0 0
CPEB1 -0.12 0.15 -9999 0 -0.3 98 98
AKT1 0.017 0.041 -9999 0 -10000 0 0
NDEL1 0.012 0 -9999 0 -10000 0 0
Aurora A/BRCA1 0.011 0.06 -9999 0 -0.31 6 6
NDEL1/TACC3 0.022 0.035 -9999 0 -10000 0 0
GADD45A 0.012 0 -9999 0 -10000 0 0
GSK3B 0.012 0.002 -9999 0 -10000 0 0
PAK1/Aurora A 0.016 0.041 -9999 0 -10000 0 0
MDM2 0.012 0 -9999 0 -10000 0 0
JUB -0.4 0.35 -9999 0 -0.7 134 134
TPX2 -0.049 0.18 -9999 0 -0.52 29 29
TP53 0.02 0.027 -9999 0 -10000 0 0
DLG7 0.009 0.04 -9999 0 -0.24 6 6
AURKAIP1 0.012 0 -9999 0 -10000 0 0
ARHGEF7 0.012 0 -9999 0 -10000 0 0
G2 phase of mitotic cell cycle 0 0 -9999 0 -10000 0 0
Aurora A/NDEL1/TACC3 0.023 0.037 -9999 0 -10000 0 0
G2/M transition of mitotic cell cycle 0.011 0.059 -9999 0 -0.31 6 6
AURKA 0.012 0.049 -9999 0 -0.28 6 6
AURKB 0.011 0.014 -9999 0 -0.12 1 1
CDC25B -0.089 0.11 -9999 0 -0.3 37 37
G2/M transition checkpoint -0.23 0.21 -9999 0 -0.41 134 134
mRNA polyadenylation -0.055 0.083 -9999 0 -0.35 3 3
Aurora A/CPEB -0.056 0.083 -9999 0 -0.35 3 3
Aurora A/TACC1/TRAP/chTOG 0.03 0.035 -9999 0 -10000 0 0
BRCA1 0.006 0.066 -9999 0 -0.7 2 2
centrosome duplication 0.016 0.04 -9999 0 -10000 0 0
regulation of centrosome cycle 0.021 0.034 -9999 0 -10000 0 0
spindle assembly 0.029 0.035 -9999 0 -10000 0 0
TDRD7 0.012 0 -9999 0 -10000 0 0
Aurora A/RasGAP/Survivin 0.023 0.061 -9999 0 -0.42 3 3
CENPA 0.013 0.023 -9999 0 -0.21 1 1
Aurora A/PP2A 0.016 0.041 -9999 0 -0.24 5 5
meiosis 0 0 -9999 0 -10000 0 0
protein catabolic process 0.023 0.033 -9999 0 -10000 0 0
negative regulation of DNA binding 0.02 0.027 -9999 0 -10000 0 0
prophase 0 0 -9999 0 -10000 0 0
GIT1/beta-PIX 0.019 0 -9999 0 -10000 0 0
RASA1 0.012 0 -9999 0 -10000 0 0
Ajuba/Aurora A -0.23 0.22 -9999 0 -0.41 134 134
mitotic prometaphase 0 0.001 -9999 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0.012 0.048 -9999 0 -0.28 6 6
TACC1 0.012 0 -9999 0 -10000 0 0
TACC3 0.012 0 -9999 0 -10000 0 0
Aurora A/Antizyme1 0.023 0.037 -9999 0 -10000 0 0
Aurora A/RasGAP 0.016 0.041 -9999 0 -0.24 5 5
OAZ1 0.012 0 -9999 0 -10000 0 0
RAN 0.012 0 -9999 0 -10000 0 0
mitosis 0 0 -9999 0 -10000 0 0
PRKACA 0.012 0.002 -9999 0 -10000 0 0
GIT1 0.012 0 -9999 0 -10000 0 0
GIT1/beta-PIX/PAK1 0.025 0 -9999 0 -10000 0 0
Importin alpha/Importin beta/TPX2 -0.049 0.18 -9999 0 -0.52 29 29
PPP2R5D 0.012 0 -9999 0 -10000 0 0
Aurora A/TPX2 -0.031 0.16 -9999 0 -0.44 29 29
PAK1 0.012 0 -9999 0 -10000 0 0
CKAP5 0.012 0 -9999 0 -10000 0 0
p75(NTR)-mediated signaling

Figure S43.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S43.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Sortilin/TRAF6 0.019 0 -9999 0 -10000 0 0
Necdin/E2F1 0.003 0.079 -9999 0 -0.52 4 4
proNGF (dimer)/p75(NTR)/Sortilin/NADE/14-3-3 E -0.02 0.083 -9999 0 -10000 0 0
NGF (dimer)/p75(NTR)/BEX1 -0.095 0.13 -9999 0 -0.33 36 36
NT-4/5 (dimer)/p75(NTR) -0.077 0.15 -9999 0 -0.59 11 11
IKBKB 0.009 0.046 -9999 0 -0.7 1 1
AKT1 -0.022 0.079 -9999 0 -10000 0 0
IKBKG 0.012 0 -9999 0 -10000 0 0
BDNF -0.012 0.13 -9999 0 -0.7 8 8
MGDIs/NGR/p75(NTR)/LINGO1 -0.06 0.14 -9999 0 -0.51 15 15
FURIN 0.012 0 -9999 0 -10000 0 0
proBDNF (dimer)/p75(NTR)/Sortilin -0.046 0.12 -9999 0 -0.48 8 8
LINGO1 -0.03 0.17 -9999 0 -0.7 14 14
Sortilin/TRAF6/NRIF -0.001 0.008 -9999 0 -10000 0 0
proBDNF (dimer) -0.012 0.13 -9999 0 -0.7 8 8
NTRK1 0.005 0.066 -9999 0 -0.7 2 2
RTN4R 0.009 0.046 -9999 0 -0.7 1 1
neuron apoptosis -0.037 0.12 -9999 0 -0.43 5 5
IRAK1 0.012 0 -9999 0 -10000 0 0
SHC1 -0.042 0.094 -9999 0 -0.32 7 7
ARHGDIA 0.012 0 -9999 0 -10000 0 0
RhoA/GTP 0.009 0 -9999 0 -10000 0 0
Gamma Secretase 0.037 0 -9999 0 -10000 0 0
proNGF (dimer)/p75(NTR)/Sortilin/MAGE-H1 -0.028 0.087 -9999 0 -0.28 7 7
MAGEH1 0.011 0.021 -9999 0 -0.3 1 1
proNGF (dimer)/p75(NTR)/Sortilin/Necdin -0.032 0.094 -9999 0 -10000 0 0
Mammalian IAPs/DIABLO 0.03 0.03 -9999 0 -0.4 1 1
proNGF (dimer) -0.006 0.072 -9999 0 -0.3 13 13
MAGED1 0.012 0 -9999 0 -10000 0 0
APP 0.012 0 -9999 0 -10000 0 0
NT-4/5 (dimer) -0.027 0.15 -9999 0 -0.7 11 11
ZNF274 0.01 0.029 -9999 0 -0.3 2 2
RhoA/GDP/RHOGDI -0.027 0.08 -9999 0 -10000 0 0
NGF -0.006 0.072 -9999 0 -0.3 13 13
cell cycle arrest -0.012 0.079 -9999 0 -10000 0 0
NGF (dimer)/p75(NTR)/TRAF6/RIP2/IRAK -0.039 0.1 -9999 0 -0.33 8 8
NT-4/5 (dimer)/p75(NTR)/TRAF6 -0.056 0.13 -9999 0 -0.51 11 11
NCSTN 0.012 0 -9999 0 -10000 0 0
mol:GTP -0.051 0.11 -9999 0 -0.33 15 15
PSENEN 0.012 0 -9999 0 -10000 0 0
mol:ceramide -0.031 0.084 -9999 0 -10000 0 0
NGF (dimer)/p75(NTR)/TRAF6/RIP2/IRAK/p62/Atypical PKCs -0.027 0.091 -9999 0 -0.29 8 8
p75(NTR)/beta APP -0.048 0.099 -9999 0 -10000 0 0
BEX1 -0.088 0.15 -9999 0 -0.31 71 71
mol:GDP -0.05 0.093 -9999 0 -0.32 7 7
NGF (dimer) -0.41 0.07 -9999 0 -0.42 228 228
MGDIs/NGR/p75(NTR)/LINGO1/RHOGDI -0.046 0.13 -9999 0 -0.47 15 15
PIK3R1 0.012 0 -9999 0 -10000 0 0
RAC1/GTP -0.033 0.08 -9999 0 -0.27 7 7
MYD88 0.012 0 -9999 0 -10000 0 0
CHUK 0.012 0 -9999 0 -10000 0 0
NGF (dimer)/p75(NTR)/PKA -0.051 0.11 -9999 0 -0.34 15 15
RHOB 0.012 0 -9999 0 -10000 0 0
RHOA 0.012 0 -9999 0 -10000 0 0
MAGE-G1/E2F1 0.009 0.07 -9999 0 -0.52 4 4
NT3 (dimer) 0.004 0.061 -9999 0 -0.38 5 5
TP53 -0.022 0.096 -9999 0 -0.38 8 8
PRDM4 -0.031 0.085 -9999 0 -0.28 7 7
BDNF (dimer) -0.74 0.18 -9999 0 -0.74 231 231
PIK3CA 0.012 0 -9999 0 -10000 0 0
SORT1 0.012 0 -9999 0 -10000 0 0
activation of caspase activity -0.022 0.081 -9999 0 -10000 0 0
proNGF (dimer)/p75(NTR)/Sortilin/TRAF6 -0.028 0.087 -9999 0 -10000 0 0
RHOC 0.012 0 -9999 0 -10000 0 0
XIAP 0.012 0 -9999 0 -10000 0 0
MAPK10 -0.066 0.15 -9999 0 -0.44 7 7
DIABLO 0.012 0 -9999 0 -10000 0 0
SMPD2 -0.031 0.085 -9999 0 -10000 0 0
APH1B 0.012 0 -9999 0 -10000 0 0
APH1A 0.012 0 -9999 0 -10000 0 0
proNGF (dimer)/p75(NTR)/Sortilin -0.04 0.096 -9999 0 -0.32 7 7
PSEN1 0.012 0 -9999 0 -10000 0 0
APAF-1/Pro-Caspase 9 0.019 0 -9999 0 -10000 0 0
NT3 (dimer)/p75(NTR) -0.054 0.11 -9999 0 -0.45 2 2
MAPK8 -0.032 0.12 -9999 0 -0.44 2 2
MAPK9 -0.032 0.12 -9999 0 -0.44 2 2
APAF1 0.012 0 -9999 0 -10000 0 0
NTF3 0.004 0.062 -9999 0 -0.38 5 5
NTF4 -0.028 0.15 -9999 0 -0.7 11 11
NDN 0.003 0.054 -9999 0 -0.3 7 7
RAC1/GDP 0.009 0 -9999 0 -10000 0 0
RhoA-B-C/GDP -0.046 0.072 -9999 0 -0.36 2 2
p75 CTF/Sortilin/TRAF6/NRIF 0.031 0.015 -9999 0 -10000 0 0
RhoA-B-C/GTP -0.051 0.11 -9999 0 -0.33 15 15
proBDNF (dimer)/p75(NTR)/Sortilin/TRAF6/NRIF -0.026 0.1 -9999 0 -0.41 8 8
proBDNF (dimer)/p75(NTR)/Sortilin/TRAF6 -0.033 0.11 -9999 0 -0.44 8 8
PRKACB -0.008 0.077 -9999 0 -0.3 15 15
proBDNF (dimer)/p75 ECD 0 0.099 -9999 0 -0.52 8 8
ChemicalAbstracts:86-01-1 0 0 -9999 0 -10000 0 0
BIRC3 0.008 0.051 -9999 0 -0.5 2 2
BIRC2 0.012 0 -9999 0 -10000 0 0
neuron projection morphogenesis -0.033 0.1 -9999 0 -0.31 7 7
BAD -0.047 0.13 -9999 0 -0.39 6 6
RIPK2 0.003 0.08 -9999 0 -0.7 3 3
NGFR -0.085 0.14 -9999 0 -0.3 72 72
CYCS -0.023 0.079 -9999 0 -10000 0 0
ADAM17 0.012 0 -9999 0 -10000 0 0
NGF (dimer)/p75(NTR)/TRAF6/RIP2 -0.033 0.099 -9999 0 -0.45 3 3
BCL2L11 -0.047 0.13 -9999 0 -0.39 6 6
BDNF (dimer)/p75(NTR) -0.066 0.14 -9999 0 -0.56 8 8
PI3K -0.028 0.087 -9999 0 -0.28 7 7
proNGF (dimer)/p75(NTR)/Sortilin/MAGE-G1 -0.028 0.087 -9999 0 -0.28 7 7
NDNL2 0.012 0 -9999 0 -10000 0 0
YWHAE 0.012 0 -9999 0 -10000 0 0
PRKCI 0.012 0 -9999 0 -10000 0 0
NGF (dimer)/p75(NTR) -0.059 0.11 -9999 0 -0.38 7 7
ChemicalAbstracts:146-91-8 0 0 -9999 0 -10000 0 0
proNGF (dimer)/p75(NTR)/Sortilin/NRAGE -0.028 0.087 -9999 0 -0.28 7 7
TRAF6 0.012 0 -9999 0 -10000 0 0
RAC1 0.012 0 -9999 0 -10000 0 0
PRKCZ 0.012 0 -9999 0 -10000 0 0
PLG -0.001 0.046 -9999 0 -0.7 1 1
oligodendrocyte cell fate commitment 0 0 -9999 0 -10000 0 0
CASP6 -0.048 0.12 -9999 0 -0.34 15 15
SQSTM1 0.012 0 -9999 0 -10000 0 0
NGFRAP1 0.011 0.021 -9999 0 -0.3 1 1
CASP3 -0.043 0.13 -9999 0 -0.36 6 6
E2F1 0 0.092 -9999 0 -0.7 4 4
CASP9 0.012 0 -9999 0 -10000 0 0
IKK complex -0.044 0.072 -9999 0 -10000 0 0
NGF (dimer)/TRKA 0.001 0.069 -9999 0 -0.52 2 2
MMP7 -0.68 0.092 -9999 0 -0.7 228 228
proNGF (dimer)/p75(NTR)/Sortilin/TRAF6/NRIF -0.02 0.083 -9999 0 -10000 0 0
MMP3 -0.57 0.27 -9999 0 -0.7 191 191
APAF-1/Caspase 9 -0.027 0.047 -9999 0 -0.39 1 1
Angiopoietin receptor Tie2-mediated signaling

Figure S44.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S44.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
AKT1 0.06 0.23 -10000 0 -0.79 13 13
NCK1/PAK1/Dok-R -0.024 0.09 -10000 0 -0.39 13 13
NCK1/Dok-R 0.042 0.23 -10000 0 -0.85 13 13
PIK3CA 0.012 0.001 -10000 0 -10000 0 0
mol:beta2-estradiol -0.002 0.041 0.24 6 -10000 0 6
RELA 0.012 0 -10000 0 -10000 0 0
SHC1 0.013 0.001 -10000 0 -10000 0 0
Rac/GDP 0.009 0 -10000 0 -10000 0 0
F2 -0.21 0.33 0.24 4 -0.71 71 75
TNIP2 0.012 0 -10000 0 -10000 0 0
NF kappa B/RelA -0.001 0.2 -10000 0 -0.8 13 13
FN1 -0.057 0.21 -10000 0 -0.63 25 25
PLD2 0.039 0.24 -10000 0 -0.89 13 13
PTPN11 0.012 0 -10000 0 -10000 0 0
GRB14 -0.026 0.14 -10000 0 -0.45 19 19
ELK1 0.046 0.22 -10000 0 -0.82 13 13
GRB7 -0.006 0.11 -10000 0 -0.7 6 6
PAK1 0.012 0 -10000 0 -10000 0 0
Tie2/Ang1/alpha5/beta1 Integrin -0.035 0.23 -10000 0 -0.85 13 13
CDKN1A 0.06 0.19 -10000 0 -0.56 12 12
ITGA5 0.012 0 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
RasGAP/Dok-R 0.042 0.23 -10000 0 -0.85 13 13
CRK 0.012 0 -10000 0 -10000 0 0
mol:NO 0.066 0.18 -10000 0 -0.59 13 13
PLG 0.032 0.24 -10000 0 -0.89 13 13
mol:GDP 0 0 -10000 0 -10000 0 0
chemokinesis 0.056 0.22 -10000 0 -0.76 13 13
GRB2 0.012 0 -10000 0 -10000 0 0
PIK3R1 0.013 0.001 -10000 0 -10000 0 0
ANGPT2 0.018 0.18 0.36 2 -0.52 8 10
BMX -0.003 0.25 -10000 0 -0.98 13 13
ANGPT1 0.05 0.19 -10000 0 -1 6 6
tube development 0.054 0.2 -10000 0 -0.63 12 12
ANGPT4 0.001 0.065 -10000 0 -0.69 2 2
response to hypoxia 0 0.015 -10000 0 -10000 0 0
Tie2/Ang1/GRB14 0.02 0.26 -10000 0 -0.95 13 13
alpha5/beta1 Integrin 0.019 0 -10000 0 -10000 0 0
FGF2 -0.017 0.089 -10000 0 -0.3 21 21
STAT5A (dimer) 0.056 0.22 -10000 0 -0.7 12 12
mol:L-citrulline 0.066 0.18 -10000 0 -0.59 13 13
AGTR1 -0.14 0.16 -10000 0 -0.3 110 110
MAPK14 0.037 0.26 -10000 0 -0.98 13 13
Tie2/SHP2 -0.01 0.19 -10000 0 -0.92 9 9
TEK -0.011 0.21 -10000 0 -1 9 9
RPS6KB1 0.059 0.22 -10000 0 -0.76 13 13
Angiotensin II/AT1 -0.091 0.11 -10000 0 -0.2 110 110
Tie2/Ang1/GRB2 0.036 0.24 -10000 0 -0.91 13 13
MAPK3 0.043 0.22 -10000 0 -0.82 13 13
MAPK1 0.043 0.22 -10000 0 -0.82 13 13
Tie2/Ang1/GRB7 0.027 0.26 -10000 0 -0.95 13 13
NFKB1 0.012 0 -10000 0 -10000 0 0
MAPK8 0.039 0.24 -10000 0 -0.89 13 13
PI3K 0.05 0.25 -10000 0 -0.9 13 13
FES 0.036 0.26 -10000 0 -0.99 13 13
Crk/Dok-R 0.042 0.23 -10000 0 -0.85 13 13
Tie2/Ang1/ABIN2 0.036 0.24 -10000 0 -0.91 13 13
blood circulation 0 0 -10000 0 -10000 0 0
negative regulation of caspase activity 0.063 0.21 -10000 0 -0.71 13 13
STAT5A 0.013 0 -10000 0 -10000 0 0
mol:ROS 0 0 -10000 0 -10000 0 0
PTK2 0.059 0.22 -10000 0 -0.76 13 13
Tie2/Ang2 0.043 0.25 -10000 0 -0.83 12 12
Tie2/Ang1 0.035 0.26 -10000 0 -0.95 13 13
FOXO1 0.067 0.21 -10000 0 -0.7 13 13
ELF1 0.017 0.02 -10000 0 -10000 0 0
ELF2 0.037 0.24 -10000 0 -0.89 13 13
mol:Choline 0.04 0.23 -10000 0 -0.86 13 13
cell migration -0.021 0.056 -10000 0 -0.22 11 11
FYN 0.051 0.22 -10000 0 -0.71 12 12
DOK2 0.012 0 -10000 0 -10000 0 0
negative regulation of cell cycle 0.061 0.18 -10000 0 -0.52 12 12
ETS1 0.014 0.04 -10000 0 -0.27 2 2
PXN 0.066 0.19 -10000 0 -0.64 13 13
ITGB1 0.012 0 -10000 0 -10000 0 0
NOS3 0.064 0.2 -10000 0 -0.67 13 13
RAC1 0.012 0 -10000 0 -10000 0 0
TNF 0.012 0.061 -10000 0 -0.4 3 3
MAPKKK cascade 0.04 0.23 -10000 0 -0.86 13 13
RASA1 0.012 0 -10000 0 -10000 0 0
Tie2/Ang1/Shc 0.037 0.24 -10000 0 -0.91 13 13
NCK1 0.012 0 -10000 0 -10000 0 0
vasculogenesis 0.068 0.17 -10000 0 -0.53 13 13
mol:Phosphatidic acid 0.04 0.23 -10000 0 -0.86 13 13
mol:Angiotensin II 0 0.005 -10000 0 -10000 0 0
mol:NADP 0.066 0.18 -10000 0 -0.59 13 13
Rac1/GTP -0.032 0.17 -10000 0 -0.72 13 13
MMP2 0.033 0.24 -10000 0 -0.89 13 13
Sphingosine 1-phosphate (S1P) pathway

Figure S45.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S45.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SPHK2 0.012 0 -9999 0 -10000 0 0
SPHK1 -0.088 0.25 -9999 0 -0.7 33 33
GNAI2 0.012 0 -9999 0 -10000 0 0
mol:S1P -0.017 0.088 -9999 0 -0.23 33 33
GNAO1 -0.13 0.16 -9999 0 -0.3 103 103
mol:Sphinganine-1-P -0.058 0.19 -9999 0 -0.52 33 33
growth factor activity 0 0 -9999 0 -10000 0 0
S1P/S1P2/G12/G13 0.009 0.066 -9999 0 -10000 0 0
GNAI3 0.012 0 -9999 0 -10000 0 0
G12/G13 0.019 0 -9999 0 -10000 0 0
S1PR3 0.012 0 -9999 0 -10000 0 0
S1PR2 0.012 0 -9999 0 -10000 0 0
EDG1 0 0 -9999 0 -10000 0 0
S1P1/S1P -0.017 0.074 -9999 0 -0.2 33 33
S1PR5 -0.018 0.14 -9999 0 -0.7 10 10
S1PR4 0.006 0.045 -9999 0 -0.3 5 5
GNAI1 0.007 0.041 -9999 0 -0.3 4 4
S1P/S1P5/G12 -0.017 0.12 -9999 0 -0.48 10 10
S1P/S1P3/Gq 0.003 0.072 -9999 0 -0.3 4 4
S1P/S1P4/Gi -0.013 0.085 -9999 0 -0.32 10 10
GNAQ 0.012 0 -9999 0 -10000 0 0
GNAZ 0.007 0.041 -9999 0 -0.3 4 4
GNA14 0.011 0.021 -9999 0 -0.3 1 1
GNA15 -0.03 0.17 -9999 0 -0.7 14 14
GNA12 0.012 0 -9999 0 -10000 0 0
GNA13 0.012 0 -9999 0 -10000 0 0
GNA11 0.012 0 -9999 0 -10000 0 0
ABCC1 0.012 0 -9999 0 -10000 0 0
Noncanonical Wnt signaling pathway

Figure S46.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S46.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC2 0.002 0.057 -9999 0 -0.3 8 8
GNB1/GNG2 -0.046 0.12 -9999 0 -0.36 14 14
mol:DAG -0.038 0.12 -9999 0 -0.33 13 13
PLCG1 -0.039 0.12 -9999 0 -0.34 13 13
YES1 -0.053 0.13 -9999 0 -0.38 13 13
FZD3 0 0.092 -9999 0 -0.7 4 4
FZD6 0.012 0 -9999 0 -10000 0 0
G protein -0.038 0.12 -9999 0 -0.34 13 13
MAP3K7 -0.03 0.11 -9999 0 -0.35 4 4
mol:Ca2+ -0.037 0.11 -9999 0 -0.32 13 13
mol:IP3 -0.038 0.12 -9999 0 -0.33 13 13
NLK 0.006 0.011 -9999 0 -10000 0 0
GNB1 0.012 0 -9999 0 -10000 0 0
CAMK2A -0.038 0.12 -9999 0 -0.36 7 7
MAP3K7IP1 0 0 -9999 0 -10000 0 0
Noncanonical Wnts/FZD -0.063 0.13 -9999 0 -0.41 13 13
CSNK1A1 0.012 0 -9999 0 -10000 0 0
GNAS -0.053 0.13 -9999 0 -0.38 13 13
GO:0007205 -0.038 0.11 -9999 0 -0.32 14 14
WNT6 -0.035 0.14 -9999 0 -0.41 25 25
WNT4 -0.003 0.084 -9999 0 -0.39 9 9
NFAT1/CK1 alpha -0.036 0.12 -9999 0 -0.37 5 5
GNG2 0.008 0.035 -9999 0 -0.3 3 3
WNT5A -0.021 0.15 -9999 0 -0.7 11 11
WNT11 -0.13 0.28 -9999 0 -0.67 48 48
CDC42 -0.045 0.12 -9999 0 -0.36 13 13
S1P5 pathway

Figure S47.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S47.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
mol:S1P 0 0 -10000 0 -10000 0 0
telencephalon oligodendrocyte cell migration 0.055 0.1 0.32 11 -10000 0 11
GNAI2 0.012 0 -10000 0 -10000 0 0
S1P/S1P5/G12 -0.003 0.095 -10000 0 -0.45 10 10
mol:GDP 0 0 -10000 0 -10000 0 0
GNAO1 -0.13 0.16 -10000 0 -0.3 103 103
RhoA/GTP -0.056 0.1 -10000 0 -0.32 11 11
negative regulation of cAMP metabolic process -0.068 0.11 -10000 0 -0.36 11 11
GNAZ 0.007 0.041 -10000 0 -0.3 4 4
GNAI3 0.012 0 -10000 0 -10000 0 0
GNA12 0.012 0 -10000 0 -10000 0 0
S1PR5 -0.018 0.14 -10000 0 -0.7 10 10
mol:GTP 0 0 -10000 0 -10000 0 0
S1P/S1P5/Gi -0.068 0.11 -10000 0 -0.36 11 11
RhoA/GDP 0.009 0 -10000 0 -10000 0 0
RHOA 0.012 0 -10000 0 -10000 0 0
GNAI1 0.007 0.041 -10000 0 -0.3 4 4
Retinoic acid receptors-mediated signaling

Figure S48.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S48.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.012 0 -10000 0 -10000 0 0
HDAC3 0.012 0 -10000 0 -10000 0 0
VDR 0.012 0 -10000 0 -10000 0 0
Cbp/p300/PCAF 0.025 0 -10000 0 -10000 0 0
EP300 0.012 0 -10000 0 -10000 0 0
RARs/AIB1/Cbp/p300/PCAF/9cRA 0.002 0.041 -10000 0 -10000 0 0
KAT2B 0.012 0 -10000 0 -10000 0 0
MAPK14 0.012 0 -10000 0 -10000 0 0
AKT1 -0.002 0.074 0.16 24 -10000 0 24
RAR alpha/9cRA/Cyclin H -0.063 0.068 -10000 0 -10000 0 0
mol:9cRA 0 0 -10000 0 -10000 0 0
RARs/Src-1/Cbp/p300/PCAF/9cRA 0 0.04 -10000 0 -10000 0 0
CDC2 0 0 -10000 0 -10000 0 0
response to UV 0.001 0 -10000 0 -10000 0 0
RAR alpha/Jnk1 -0.059 0.087 -10000 0 -10000 0 0
NCOR2 0.012 0 -10000 0 -10000 0 0
VDR/VDR/Vit D3 0.009 0 -10000 0 -10000 0 0
RXRs/RARs/NRIP1/9cRA -0.084 0.13 -10000 0 -10000 0 0
NCOA2 0.012 0 -10000 0 -10000 0 0
NCOA3 0.012 0 -10000 0 -10000 0 0
NCOA1 0.012 0 -10000 0 -10000 0 0
VDR/VDR/DNA 0.012 0 -10000 0 -10000 0 0
RARG 0.013 0 -10000 0 -10000 0 0
RAR gamma1/9cRA 0.017 0 -10000 0 -10000 0 0
MAPK3 0.013 0 -10000 0 -10000 0 0
MAPK1 0.012 0 -10000 0 -10000 0 0
MAPK8 0.013 0 -10000 0 -10000 0 0
mol:Vit D3 0 0 -10000 0 -10000 0 0
RXRs/VDR/DNA/Vit D3 -0.11 0.13 -10000 0 -10000 0 0
RARA -0.072 0.1 -10000 0 -0.18 108 108
negative regulation of phosphoinositide 3-kinase cascade 0 0 -10000 0 -10000 0 0
RARs/TIF2/Cbp/p300/PCAF/9cRA 0 0.04 -10000 0 -10000 0 0
PRKCA 0.015 0.001 -10000 0 -10000 0 0
RXRs/RARs/NRIP1/9cRA/HDAC1 -0.1 0.13 -10000 0 -10000 0 0
RXRG -0.24 0.22 -10000 0 -0.41 115 115
RXRA -0.06 0.096 -10000 0 -10000 0 0
RXRB -0.12 0.16 -10000 0 -0.29 108 108
VDR/Vit D3/DNA 0.009 0 -10000 0 -10000 0 0
RBP1 -0.095 0.25 -10000 0 -0.7 35 35
CRBP1/9-cic-RA -0.072 0.19 -10000 0 -0.53 35 35
RARB 0.013 0.021 -10000 0 -0.3 1 1
PRKCG -0.32 0.35 -10000 0 -0.69 108 108
MNAT1 0.012 0 -10000 0 -10000 0 0
RAR alpha/RXRs -0.072 0.14 -10000 0 -10000 0 0
RXRs/RARs/SMRT(N-CoR2)/9cRA -0.074 0.12 -10000 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process -0.025 0.072 -10000 0 -10000 0 0
RXRs/RARs/NRIP1/9cRA/HDAC3 -0.1 0.13 -10000 0 -10000 0 0
positive regulation of DNA binding -0.061 0.065 -10000 0 -10000 0 0
NRIP1 -0.097 0.12 -10000 0 -10000 0 0
RXRs/RARs -0.11 0.13 -10000 0 -0.3 45 45
RXRs/RXRs/DNA/9cRA -0.12 0.14 -10000 0 -0.29 45 45
PRKACA 0.012 0 -10000 0 -10000 0 0
CDK7 0.012 0 -10000 0 -10000 0 0
TFIIH 0.025 0 -10000 0 -10000 0 0
RAR alpha/9cRA -0.045 0.053 -10000 0 -10000 0 0
CCNH 0.012 0 -10000 0 -10000 0 0
CREBBP 0.012 0 -10000 0 -10000 0 0
RAR gamma2/9cRA 0 0 -10000 0 -10000 0 0
EPHB forward signaling

Figure S49.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S49.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Ephrin A5/EPHB2 -0.014 0.072 -10000 0 -0.45 1 1
cell-cell adhesion 0.075 0.13 0.51 2 -10000 0 2
Ephrin B/EPHB2/RasGAP 0.031 0.048 -10000 0 -0.38 3 3
ITSN1 0.012 0 -10000 0 -10000 0 0
PIK3CA 0.012 0 -10000 0 -10000 0 0
SHC1 0.012 0 -10000 0 -10000 0 0
Ephrin B1/EPHB3 -0.032 0.14 -10000 0 -0.45 24 24
Ephrin B1/EPHB1 -0.093 0.2 -10000 0 -0.45 54 54
HRAS/GDP -0.075 0.14 -10000 0 -0.54 2 2
Ephrin B/EPHB1/GRB7 -0.074 0.2 -10000 0 -0.4 58 58
Endophilin/SYNJ1 0.024 0.044 -10000 0 -0.35 3 3
KRAS 0.012 0 -10000 0 -10000 0 0
Ephrin B/EPHB1/Src -0.064 0.18 -10000 0 -0.39 55 55
endothelial cell migration 0.027 0 -10000 0 -10000 0 0
GRB2 0.012 0 -10000 0 -10000 0 0
GRB7 -0.006 0.11 -10000 0 -0.7 6 6
PAK1 0.03 0.046 -10000 0 -0.35 3 3
HRAS 0.012 0 -10000 0 -10000 0 0
RRAS 0.025 0.045 -10000 0 -0.36 3 3
DNM1 0.012 0 -10000 0 -10000 0 0
cell-cell signaling 0 0 -10000 0 -10000 0 0
CRK -0.064 0.17 -10000 0 -0.37 55 55
lamellipodium assembly -0.075 0.13 -10000 0 -0.51 2 2
Ephrin B/EPHB1/Src/p52 SHC/GRB2 -0.024 0.1 -10000 0 -0.37 2 2
PIK3R1 0.012 0 -10000 0 -10000 0 0
EPHB2 0.009 0.046 -10000 0 -0.7 1 1
EPHB3 -0.061 0.22 -10000 0 -0.7 24 24
EPHB1 -0.15 0.3 -10000 0 -0.69 55 55
EPHB4 0.012 0 -10000 0 -10000 0 0
mol:GDP -0.026 0.14 -10000 0 -0.44 3 3
Ephrin B/EPHB2 0.024 0.047 -10000 0 -0.38 3 3
Ephrin B/EPHB3 -0.017 0.13 -10000 0 -0.38 26 26
JNK cascade -0.064 0.17 -10000 0 -0.37 55 55
Ephrin B/EPHB1 -0.071 0.18 -10000 0 -0.39 55 55
RAP1/GDP -0.012 0.13 -10000 0 -0.44 2 2
EFNB2 0.012 0 -10000 0 -10000 0 0
EFNB3 0.005 0.069 -10000 0 -0.56 3 3
EFNB1 0.012 0 -10000 0 -10000 0 0
Ephrin B2/EPHB1-2 -0.079 0.18 -10000 0 -0.41 55 55
RAP1B 0.012 0 -10000 0 -10000 0 0
RAP1A 0.012 0 -10000 0 -10000 0 0
CDC42/GTP -0.076 0.14 -10000 0 -0.54 2 2
Rap1/GTP -0.075 0.13 -10000 0 -0.52 2 2
axon guidance -0.014 0.072 -10000 0 -0.45 1 1
MAPK3 -0.011 0.094 -10000 0 -0.32 2 2
MAPK1 -0.011 0.094 -10000 0 -0.32 2 2
Rac1/GDP -0.017 0.14 -10000 0 -0.46 2 2
actin cytoskeleton reorganization -0.061 0.11 -10000 0 -0.41 2 2
CDC42/GDP -0.017 0.14 -10000 0 -0.46 2 2
PI3K 0.029 0 -10000 0 -10000 0 0
EFNA5 -0.039 0.12 -10000 0 -0.3 38 38
Ephrin B2/EPHB4 0.017 0 -10000 0 -10000 0 0
Ephrin B/EPHB2/Intersectin/N-WASP 0.028 0.029 -10000 0 -10000 0 0
CDC42 0.012 0 -10000 0 -10000 0 0
RAS family/GTP -0.073 0.13 -10000 0 -0.5 2 2
PTK2 0.02 0.036 -10000 0 -10000 0 0
MAP4K4 -0.065 0.17 -10000 0 -0.37 55 55
SRC 0.012 0 -10000 0 -10000 0 0
KALRN 0.011 0.021 -10000 0 -0.3 1 1
Intersectin/N-WASP 0.019 0 -10000 0 -10000 0 0
neuron projection morphogenesis -0.014 0.12 -10000 0 -0.39 2 2
MAP2K1 -0.017 0.099 -10000 0 -0.35 2 2
WASL 0.012 0 -10000 0 -10000 0 0
Ephrin B1/EPHB1-2/NCK1 -0.072 0.18 -10000 0 -0.4 55 55
cell migration -0.01 0.1 -10000 0 -0.39 2 2
NRAS 0.012 0 -10000 0 -10000 0 0
SYNJ1 0.025 0.045 -10000 0 -0.36 3 3
PXN 0.012 0 -10000 0 -10000 0 0
TF 0.019 0.069 -10000 0 -0.41 5 5
HRAS/GTP -0.08 0.14 -10000 0 -0.55 2 2
Ephrin B1/EPHB1-2 -0.079 0.18 -10000 0 -0.41 55 55
cell adhesion mediated by integrin 0.004 0.064 0.36 2 -10000 0 2
RAC1 0.012 0 -10000 0 -10000 0 0
mol:GTP -0.057 0.17 -10000 0 -0.35 56 56
RAC1-CDC42/GTP -0.11 0.16 -10000 0 -0.58 7 7
RASA1 0.012 0 -10000 0 -10000 0 0
RAC1-CDC42/GDP -0.012 0.13 -10000 0 -0.44 2 2
ruffle organization -0.039 0.16 -10000 0 -0.52 2 2
NCK1 0.012 0 -10000 0 -10000 0 0
receptor internalization 0.029 0.043 -10000 0 -0.34 3 3
Ephrin B/EPHB2/KALRN 0.03 0.049 -10000 0 -0.38 3 3
ROCK1 -0.023 0.13 -10000 0 -0.41 24 24
RAS family/GDP -0.052 0.094 -10000 0 -0.39 2 2
Rac1/GTP -0.079 0.14 -10000 0 -0.54 2 2
Ephrin B/EPHB1/Src/Paxillin -0.027 0.11 -10000 0 -0.4 2 2
LPA receptor mediated events

Figure S50.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S50.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GNB1/GNG2 0.001 0.065 -9999 0 -0.28 1 1
NF kappa B1 p50/RelA/I kappa B alpha 0.009 0.067 -9999 0 -0.35 1 1
AP1 -0.033 0.076 -9999 0 -0.39 5 5
mol:PIP3 -0.027 0.065 -9999 0 -0.5 1 1
AKT1 0.032 0.047 -9999 0 -10000 0 0
PTK2B -0.004 0.061 -9999 0 -0.2 4 4
RHOA 0.02 0.026 -9999 0 -10000 0 0
PIK3CB 0.012 0 -9999 0 -10000 0 0
mol:Ca2+ 0.01 0.061 -9999 0 -0.39 1 1
MAGI3 0.012 0 -9999 0 -10000 0 0
RELA 0.012 0 -9999 0 -10000 0 0
apoptosis -0.024 0.094 -9999 0 -0.34 8 8
HRAS/GDP 0.009 0 -9999 0 -10000 0 0
positive regulation of microtubule depolymerization -0.023 0.09 -9999 0 -0.25 18 18
NF kappa B1 p50/RelA -0.03 0.066 -9999 0 -0.51 1 1
endothelial cell migration -0.01 0.093 -9999 0 -0.63 3 3
ADCY4 -0.07 0.15 -9999 0 -0.41 29 29
ADCY5 -0.15 0.21 -9999 0 -0.39 86 86
ADCY6 -0.07 0.15 -9999 0 -0.41 29 29
ADCY7 -0.07 0.15 -9999 0 -0.41 29 29
ADCY1 -0.075 0.15 -9999 0 -0.4 32 32
ADCY2 -0.11 0.2 -9999 0 -0.4 60 60
ADCY3 -0.07 0.15 -9999 0 -0.41 29 29
ADCY8 -0.074 0.15 -9999 0 -0.42 29 29
ADCY9 -0.071 0.15 -9999 0 -0.41 30 30
GSK3B 0.002 0.058 -9999 0 -0.21 1 1
arachidonic acid secretion -0.079 0.16 -9999 0 -0.43 29 29
GNG2 0.008 0.035 -9999 0 -0.3 3 3
TRIP6 0.02 0.007 -9999 0 -10000 0 0
GNAO1 -0.033 0.11 -9999 0 -0.31 32 32
HRAS 0.012 0 -9999 0 -10000 0 0
NFKBIA 0.004 0.073 -9999 0 -0.4 1 1
GAB1 0.012 0 -9999 0 -10000 0 0
mol:GTP 0 0 -9999 0 -10000 0 0
lamellipodium assembly -0.046 0.23 -9999 0 -0.82 19 19
JUN 0.012 0 -9999 0 -10000 0 0
LPA/LPA2/NHERF2 0.017 0.012 -9999 0 -10000 0 0
TIAM1 -0.076 0.26 -9999 0 -0.96 19 19
PIK3R1 0.012 0 -9999 0 -10000 0 0
mol:IP3 0.01 0.062 -9999 0 -0.4 1 1
PLCB3 0.021 0.01 -9999 0 -10000 0 0
FOS 0.009 0.029 -9999 0 -0.3 2 2
positive regulation of mitosis -0.079 0.16 -9999 0 -0.43 29 29
LPA/LPA1-2-3 -0.019 0.096 -9999 0 -0.39 8 8
mol:Ca ++ 0 0 -9999 0 -10000 0 0
JNK cascade -0.001 0.001 -9999 0 -10000 0 0
BCAR1 0.012 0 -9999 0 -10000 0 0
stress fiber formation -0.002 0.071 -9999 0 -0.25 4 4
GNAZ -0.007 0.07 -9999 0 -0.27 4 4
EGFR/PI3K-beta/Gab1 -0.028 0.067 -9999 0 -0.52 1 1
positive regulation of dendritic cell cytokine production -0.02 0.095 -9999 0 -0.38 8 8
LPA/LPA2/MAGI-3 0.017 0.012 -9999 0 -10000 0 0
ARHGEF1 0.007 0.056 -9999 0 -10000 0 0
GNAI2 -0.006 0.067 -9999 0 -10000 0 0
GNAI3 -0.006 0.067 -9999 0 -0.25 3 3
GNAI1 -0.008 0.074 -9999 0 -0.28 6 6
LPA/LPA3 -0.016 0.093 -9999 0 -0.3 18 18
LPA/LPA2 0.009 0.014 -9999 0 -10000 0 0
LPA/LPA1 -0.018 0.081 -9999 0 -0.31 3 3
HB-EGF/EGFR -0.1 0.2 -9999 0 -0.45 57 57
HBEGF -0.12 0.23 -9999 0 -0.52 57 57
mol:DAG 0.01 0.062 -9999 0 -0.4 1 1
cAMP biosynthetic process -0.093 0.16 -9999 0 -0.45 29 29
NFKB1 0.012 0 -9999 0 -10000 0 0
SRC 0.012 0 -9999 0 -10000 0 0
GNB1 0.012 0 -9999 0 -10000 0 0
LYN 0.004 0.073 -9999 0 -0.4 1 1
GNAQ 0 0.064 -9999 0 -0.32 5 5
LPAR2 0.012 0.001 -9999 0 -10000 0 0
LPAR3 -0.023 0.12 -9999 0 -0.41 18 18
LPAR1 -0.031 0.11 -9999 0 -0.3 33 33
IL8 -0.21 0.19 -9999 0 -0.42 58 58
PTK2 -0.012 0.089 -9999 0 -0.42 5 5
Rac1/GDP 0.009 0 -9999 0 -10000 0 0
CASP3 -0.024 0.094 -9999 0 -0.35 8 8
EGFR 0.011 0.001 -9999 0 -10000 0 0
PLCG1 0 0.071 -9999 0 -0.32 5 5
PLD2 -0.012 0.089 -9999 0 -0.42 5 5
G12/G13 0.004 0.062 -9999 0 -10000 0 0
PI3K-beta -0.012 0.032 -9999 0 -10000 0 0
cell migration -0.003 0.084 -9999 0 -0.25 19 19
SLC9A3R2 0.012 0 -9999 0 -10000 0 0
PXN -0.002 0.072 -9999 0 -0.26 4 4
HRAS/GTP -0.081 0.16 -9999 0 -0.44 29 29
RAC1 0.012 0 -9999 0 -10000 0 0
MMP9 -0.15 0.3 -9999 0 -0.7 53 53
PRKCE 0.012 0.001 -9999 0 -10000 0 0
PRKCD 0.014 0.059 -9999 0 -0.38 1 1
Gi(beta/gamma) -0.038 0.14 -9999 0 -0.38 29 29
mol:LPA 0.001 0.021 -9999 0 -0.18 3 3
TRIP6/p130 Cas/FAK1/Paxillin 0.004 0.088 -9999 0 -0.48 1 1
MAPKKK cascade -0.079 0.16 -9999 0 -0.43 29 29
contractile ring contraction involved in cytokinesis 0.02 0.026 -9999 0 -10000 0 0
mol:GDP 0 0 -9999 0 -10000 0 0
GNA14 -0.001 0.065 -9999 0 -0.32 5 5
GNA15 -0.019 0.1 -9999 0 -0.33 18 18
GNA12 0.012 0 -9999 0 -10000 0 0
GNA13 0.012 0 -9999 0 -10000 0 0
MAPT -0.024 0.092 -9999 0 -0.26 18 18
GNA11 0 0.064 -9999 0 -0.32 5 5
Rac1/GTP -0.049 0.25 -9999 0 -0.87 19 19
MMP2 -0.011 0.094 -9999 0 -0.63 3 3
Signaling events regulated by Ret tyrosine kinase

Figure S51.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S51.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 -0.009 0.041 -9999 0 -10000 0 0
Crk/p130 Cas/Paxillin -0.078 0.094 -9999 0 -0.36 3 3
JUN -0.054 0.11 -9999 0 -0.29 25 25
HRAS 0.012 0 -9999 0 -10000 0 0
RET51/GFRalpha1/GDNF/GRB10 -0.065 0.12 -9999 0 -0.32 27 27
RAP1A 0.012 0 -9999 0 -10000 0 0
FRS2 0.012 0 -9999 0 -10000 0 0
RAP1A/GDP 0.009 0 -9999 0 -10000 0 0
RET51/GFRalpha1/GDNF/DOK1 -0.065 0.12 -9999 0 -0.32 27 27
EntrezGene:5979 0 0 -9999 0 -10000 0 0
PTPN11 0.012 0 -9999 0 -10000 0 0
mol:GTP 0 0 -9999 0 -10000 0 0
CRK 0.012 0 -9999 0 -10000 0 0
RET9/GFRalpha1/GDNF/Enigma -0.038 0.079 -9999 0 -10000 0 0
RHOA 0.012 0 -9999 0 -10000 0 0
RAP1A/GTP -0.054 0.11 -9999 0 -0.44 5 5
GRB7 -0.006 0.11 -9999 0 -0.7 6 6
RET51/GFRalpha1/GDNF -0.065 0.12 -9999 0 -0.32 27 27
MAPKKK cascade -0.075 0.099 -9999 0 -0.43 3 3
BCAR1 0.012 0 -9999 0 -10000 0 0
RET9/GFRalpha1/GDNF/IRS1 -0.038 0.079 -9999 0 -10000 0 0
lamellipodium assembly -0.078 0.094 -9999 0 -0.26 25 25
RET51/GFRalpha1/GDNF/SHC -0.065 0.12 -9999 0 -0.32 27 27
PIK3CA 0.012 0 -9999 0 -10000 0 0
RET9/GFRalpha1/GDNF/SHC -0.038 0.079 -9999 0 -10000 0 0
RET9/GFRalpha1/GDNF/Shank3 -0.038 0.079 -9999 0 -10000 0 0
MAPK3 -0.046 0.1 -9999 0 -0.41 5 5
DOK1 0.012 0 -9999 0 -10000 0 0
DOK6 0.003 0.054 -9999 0 -0.3 7 7
PXN 0.012 0 -9999 0 -10000 0 0
neurite development -0.038 0.1 -9999 0 -0.45 3 3
DOK5 -0.003 0.084 -9999 0 -0.39 9 9
GFRA1 -0.1 0.15 -9999 0 -0.3 86 86
MAPK8 -0.062 0.12 -9999 0 -0.31 25 25
HRAS/GTP -0.087 0.11 -9999 0 -0.34 27 27
tube development -0.029 0.074 -9999 0 -10000 0 0
MAPK1 -0.046 0.1 -9999 0 -0.41 5 5
RET9/GFRalpha1/GDNF/FRS2/SHP2/Grb2 -0.043 0.089 -9999 0 -10000 0 0
Rac1/GDP 0.009 0 -9999 0 -10000 0 0
SRC 0.012 0 -9999 0 -10000 0 0
PDLIM7 0.012 0 -9999 0 -10000 0 0
RET51/GFRalpha1/GDNF/Dok6 -0.058 0.12 -9999 0 -0.45 8 8
SHC1 0.012 0 -9999 0 -10000 0 0
RET51/GFRalpha1/GDNF/Dok4 -0.065 0.12 -9999 0 -0.49 5 5
RET51/GFRalpha1/GDNF/Dok5 -0.073 0.13 -9999 0 -0.33 32 32
PRKCA 0.012 0 -9999 0 -10000 0 0
HRAS/GDP 0.009 0 -9999 0 -10000 0 0
CREB1 -0.076 0.13 -9999 0 -0.34 25 25
PIK3R1 0.012 0 -9999 0 -10000 0 0
RET9/GFRalpha1/GDNF/SHC/GAB1/Grb2 -0.043 0.089 -9999 0 -10000 0 0
RET51/GFRalpha1/GDNF/Grb7 -0.076 0.14 -9999 0 -0.36 31 31
mol:GDP 0 0 -9999 0 -10000 0 0
RET -0.054 0.15 -9999 0 -0.35 43 43
DOK4 0.012 0 -9999 0 -10000 0 0
JNK cascade -0.053 0.11 -9999 0 -0.29 25 25
RET9/GFRalpha1/GDNF/FRS2 -0.038 0.079 -9999 0 -10000 0 0
SHANK3 0.012 0 -9999 0 -10000 0 0
RASA1 0.012 0 -9999 0 -10000 0 0
NCK1 0.012 0 -9999 0 -10000 0 0
RET9/GFRalpha1/GDNF/SHC/Grb2/SOS1 -0.043 0.09 -9999 0 -10000 0 0
RET51/GFRalpha1/GDNF/FRS2/SHP2/Grb2 -0.072 0.13 -9999 0 -0.34 25 25
RET51/GFRalpha1/GDNF/DOK/RasGAP/NCK -0.072 0.13 -9999 0 -0.34 25 25
RET51/GFRalpha1/GDNF/SHC/Grb2/SOS1 -0.079 0.14 -9999 0 -0.4 25 25
PI3K -0.082 0.16 -9999 0 -0.38 25 25
SOS1 0.012 0 -9999 0 -10000 0 0
RET9/GFRalpha1/GDNF/Shank3/Grb2 -0.028 0.074 -9999 0 -10000 0 0
GRB10 0.012 0 -9999 0 -10000 0 0
activation of MAPKK activity -0.058 0.11 -9999 0 -0.27 25 25
RET51/GFRalpha1/GDNF/FRS2 -0.065 0.12 -9999 0 -0.32 27 27
GAB1 0.012 0 -9999 0 -10000 0 0
IRS1 0.012 0 -9999 0 -10000 0 0
IRS2 0.009 0.046 -9999 0 -0.7 1 1
RET51/GFRalpha1/GDNF/SHC/GAB1/Grb2 -0.079 0.14 -9999 0 -0.4 25 25
RET51/GFRalpha1/GDNF/PKC alpha -0.065 0.12 -9999 0 -0.32 27 27
GRB2 0.012 0 -9999 0 -10000 0 0
PRKACA 0.012 0 -9999 0 -10000 0 0
GDNF 0.009 0.005 -9999 0 -10000 0 0
RAC1 0.012 0 -9999 0 -10000 0 0
RET51/GFRalpha1/GDNF/IRS1 -0.065 0.12 -9999 0 -0.32 27 27
Rac1/GTP -0.091 0.11 -9999 0 -0.31 25 25
RET9/GFRalpha1/GDNF -0.051 0.087 -9999 0 -10000 0 0
GFRalpha1/GDNF -0.063 0.1 -9999 0 -10000 0 0
TCR signaling in naïve CD8+ T cells

Figure S52.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S52.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GRB2/SOS1/SHC 0.01 0.13 -10000 0 -0.48 11 11
FYN -0.001 0.16 -10000 0 -0.52 15 15
LAT/GRAP2/SLP76 -0.031 0.12 -10000 0 -0.51 11 11
IKBKB 0.009 0.046 -10000 0 -0.7 1 1
AKT1 0.013 0.12 -10000 0 -0.41 11 11
B2M 0.013 0.003 -10000 0 -10000 0 0
IKBKG -0.017 0.04 -10000 0 -0.15 7 7
MAP3K8 0.012 0 -10000 0 -10000 0 0
mol:Ca2+ -0.021 0.049 -10000 0 -0.14 32 32
integrin-mediated signaling pathway 0.017 0 -10000 0 -10000 0 0
LAT/GRAP2/SLP76/VAV1/PI3K Class IA 0.003 0.16 -10000 0 -0.58 12 12
TRPV6 -0.097 0.24 -10000 0 -0.7 32 32
CD28 0.003 0.054 -10000 0 -0.3 7 7
SHC1 -0.003 0.16 -10000 0 -0.52 15 15
receptor internalization -0.013 0.17 -10000 0 -0.52 19 19
PRF1 -0.008 0.19 -10000 0 -0.74 11 11
KRAS 0.012 0 -10000 0 -10000 0 0
GRB2 0.012 0 -10000 0 -10000 0 0
COT/AKT1 0.019 0.095 -10000 0 -0.33 10 10
LAT -0.003 0.16 -10000 0 -0.5 16 16
EntrezGene:6955 0.001 0.003 -10000 0 -10000 0 0
CD3D 0.001 0.062 -10000 0 -0.31 9 9
CD3E 0 0.066 -10000 0 -0.31 10 10
CD3G -0.014 0.089 -10000 0 -0.3 20 20
RASGRP2 -0.018 0.061 -10000 0 -0.16 34 34
RASGRP1 0.019 0.12 -10000 0 -0.41 11 11
HLA-A 0.013 0.003 -10000 0 -10000 0 0
RASSF5 0.012 0 -10000 0 -10000 0 0
RAP1A/GTP/RAPL 0.017 0 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
mol:GDP 0.018 0.044 -10000 0 -0.12 10 10
PDK1/CARD11/BCL10/MALT1/TRAF6 -0.031 0.07 -10000 0 -0.24 14 14
PRKCA -0.013 0.063 -10000 0 -0.26 8 8
GRAP2 0.004 0.05 -10000 0 -0.3 6 6
mol:IP3 0.002 0.13 0.25 31 -0.39 11 42
EntrezGene:6957 0.001 0.003 -10000 0 -10000 0 0
TCR/CD3/MHC I/CD8 -0.009 0.15 -10000 0 -0.45 18 18
ORAI1 0.053 0.12 0.35 32 -10000 0 32
CSK -0.003 0.16 -10000 0 -0.58 12 12
B7 family/CD28 -0.01 0.17 -10000 0 -0.6 11 11
CHUK 0.012 0 -10000 0 -10000 0 0
TCR/CD3/MHC I/CD8/LCK/ZAP-70 -0.011 0.18 -10000 0 -0.57 16 16
PTPN6 -0.004 0.15 -10000 0 -0.5 15 15
VAV1 -0.006 0.16 -10000 0 -0.56 14 14
Monovalent TCR/CD3 -0.014 0.13 -10000 0 -0.55 11 11
CBL 0.012 0 -10000 0 -10000 0 0
LCK -0.005 0.16 -10000 0 -0.5 16 16
PAG1 -0.003 0.16 -10000 0 -0.55 13 13
RAP1A 0.012 0 -10000 0 -10000 0 0
TCR/CD3/MHC I/CD8/LCK -0.011 0.17 -10000 0 -0.55 16 16
CD80 -0.024 0.16 -10000 0 -0.7 12 12
CD86 0.01 0.029 -10000 0 -0.3 2 2
PDK1/CARD11/BCL10/MALT1 -0.038 0.085 -10000 0 -0.28 17 17
HRAS 0.012 0 -10000 0 -10000 0 0
GO:0035030 -0.007 0.14 -10000 0 -0.5 11 11
CD8A -0.005 0.082 -10000 0 -0.34 12 12
CD8B 0 0.081 -10000 0 -0.42 7 7
PTPRC -0.008 0.078 -10000 0 -0.3 15 15
PDK1/PKC theta 0.014 0.14 -10000 0 -0.5 11 11
CSK/PAG1 0.002 0.15 -10000 0 -0.57 11 11
SOS1 0.012 0 -10000 0 -10000 0 0
peptide-MHC class I 0.02 0.005 -10000 0 -10000 0 0
GRAP2/SLP76 -0.039 0.14 -10000 0 -0.6 11 11
STIM1 0.026 0.06 -10000 0 -10000 0 0
RAS family/GTP 0.03 0.052 -10000 0 -0.16 8 8
TCR/CD3/MHC I/CD8/LCK/ZAP-70/CBL/ubiquitin -0.015 0.19 -10000 0 -0.56 19 19
mol:DAG -0.014 0.095 -10000 0 -0.35 11 11
RAP1A/GDP 0.009 0.02 -10000 0 -0.063 1 1
PLCG1 0.012 0 -10000 0 -10000 0 0
CD247 0.004 0.055 -10000 0 -0.3 7 7
cytotoxic T cell degranulation -0.007 0.18 -10000 0 -0.7 11 11
RAP1A/GTP -0.01 0.021 -10000 0 -0.065 14 14
mol:PI-3-4-5-P3 0.008 0.14 -10000 0 -0.48 12 12
LAT/GRAP2/SLP76/VAV1/PLCgamma1 -0.004 0.16 0.26 31 -0.5 11 42
NRAS 0.012 0 -10000 0 -10000 0 0
ZAP70 -0.003 0.092 -10000 0 -0.45 8 8
GRB2/SOS1 0.019 0 -10000 0 -10000 0 0
LAT/GRAP2/SLP76/VAV1 -0.032 0.12 -10000 0 -0.48 12 12
MALT1 0.012 0 -10000 0 -10000 0 0
TRAF6 0.012 0 -10000 0 -10000 0 0
CD8 heterodimer -0.001 0.094 -10000 0 -0.63 3 3
CARD11 -0.06 0.21 -10000 0 -0.64 26 26
PRKCB -0.025 0.082 -10000 0 -0.27 17 17
PRKCE -0.013 0.063 -10000 0 -0.26 8 8
PRKCQ 0.006 0.16 -10000 0 -0.55 12 12
LCP2 0.012 0 -10000 0 -10000 0 0
BCL10 0.012 0 -10000 0 -10000 0 0
regulation of survival gene product expression 0.015 0.1 -10000 0 -0.35 11 11
IKK complex 0.018 0.045 -10000 0 -0.11 8 8
RAS family/GDP -0.002 0.007 -10000 0 -10000 0 0
MAP3K14 0.023 0.075 -10000 0 -0.27 8 8
PDPK1 0.015 0.11 -10000 0 -0.4 10 10
TCR/CD3/MHC I/CD8/Fyn -0.01 0.17 -10000 0 -0.61 14 14
Plasma membrane estrogen receptor signaling

Figure S53.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S53.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GNB1/GNG2 0.013 0.052 -10000 0 -10000 0 0
ER alpha/Gai/GDP/Gbeta gamma -0.11 0.2 -10000 0 -0.58 23 23
AKT1 -0.052 0.22 -10000 0 -0.78 20 20
PIK3CA 0.012 0 -10000 0 -10000 0 0
E2/ER alpha (dimer)/PELP1/Src/PI3K -0.057 0.23 -10000 0 -0.8 20 20
mol:Ca2+ 0.015 0.062 -10000 0 -0.32 1 1
IGF1R 0.012 0 -10000 0 -10000 0 0
E2/ER alpha (dimer)/Striatin 0.001 0.05 -10000 0 -10000 0 0
SHC1 0.012 0 -10000 0 -10000 0 0
apoptosis 0.048 0.21 0.74 20 -10000 0 20
RhoA/GTP -0.009 0.028 -10000 0 -10000 0 0
E2/ER alpha (dimer)/PELP1/Src/p130 Cas -0.092 0.14 -10000 0 -0.52 18 18
regulation of stress fiber formation -0.03 0.032 -10000 0 -10000 0 0
E2/ERA-ERB (dimer) -0.001 0.055 -10000 0 -0.32 1 1
KRAS 0.012 0 -10000 0 -10000 0 0
G13/GTP 0.002 0.045 -10000 0 -10000 0 0
pseudopodium formation 0.03 0.032 -10000 0 -10000 0 0
E2/ER alpha (dimer)/PELP1 0.001 0.05 -10000 0 -10000 0 0
GRB2 0.012 0 -10000 0 -10000 0 0
GNG2 0.008 0.035 -10000 0 -0.3 3 3
GNAO1 -0.13 0.16 -10000 0 -0.3 103 103
HRAS 0.012 0 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
mol:NO -0.06 0.18 -10000 0 -0.57 21 21
E2/ER beta (dimer) 0.006 0.024 -10000 0 -0.2 3 3
mol:GDP -0.024 0.074 -10000 0 -0.39 1 1
mol:NADP -0.06 0.18 -10000 0 -0.57 21 21
PIK3R1 0.012 0 -10000 0 -10000 0 0
mol:IP3 0.015 0.063 -10000 0 -0.33 1 1
IGF-1R heterotetramer 0.012 0 -10000 0 -10000 0 0
PLCB1 0.01 0.065 -10000 0 -0.32 2 2
PLCB2 0.012 0.059 -10000 0 -0.3 1 1
IGF1 -0.057 0.14 -10000 0 -0.32 49 49
mol:L-citrulline -0.06 0.18 -10000 0 -0.57 21 21
RHOA 0.012 0 -10000 0 -10000 0 0
Gai/GDP -0.25 0.32 -10000 0 -0.6 103 103
JNK cascade 0.006 0.024 -10000 0 -0.2 3 3
BCAR1 0.012 0 -10000 0 -10000 0 0
ESR2 0.008 0.035 -10000 0 -0.3 3 3
GNAQ 0.012 0 -10000 0 -10000 0 0
ESR1 -0.015 0.088 -10000 0 -0.3 20 20
Gq family/GDP/Gbeta gamma 0.017 0.065 -10000 0 -10000 0 0
E2/ER alpha (dimer)/PELP1/Src/p52 SHC/GRB2/SOS1 -0.004 0.07 -10000 0 -10000 0 0
E2/ER alpha (dimer)/PELP1/Src/p52 SHC -0.092 0.14 -10000 0 -0.52 18 18
GNAZ 0.007 0.041 -10000 0 -0.3 4 4
E2/ER alpha (dimer) -0.009 0.06 -10000 0 -0.2 20 20
STRN 0.012 0 -10000 0 -10000 0 0
GNAL -0.006 0.075 -10000 0 -0.3 14 14
PELP1 0.012 0 -10000 0 -10000 0 0
MAPK11 0.014 0.02 -10000 0 -10000 0 0
GNAI2 0.012 0 -10000 0 -10000 0 0
GNAI3 0.012 0 -10000 0 -10000 0 0
GNAI1 0.007 0.041 -10000 0 -0.3 4 4
HBEGF -0.13 0.17 -10000 0 -0.48 29 29
cAMP biosynthetic process -0.02 0.055 -10000 0 -0.25 7 7
SRC -0.098 0.19 -10000 0 -0.55 23 23
PI3K 0.019 0 -10000 0 -10000 0 0
GNB1 0.012 0 -10000 0 -10000 0 0
G13/GDP/Gbeta gamma -0.021 0.064 -10000 0 -0.33 2 2
SOS1 0.012 0 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1 -0.095 0.14 -10000 0 -0.46 20 20
Gs family/GTP -0.004 0.061 -10000 0 -0.26 7 7
EntrezGene:2778 0 0 -10000 0 -10000 0 0
RAS family/GTP 0.024 0 -10000 0 -10000 0 0
vasodilation -0.057 0.17 -10000 0 -0.55 21 21
mol:DAG 0.015 0.063 -10000 0 -0.33 1 1
Gs family/GDP/Gbeta gamma -0.026 0.073 -10000 0 -0.31 8 8
MSN 0.031 0.033 -10000 0 -10000 0 0
Gq family/GTP 0.007 0.062 -10000 0 -0.29 3 3
mol:PI-3-4-5-P3 -0.054 0.22 -10000 0 -0.77 20 20
NRAS 0.012 0 -10000 0 -10000 0 0
mol:E2 0 0 -10000 0 -10000 0 0
cell adhesion 0.057 0.17 0.55 21 -10000 0 21
GRB2/SOS1 0.019 0 -10000 0 -10000 0 0
RhoA/GDP -0.022 0.069 -10000 0 -0.36 1 1
NOS3 -0.064 0.19 -10000 0 -0.61 21 21
GNA11 0.012 0 -10000 0 -10000 0 0
MAPKKK cascade -0.044 0.18 -10000 0 -0.6 20 20
E2/ER alpha (dimer)/PELP1/Src -0.098 0.15 -10000 0 -0.55 18 18
ruffle organization 0.03 0.032 -10000 0 -10000 0 0
ROCK2 0.027 0.035 -10000 0 -10000 0 0
GNA14 0.011 0.021 -10000 0 -0.3 1 1
GNA15 -0.03 0.17 -10000 0 -0.7 14 14
GNA13 0.012 0 -10000 0 -10000 0 0
MMP9 -0.17 0.2 -10000 0 -0.41 70 70
MMP2 -0.092 0.18 -10000 0 -0.57 18 18
ErbB4 signaling events

Figure S54.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S54.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ErbB4/ErbB4/HBEGF/HBEGF 0.023 0.059 -9999 0 -0.42 4 4
epithelial cell differentiation -0.022 0.077 -9999 0 -0.57 1 1
ITCH 0.013 0.002 -9999 0 -10000 0 0
WWP1 0.029 0.008 -9999 0 -10000 0 0
FYN 0.012 0 -9999 0 -10000 0 0
EGFR 0.012 0 -9999 0 -10000 0 0
PRL -0.03 0.16 -9999 0 -0.7 12 12
neuron projection morphogenesis 0.035 0.045 -9999 0 -10000 0 0
PTPRZ1 -0.11 0.15 -9999 0 -0.3 92 92
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta/GRB2/SHC 0.028 0.048 -9999 0 -10000 0 0
ErbB4 CYT2/ErbB4 CYT2/neuregulin 1 beta/neuregulin 1 beta 0.027 0.013 -9999 0 -10000 0 0
ADAM17 0.013 0.002 -9999 0 -10000 0 0
ErbB4/ErbB4 0.03 0.01 -9999 0 -10000 0 0
ErbB4/ErbB4/neuregulin 3/neuregulin 3 0.027 0.009 -9999 0 -10000 0 0
NCOR1 0.012 0 -9999 0 -10000 0 0
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta/Fyn 0.016 0.051 -9999 0 -10000 0 0
GRIN2B -0.11 0.19 -9999 0 -0.36 78 78
ErbB4/ErbB2/betacellulin 0.032 0.041 -9999 0 -0.37 2 2
STAT1 0 0.092 -9999 0 -0.7 4 4
HBEGF 0 0.092 -9999 0 -0.7 4 4
PRLR 0.004 0.05 -9999 0 -0.3 6 6
E4ICDs/ETO2 0.017 0.069 -9999 0 -0.44 5 5
axon guidance 0.061 0.067 -9999 0 -10000 0 0
NEDD4 0.013 0.002 -9999 0 -10000 0 0
Prolactin receptor/Prolactin receptor/Prolactin -0.019 0.12 -9999 0 -0.52 12 12
CBFA2T3 -0.039 0.14 -9999 0 -0.36 32 32
ErbB4/ErbB2/HBEGF 0.026 0.065 -9999 0 -0.37 6 6
MAPK3 0.031 0.046 -9999 0 -10000 0 0
STAT1 (dimer) 0.023 0.059 -9999 0 -0.42 4 4
MAPK1 0.031 0.046 -9999 0 -10000 0 0
JAK2 0.012 0 -9999 0 -10000 0 0
ErbB4/ErbB2/neuregulin 1 beta 0.011 0.066 -9999 0 -0.44 2 2
NRG1 -0.011 0.075 -9999 0 -10000 0 0
NRG3 0.008 0.006 -9999 0 -10000 0 0
NRG2 -0.06 0.13 -9999 0 -0.3 51 51
NRG4 0.01 0.005 -9999 0 -10000 0 0
heart development 0.061 0.067 -9999 0 -10000 0 0
neural crest cell migration 0.011 0.065 -9999 0 -0.44 2 2
ERBB2 0.015 0.051 -9999 0 -0.53 2 2
WWOX/E4ICDs 0.031 0.008 -9999 0 -10000 0 0
SHC1 0.012 0 -9999 0 -10000 0 0
ErbB4/EGFR/neuregulin 4 0.035 0.008 -9999 0 -10000 0 0
apoptosis 0.025 0.046 -9999 0 -10000 0 0
ErbB4/ErbB4/neuregulin 2 beta/neuregulin 2 beta 0.021 0.014 -9999 0 -10000 0 0
ErbB4/ErbB2/epiregulin -0.17 0.21 -9999 0 -0.38 112 112
ErbB4/ErbB4/betacellulin/betacellulin 0.03 0.009 -9999 0 -10000 0 0
ErbB4/ErbB4/HBEGF/HBEGF/Prolactin receptor/Prolactin receptor/Prolactin/JAK2 0.013 0.11 -9999 0 -0.57 2 2
MDM2 0.032 0.008 -9999 0 -10000 0 0
ErbB4 JM-B/ErbB4 JM-B/neuregulin 1 beta/neuregulin 1 beta 0.011 0.052 -9999 0 -10000 0 0
STAT5A 0.062 0.062 -9999 0 -10000 0 0
ErbB4/EGFR/neuregulin 1 beta 0.016 0.051 -9999 0 -10000 0 0
DLG4 0.012 0 -9999 0 -10000 0 0
GRB2/SHC 0.019 0 -9999 0 -10000 0 0
E4ICDs/TAB2/NCoR1 0.028 0.008 -9999 0 -10000 0 0
STAT5A (dimer) -0.023 0.083 -9999 0 -0.63 1 1
MAP3K7IP2 0 0 -9999 0 -10000 0 0
STAT5B (dimer) 0.063 0.057 -9999 0 -10000 0 0
LRIG1 0.012 0 -9999 0 -10000 0 0
EREG -0.34 0.35 -9999 0 -0.67 119 119
BTC 0.01 0.029 -9999 0 -0.3 2 2
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta 0.062 0.067 -9999 0 -10000 0 0
ERBB4 0.03 0.01 -9999 0 -10000 0 0
STAT5B 0.012 0 -9999 0 -10000 0 0
YAP1 0.016 0.003 -9999 0 -10000 0 0
GRB2 0.012 0 -9999 0 -10000 0 0
ErbB4/ErbB2/neuregulin 4 0.031 0.038 -9999 0 -0.37 2 2
glial cell differentiation -0.027 0.007 -9999 0 -10000 0 0
WWOX 0.012 0 -9999 0 -10000 0 0
cell proliferation 0.033 0.078 -9999 0 -0.48 1 1
Visual signal transduction: Cones

Figure S55.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S55.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Cone Metarhodopsin II/Cone Transducin 0.02 0.014 -9999 0 -10000 0 0
RGS9BP 0.012 0.003 -9999 0 -10000 0 0
mol:GTP 0 0 -9999 0 -10000 0 0
GRK1 -0.004 0.065 -9999 0 -0.7 2 2
mol:Na + -0.099 0.15 -9999 0 -0.54 18 18
mol:ADP 0.003 0.05 -9999 0 -0.52 2 2
GNAT2 0.011 0.004 -9999 0 -10000 0 0
RGS9-1/Gbeta5/R9AP -0.014 0.074 -9999 0 -10000 0 0
mol:GDP 0 0 -9999 0 -10000 0 0
PDE6H/GNAT2/GTP 0.008 0.003 -9999 0 -10000 0 0
GRK7 0.009 0.006 -9999 0 -10000 0 0
CNGB3 -0.047 0.18 -9999 0 -0.7 17 17
Cone Metarhodopsin II/X-Arrestin -0.001 0.035 -9999 0 -0.53 1 1
mol:Ca2+ -0.11 0.17 -9999 0 -0.5 29 29
Cone PDE6 -0.01 0.067 -9999 0 -0.39 1 1
Cone Metarhodopsin II 0.003 0.04 -9999 0 -0.42 2 2
Na + (4 Units) -0.11 0.17 -9999 0 -0.5 29 29
GNAT2/GDP -0.004 0.062 -9999 0 -10000 0 0
GNB5 0.012 0 -9999 0 -10000 0 0
mol:GMP (4 units) 0.007 0.028 -9999 0 -0.42 1 1
Cone Transducin 0.022 0.015 -9999 0 -10000 0 0
SLC24A2 -0.031 0.16 -9999 0 -0.7 13 13
GNB3/GNGT2 0.017 0.02 -9999 0 -10000 0 0
GNB3 0.012 0 -9999 0 -10000 0 0
GNAT2/GTP 0.008 0.003 -9999 0 -10000 0 0
CNGA3 -0.12 0.16 -9999 0 -0.31 98 98
ARR3 -0.001 0.046 -9999 0 -0.7 1 1
absorption of light 0 0 -9999 0 -10000 0 0
cGMP/Cone CNG Channel -0.1 0.16 -9999 0 -0.54 18 18
mol:Pi -0.014 0.074 -9999 0 -10000 0 0
Cone CNG Channel -0.076 0.13 -9999 0 -0.45 19 19
mol:all-trans-retinal 0 0 -9999 0 -10000 0 0
mol:K + -0.031 0.16 -9999 0 -0.7 13 13
RGS9 -0.055 0.13 -9999 0 -0.3 50 50
PDE6C 0 0.046 -9999 0 -0.7 1 1
GNGT2 0.01 0.029 -9999 0 -0.3 2 2
mol:cGMP (4 units) 0 0 -9999 0 -10000 0 0
PDE6H 0.001 0.003 -9999 0 -10000 0 0
Nectin adhesion pathway

Figure S56.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S56.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB 0 0.092 -9999 0 -0.7 4 4
alphaV beta3 Integrin 0.014 0.031 -9999 0 -10000 0 0
PTK2 0.029 0.053 -9999 0 -10000 0 0
positive regulation of JNK cascade -0.007 0.041 -9999 0 -0.24 7 7
CDC42/GDP 0.04 0.064 -9999 0 -0.32 7 7
Rac1/GDP 0.041 0.064 -9999 0 -0.31 7 7
RAP1B 0.012 0 -9999 0 -10000 0 0
RAP1A 0.012 0 -9999 0 -10000 0 0
CTNNB1 0.012 0 -9999 0 -10000 0 0
CDC42/GTP -0.009 0.05 -9999 0 -0.29 7 7
nectin-3/I-afadin 0.012 0.037 -9999 0 -10000 0 0
RAPGEF1 0.035 0.067 -9999 0 -0.34 7 7
mol:GTP 0 0 -9999 0 -10000 0 0
CRK 0.031 0.074 -9999 0 -0.38 7 7
PDGFB-D/PDGFRB 0 0.092 -9999 0 -0.7 4 4
TLN1 0.023 0.02 -9999 0 -10000 0 0
Rap1/GTP -0.007 0.042 -9999 0 -10000 0 0
IQGAP1 0.012 0 -9999 0 -10000 0 0
Rap1/GTP/I-afadin 0.023 0.011 -9999 0 -10000 0 0
nectin-3(dimer)/I-afadin/I-afadin/nectin-3(dimer)/I-afadin/I-afadin 0.012 0.037 -9999 0 -10000 0 0
PVR 0.012 0 -9999 0 -10000 0 0
Necl-5(dimer) 0.012 0 -9999 0 -10000 0 0
mol:GDP 0.038 0.075 -9999 0 -0.38 7 7
MLLT4 0.011 0.021 -9999 0 -0.3 1 1
PIK3CA 0.012 0 -9999 0 -10000 0 0
PI3K 0.025 0.059 -9999 0 -0.38 4 4
nectin-1(dimer)/I-afadin/I-afadin/nectin-1(dimer)/I-afadin/I-afadin 0.018 0.014 -9999 0 -10000 0 0
positive regulation of lamellipodium assembly -0.009 0.046 -9999 0 -0.25 8 8
PVRL1 0.012 0 -9999 0 -10000 0 0
PVRL3 0.004 0.05 -9999 0 -0.3 6 6
PVRL2 0.012 0 -9999 0 -10000 0 0
PIK3R1 0.012 0 -9999 0 -10000 0 0
CDH1 0.012 0 -9999 0 -10000 0 0
CLDN1 -0.64 0.18 -9999 0 -0.7 215 215
JAM-A/CLDN1 -0.38 0.12 -9999 0 -0.41 215 215
SRC 0.026 0.079 -9999 0 -0.42 7 7
ITGB3 0.006 0.045 -9999 0 -0.3 5 5
nectin-1(dimer)/I-afadin/I-afadin 0.018 0.014 -9999 0 -10000 0 0
FARP2 0.034 0.072 -9999 0 -0.37 7 7
RAC1 0.012 0 -9999 0 -10000 0 0
CTNNA1 0.012 0 -9999 0 -10000 0 0
nectin-3(dimer)/I-afadin/I-afadin/Necl-5(dimer) 0.02 0.031 -9999 0 -10000 0 0
nectin-1/I-afadin 0.018 0.014 -9999 0 -10000 0 0
nectin-2/I-afadin 0.018 0.014 -9999 0 -10000 0 0
RAC1/GTP/IQGAP1/filamentous actin 0.017 0 -9999 0 -10000 0 0
nectin-1(dimer)/I-afadin/I-afadin/nectin-3(dimer/I-afadin/I-afadin 0.02 0.031 -9999 0 -10000 0 0
CDC42/GTP/IQGAP1/filamentous actin 0.017 0 -9999 0 -10000 0 0
F11R 0.012 0 -9999 0 -10000 0 0
positive regulation of filopodium formation -0.007 0.041 -9999 0 -0.24 7 7
alphaV/beta3 Integrin/Talin 0.032 0.027 -9999 0 -10000 0 0
nectin-2(dimer)/I-afadin/I-afadin/nectin-2(dimer/I-afadin/I-afadin 0.018 0.014 -9999 0 -10000 0 0
nectin-2(dimer)/I-afadin/I-afadin 0.018 0.014 -9999 0 -10000 0 0
PIP5K1C 0.018 0.022 -9999 0 -10000 0 0
VAV2 0.032 0.079 -9999 0 -0.38 8 8
RAP1/GDP -0.009 0.05 -9999 0 -0.29 7 7
ITGAV 0.012 0 -9999 0 -10000 0 0
nectin-3(dimer)/I-afadin/I-afadin/nectin-2(dimer)/I-afadin/I-afadin 0.02 0.031 -9999 0 -10000 0 0
nectin-3(dimer)/I-afadin/I-afadin 0.012 0.037 -9999 0 -10000 0 0
Rac1/GTP -0.01 0.054 -9999 0 -0.3 8 8
PTPRM 0.012 0.024 -9999 0 -10000 0 0
E-cadherin/beta catenin/alpha catenin 0.036 0.009 -9999 0 -10000 0 0
adherens junction assembly 0 0 -9999 0 -10000 0 0
CDC42 0.012 0 -9999 0 -10000 0 0
Integrins in angiogenesis

Figure S57.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S57.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR2 homodimer/VEGFA homodimer -0.016 0.13 -9999 0 -0.52 15 15
alphaV beta3 Integrin 0.005 0.061 -9999 0 -0.32 2 2
PTK2 -0.007 0.11 -9999 0 -0.35 5 5
IGF1R 0.012 0 -9999 0 -10000 0 0
PI4KB 0.012 0 -9999 0 -10000 0 0
MFGE8 0.009 0.046 -9999 0 -0.7 1 1
SRC 0.012 0 -9999 0 -10000 0 0
CDKN1B 0.003 0.064 -9999 0 -0.3 8 8
VEGFA -0.033 0.17 -9999 0 -0.7 15 15
ILK 0.003 0.064 -9999 0 -0.3 8 8
ROCK1 0.012 0 -9999 0 -10000 0 0
AKT1 0.01 0.06 -9999 0 -10000 0 0
PTK2B 0.002 0.1 -9999 0 -0.37 15 15
alphaV/beta3 Integrin/JAM-A 0.004 0.089 -9999 0 -0.38 8 8
CBL 0.012 0 -9999 0 -10000 0 0
mol:GTP 0 0 -9999 0 -10000 0 0
alphaV beta3 Integrin/ANGPTL3 0.017 0.026 -9999 0 -10000 0 0
IGF-1R heterotetramer/IGF1/IRS1/Shp2 -0.005 0.075 -9999 0 -0.4 2 2
VEGF/Rho/ROCK/alphaV/beta3 Integrin 0.013 0.061 -9999 0 -10000 0 0
alphaV/beta3 Integrin/Syndecan-1 0.021 0.026 -9999 0 -10000 0 0
PI4KA 0.012 0 -9999 0 -10000 0 0
IGF-1R heterotetramer/IGF1/IRS1 -0.069 0.12 -9999 0 -0.38 23 23
PI4 Kinase 0.019 0 -9999 0 -10000 0 0
PIK3CA 0.012 0 -9999 0 -10000 0 0
alphaV/beta3 Integrin/Osteopontin -0.21 0.23 -9999 0 -0.45 115 115
RPS6KB1 -0.035 0.13 -9999 0 -0.48 5 5
TLN1 0.012 0 -9999 0 -10000 0 0
MAPK3 -0.032 0.14 -9999 0 -0.4 24 24
GPR124 0.012 0 -9999 0 -10000 0 0
MAPK1 -0.032 0.14 -9999 0 -0.4 24 24
PXN 0.012 0 -9999 0 -10000 0 0
PIK3R1 0.012 0 -9999 0 -10000 0 0
alphaV/beta3 Integrin/Tumstatin -0.019 0.11 -9999 0 -0.45 9 9
cell adhesion 0.023 0.035 -9999 0 -0.32 1 1
ANGPTL3 0.006 0.006 -9999 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/Src -0.005 0.12 -9999 0 -0.45 15 15
IGF-1R heterotetramer 0.012 0 -9999 0 -10000 0 0
Rac1/GDP 0.009 0 -9999 0 -10000 0 0
TGFBR2 0.012 0 -9999 0 -10000 0 0
ITGB3 0.006 0.045 -9999 0 -0.3 5 5
IGF1 -0.057 0.14 -9999 0 -0.32 49 49
RAC1 0.012 0 -9999 0 -10000 0 0
regulation of cell-matrix adhesion 0.021 0.026 -9999 0 -10000 0 0
apoptosis 0.012 0 -9999 0 -10000 0 0
CD47 0.012 0 -9999 0 -10000 0 0
alphaV/beta3 Integrin/CD47 0.021 0.026 -9999 0 -10000 0 0
VCL 0.012 0 -9999 0 -10000 0 0
alphaV/beta3 Integrin/Del1 -0.008 0.078 -9999 0 -0.32 5 5
CSF1 0.011 0.021 -9999 0 -0.3 1 1
PIK3C2A 0.003 0.064 -9999 0 -0.3 8 8
PI4 Kinase/Pyk2 -0.041 0.1 -9999 0 -0.43 3 3
VEGFR2 homodimer/VEGFA homodimer/alphaV beta3 Integrin 0 0.11 -9999 0 -0.4 15 15
FAK1/Vinculin 0.001 0.094 -9999 0 -10000 0 0
alphaV beta3/Integrin/ppsTEM5 0.021 0.026 -9999 0 -10000 0 0
RHOA 0.012 0 -9999 0 -10000 0 0
VTN -0.013 0.13 -9999 0 -0.7 8 8
BCAR1 0.012 0 -9999 0 -10000 0 0
FGF2 -0.016 0.09 -9999 0 -0.3 21 21
F11R -0.001 0.062 -9999 0 -10000 0 0
alphaV/beta3 Integrin/Lactadherin 0.019 0.04 -9999 0 -0.45 1 1
alphaV/beta3 Integrin/TGFBR2 0.021 0.026 -9999 0 -10000 0 0
alphaV/beta3 Integrin/c-FMS/Cbl/Cas 0.031 0.011 -9999 0 -10000 0 0
HSP90AA1 0.012 0 -9999 0 -10000 0 0
alphaV/beta3 Integrin/Talin 0.021 0.023 -9999 0 -10000 0 0
mol:GDP 0 0 -9999 0 -10000 0 0
FN1 -0.057 0.21 -9999 0 -0.63 25 25
alphaV/beta3 Integrin/Pyk2 0.005 0.1 -9999 0 -0.37 15 15
SDC1 0.012 0 -9999 0 -10000 0 0
VAV3 0.027 0.014 -9999 0 -10000 0 0
PTPN11 0.012 0 -9999 0 -10000 0 0
IRS1 0.012 0 -9999 0 -10000 0 0
FAK1/Paxillin 0.001 0.094 -9999 0 -10000 0 0
cell migration 0.008 0.088 -9999 0 -10000 0 0
ITGAV 0.012 0 -9999 0 -10000 0 0
PI3K 0.011 0.08 -9999 0 -0.34 8 8
SPP1 -0.34 0.35 -9999 0 -0.69 116 116
KDR 0.012 0 -9999 0 -10000 0 0
mol:PI-4-5-P2 0 0 -9999 0 -10000 0 0
alphaV/beta3 Integrin/Caspase 8 0.012 0 -9999 0 -10000 0 0
COL4A3 -0.054 0.16 -9999 0 -0.4 36 36
angiogenesis -0.029 0.14 -9999 0 -0.4 24 24
Rac1/GTP 0.018 0.046 -9999 0 -10000 0 0
EDIL3 -0.039 0.12 -9999 0 -0.3 38 38
cell proliferation 0.021 0.026 -9999 0 -10000 0 0
Nongenotropic Androgen signaling

Figure S58.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S58.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 0.009 0 -10000 0 -10000 0 0
GNB1/GNG2 -0.008 0.072 -10000 0 -0.32 4 4
regulation of S phase of mitotic cell cycle -0.006 0.07 -10000 0 -10000 0 0
GNAO1 -0.13 0.16 -10000 0 -0.3 103 103
HRAS 0.013 0 -10000 0 -10000 0 0
SHBG/T-DHT 0.001 0.053 -10000 0 -0.46 3 3
PELP1 0.013 0 -10000 0 -10000 0 0
AKT1 0.009 0 -10000 0 -10000 0 0
MAP2K1 0.013 0.054 -10000 0 -0.32 1 1
T-DHT/AR -0.031 0.086 -10000 0 -0.21 41 41
G-protein coupled receptor activity 0 0 -10000 0 -10000 0 0
mol:GTP 0 0.001 -10000 0 -0.007 2 2
GNAI2 0.012 0 -10000 0 -10000 0 0
GNAI3 0.012 0 -10000 0 -10000 0 0
GNAI1 0.007 0.041 -10000 0 -0.3 4 4
mol:GDP -0.049 0.11 -10000 0 -0.28 41 41
cell proliferation 0.017 0.069 -10000 0 -0.36 2 2
PIK3CA 0.012 0 -10000 0 -10000 0 0
FOS 0.023 0.079 -10000 0 -0.72 2 2
mol:Ca2+ -0.013 0.028 -10000 0 -0.074 40 40
MAPK3 0.015 0.062 -10000 0 -10000 0 0
MAPK1 0.015 0.034 -10000 0 -10000 0 0
PIK3R1 0.012 0 -10000 0 -10000 0 0
mol:IP3 0 0 -10000 0 -0.005 2 2
cAMP biosynthetic process 0.006 0.054 -10000 0 -0.41 3 3
GNG2 0.008 0.035 -10000 0 -0.3 3 3
potassium channel inhibitor activity 0 0 -10000 0 -0.005 2 2
HRAS/GTP 0 0.058 -10000 0 -0.36 1 1
actin cytoskeleton reorganization 0 0 -10000 0 -10000 0 0
SRC 0.013 0 -10000 0 -10000 0 0
voltage-gated calcium channel activity 0 0 -10000 0 -0.005 2 2
PI3K 0.017 0 -10000 0 -10000 0 0
apoptosis -0.021 0.055 0.38 2 -10000 0 2
T-DHT/AR/PELP1 -0.016 0.073 -10000 0 -0.45 1 1
HRAS/GDP -0.046 0.099 -10000 0 -0.26 41 41
CREB1 0.021 0.058 -10000 0 -0.4 2 2
RAC1-CDC42/GTP 0.024 0 -10000 0 -10000 0 0
AR -0.046 0.12 -10000 0 -0.31 41 41
GNB1 0.012 0 -10000 0 -10000 0 0
RAF1 0.007 0.056 -10000 0 -0.34 1 1
RAC1-CDC42/GDP -0.017 0.11 -10000 0 -0.28 1 1
T-DHT/AR/PELP1/Src -0.006 0.066 -10000 0 -0.41 1 1
MAP2K2 0.013 0.054 -10000 0 -10000 0 0
T-DHT/AR/PELP1/Src/PI3K -0.006 0.07 -10000 0 -10000 0 0
GNAZ 0.007 0.041 -10000 0 -0.3 4 4
SHBG 0.002 0.08 -10000 0 -0.7 3 3
Gi family/GNB1/GNG2/GDP -0.1 0.17 -10000 0 -0.37 38 38
mol:T-DHT 0 0 -10000 0 -0.002 2 2
RAC1 0.012 0 -10000 0 -10000 0 0
GNRH1 0.009 0.001 -10000 0 -10000 0 0
Gi family/GTP -0.067 0.12 -10000 0 -0.28 38 38
CDC42 0.012 0 -10000 0 -10000 0 0
S1P4 pathway

Figure S59.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S59.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
mol:S1P 0 0 -9999 0 -10000 0 0
GNAO1 -0.13 0.16 -9999 0 -0.3 103 103
CDC42/GTP -0.05 0.096 -9999 0 -0.29 10 10
PLCG1 -0.052 0.099 -9999 0 -0.3 10 10
mol:GTP 0 0 -9999 0 -10000 0 0
GNAI2 0.012 0 -9999 0 -10000 0 0
GNAI3 0.012 0 -9999 0 -10000 0 0
G12/G13 0.019 0 -9999 0 -10000 0 0
cell migration -0.049 0.094 -9999 0 -0.29 10 10
S1PR5 -0.018 0.14 -9999 0 -0.7 10 10
S1PR4 0.006 0.045 -9999 0 -0.3 5 5
MAPK3 -0.052 0.099 -9999 0 -0.3 10 10
MAPK1 -0.052 0.099 -9999 0 -0.3 10 10
S1P/S1P5/Gi -0.068 0.11 -9999 0 -0.36 11 11
GNAI1 0.007 0.041 -9999 0 -0.3 4 4
CDC42/GDP 0.009 0 -9999 0 -10000 0 0
S1P/S1P5/G12 -0.003 0.095 -9999 0 -0.45 10 10
RHOA 0.023 0.021 -9999 0 -10000 0 0
S1P/S1P4/Gi -0.061 0.1 -9999 0 -0.33 10 10
mol:GDP 0 0 -9999 0 -10000 0 0
GNAZ 0.007 0.041 -9999 0 -0.3 4 4
S1P/S1P4/G12/G13 0.021 0.023 -9999 0 -10000 0 0
GNA12 0.012 0 -9999 0 -10000 0 0
GNA13 0.012 0 -9999 0 -10000 0 0
CDC42 0.012 0 -9999 0 -10000 0 0
Thromboxane A2 receptor signaling

Figure S60.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S60.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGM2 0.005 0.066 -10000 0 -0.7 2 2
GNB1/GNG2 -0.073 0.056 -10000 0 -0.18 15 15
AKT1 -0.052 0.078 -10000 0 -0.21 1 1
EGF -0.093 0.2 -10000 0 -0.41 57 57
mol:TXA2 0 0 -10000 0 -10000 0 0
FGR -0.032 0.067 -10000 0 -0.31 1 1
mol:Ca2+ -0.086 0.11 -10000 0 -0.27 17 17
LYN -0.03 0.064 -10000 0 -10000 0 0
RhoA/GTP -0.042 0.04 -10000 0 -10000 0 0
mol:PGI2 0 0 -10000 0 -10000 0 0
SYK -0.096 0.12 -10000 0 -0.33 7 7
GNG2 0.008 0.035 -10000 0 -0.3 3 3
ARRB2 0.012 0 -10000 0 -10000 0 0
TP alpha/Gq family/GDP/G beta5/gamma2 -0.003 0.063 -10000 0 -0.26 6 6
G beta5/gamma2 -0.09 0.071 -10000 0 -0.25 6 6
PRKCH -0.092 0.12 -10000 0 -0.34 7 7
DNM1 0.012 0 -10000 0 -10000 0 0
TXA2/TP beta/beta Arrestin3 -0.016 0.019 -10000 0 -10000 0 0
mol:GTP -0.001 0.001 -10000 0 -10000 0 0
PTGDR -0.15 0.16 -10000 0 -0.31 115 115
G12 family/GTP -0.1 0.092 -10000 0 -0.29 7 7
ADRBK1 0.012 0 -10000 0 -10000 0 0
ADRBK2 0.012 0 -10000 0 -10000 0 0
RhoA/GTP/ROCK1 0.016 0.001 -10000 0 -10000 0 0
mol:GDP 0.075 0.077 0.23 10 -10000 0 10
mol:NADP 0.006 0.065 -10000 0 -0.7 2 2
RAB11A 0.012 0 -10000 0 -10000 0 0
PRKG1 -0.003 0.067 -10000 0 -0.3 11 11
mol:IP3 -0.11 0.13 -10000 0 -0.33 17 17
cell morphogenesis 0.016 0.001 -10000 0 -10000 0 0
PLCB2 -0.14 0.16 -10000 0 -0.44 17 17
mol:cGMP 0 0 -10000 0 -10000 0 0
BLK -0.068 0.099 -10000 0 -10000 0 0
mol:PDG2 0 0 -10000 0 -10000 0 0
HCK -0.031 0.066 -10000 0 -10000 0 0
RHOA 0.012 0 -10000 0 -10000 0 0
PTGIR 0.012 0 -10000 0 -10000 0 0
PRKCB1 -0.1 0.12 -10000 0 -0.36 8 8
GNAQ 0.012 0 -10000 0 -10000 0 0
mol:L-citrulline 0.006 0.065 -10000 0 -0.7 2 2
TXA2/TXA2-R family -0.14 0.17 -10000 0 -0.46 16 16
LCK -0.042 0.086 -10000 0 -0.35 8 8
TXA2/TP beta/beta Arrestin3/RAB11/GDP -0.059 0.068 -10000 0 -0.34 1 1
TXA2-R family/G12 family/GDP/G beta/gamma 0 0.033 -10000 0 -10000 0 0
TXA2/TP beta/beta Arrestin2/RAB11/GDP -0.043 0.076 -10000 0 -10000 0 0
MAPK14 -0.062 0.086 -10000 0 -0.22 5 5
TGM2/GTP -0.12 0.15 -10000 0 -0.39 17 17
MAPK11 -0.062 0.086 -10000 0 -0.22 5 5
ARHGEF1 -0.049 0.069 -10000 0 -0.19 1 1
GNAI2 0.012 0 -10000 0 -10000 0 0
JNK cascade -0.11 0.13 -10000 0 -0.35 16 16
RAB11/GDP 0.013 0.001 -10000 0 -10000 0 0
ICAM1 -0.08 0.11 -10000 0 -0.36 7 7
cAMP biosynthetic process -0.11 0.12 -10000 0 -0.32 17 17
Gq family/GTP/EBP50 0.011 0.052 -10000 0 -10000 0 0
actin cytoskeleton reorganization 0.016 0.001 -10000 0 -10000 0 0
SRC -0.03 0.064 -10000 0 -10000 0 0
GNB5 0.012 0 -10000 0 -10000 0 0
GNB1 0.012 0 -10000 0 -10000 0 0
EGF/EGFR -0.063 0.083 -10000 0 -0.26 5 5
VCAM1 -0.084 0.11 -10000 0 -0.31 6 6
TP beta/Gq family/GDP/G beta5/gamma2 -0.003 0.063 -10000 0 -0.26 6 6
platelet activation -0.082 0.11 -10000 0 -0.3 6 6
PGI2/IP 0.009 0.001 -10000 0 -10000 0 0
PRKACA -0.072 0.09 -10000 0 -0.26 2 2
Gq family/GDP/G beta5/gamma2 -0.011 0.064 -10000 0 -0.27 6 6
TXA2/TP beta/beta Arrestin2 -0.007 0.008 -10000 0 -10000 0 0
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
TBXA2R -0.062 0.084 -10000 0 -0.24 2 2
mol:DAG -0.11 0.14 -10000 0 -0.4 8 8
EGFR 0.012 0 -10000 0 -10000 0 0
TXA2/TP alpha -0.14 0.16 -10000 0 -0.44 17 17
Gq family/GTP 0 0.047 -10000 0 -10000 0 0
YES1 -0.03 0.064 -10000 0 -10000 0 0
GNAI2/GTP -0.054 0.055 -10000 0 -10000 0 0
PGD2/DP -0.099 0.11 -10000 0 -0.21 115 115
SLC9A3R1 0.012 0 -10000 0 -10000 0 0
FYN -0.03 0.064 -10000 0 -10000 0 0
mol:NO 0.006 0.065 -10000 0 -0.7 2 2
GNA15 -0.03 0.17 -10000 0 -0.7 14 14
PGK/cGMP 0.004 0.057 -10000 0 -0.45 2 2
RhoA/GDP 0.013 0.001 -10000 0 -10000 0 0
TP alpha/TGM2/GDP/G beta/gamma -0.041 0.087 -10000 0 -0.4 2 2
NOS3 0.006 0.066 -10000 0 -0.7 2 2
RAC1 0.012 0 -10000 0 -10000 0 0
PRKCA -0.092 0.12 -10000 0 -0.34 7 7
PRKCB -0.11 0.12 -10000 0 -0.34 9 9
PRKCE -0.089 0.12 -10000 0 -0.34 7 7
PRKCD -0.096 0.12 -10000 0 -0.36 7 7
PRKCG -0.17 0.18 -10000 0 -0.44 38 38
muscle contraction -0.14 0.16 -10000 0 -0.43 16 16
PRKCZ -0.096 0.12 -10000 0 -0.33 7 7
ARR3 -0.001 0.046 -10000 0 -0.7 1 1
TXA2/TP beta -0.046 0.076 -10000 0 -10000 0 0
PRKCQ -0.094 0.13 -10000 0 -0.36 11 11
MAPKKK cascade -0.12 0.15 -10000 0 -0.39 17 17
SELE -0.11 0.14 -10000 0 -0.3 67 67
TP beta/GNAI2/GDP/G beta/gamma -0.038 0.08 -10000 0 -10000 0 0
ROCK1 0.012 0 -10000 0 -10000 0 0
GNA14 0.011 0.021 -10000 0 -0.3 1 1
chemotaxis -0.16 0.19 -10000 0 -0.51 16 16
GNA12 0.012 0 -10000 0 -10000 0 0
GNA13 0.012 0 -10000 0 -10000 0 0
GNA11 0.012 0 -10000 0 -10000 0 0
Rac1/GTP 0.008 0.001 -10000 0 -10000 0 0
Signaling events mediated by PTP1B

Figure S61.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S61.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB 0 0.092 -10000 0 -0.7 4 4
Jak2/Leptin Receptor -0.036 0.069 -10000 0 -0.29 5 5
PTP1B/AKT1 -0.048 0.069 -10000 0 -0.24 2 2
FYN 0.012 0 -10000 0 -10000 0 0
p210 bcr-abl/PTP1B -0.061 0.077 -10000 0 -0.27 2 2
EGFR 0.008 0.005 -10000 0 -10000 0 0
EGF/EGFR -0.091 0.13 -10000 0 -0.32 40 40
CSF1 0.011 0.021 -10000 0 -0.3 1 1
AKT1 0.012 0.001 -10000 0 -10000 0 0
INSR 0.012 0.001 -10000 0 -10000 0 0
PTP1B/N-cadherin -0.064 0.1 -10000 0 -0.55 5 5
Insulin Receptor/Insulin -0.04 0.042 -10000 0 -10000 0 0
HCK 0.01 0.029 -10000 0 -0.3 2 2
CRK 0.012 0 -10000 0 -10000 0 0
TYK2 -0.052 0.073 -10000 0 -0.26 2 2
EGF -0.095 0.2 -10000 0 -0.42 57 57
YES1 0.012 0 -10000 0 -10000 0 0
CAV1 -0.059 0.084 -10000 0 -0.29 2 2
TXN 0.011 0.003 -10000 0 -10000 0 0
PTP1B/IRS1/GRB2 -0.044 0.071 -10000 0 -0.24 1 1
cell migration 0.061 0.077 0.27 2 -10000 0 2
STAT3 0.012 0.001 -10000 0 -10000 0 0
PRLR 0.004 0.05 -10000 0 -0.3 6 6
ITGA2B -0.014 0.13 -10000 0 -0.7 8 8
CSF1R 0.004 0.05 -10000 0 -0.3 6 6
Prolactin Receptor/Prolactin -0.02 0.12 -10000 0 -0.52 12 12
FGR 0.008 0.051 -10000 0 -0.5 2 2
PTP1B/p130 Cas -0.052 0.073 -10000 0 -0.26 2 2
Crk/p130 Cas -0.044 0.071 -10000 0 -10000 0 0
DOK1 -0.041 0.074 -10000 0 -0.34 4 4
JAK2 -0.039 0.071 -10000 0 -0.27 10 10
Jak2/Leptin Receptor/Leptin -0.06 0.084 -10000 0 -0.39 8 8
PIK3R1 0.012 0 -10000 0 -10000 0 0
PTPN1 -0.061 0.077 -10000 0 -0.28 2 2
LYN 0.012 0 -10000 0 -10000 0 0
CDH2 -0.015 0.12 -10000 0 -0.44 14 14
SRC -0.011 0.032 -10000 0 -10000 0 0
ITGB3 0.005 0.046 -10000 0 -0.3 5 5
CAT1/PTP1B -0.096 0.11 -10000 0 -0.32 18 18
CAPN1 0.012 0.002 -10000 0 -10000 0 0
CSK 0.012 0 -10000 0 -10000 0 0
PI3K -0.031 0.036 -10000 0 -10000 0 0
mol:H2O2 0.001 0.005 -10000 0 -10000 0 0
STAT3 (dimer) -0.054 0.075 -10000 0 -0.37 5 5
negative regulation of transcription -0.039 0.071 -10000 0 -0.27 10 10
FCGR2A 0.006 0.066 -10000 0 -0.7 2 2
FER 0.011 0.003 -10000 0 -10000 0 0
alphaIIb/beta3 Integrin -0.007 0.1 -10000 0 -0.52 8 8
BLK -0.12 0.15 -10000 0 -0.3 99 99
Insulin Receptor/Insulin/Shc 0.017 0.001 -10000 0 -10000 0 0
RHOA 0.012 0.002 -10000 0 -10000 0 0
LEPR 0.01 0.029 -10000 0 -0.3 2 2
BCAR1 0.012 0 -10000 0 -10000 0 0
p210 bcr-abl/Grb2 0.012 0 -10000 0 -10000 0 0
mol:NADPH -0.002 0.003 -10000 0 -10000 0 0
TRPV6 -0.087 0.13 -10000 0 -0.34 23 23
PRL -0.03 0.16 -10000 0 -0.7 12 12
SOCS3 0.017 0.011 -10000 0 -10000 0 0
SPRY2 0.014 0.004 -10000 0 -10000 0 0
Insulin Receptor/Insulin/IRS1 0.017 0.001 -10000 0 -10000 0 0
CSF1/CSF1R -0.048 0.075 -10000 0 -0.28 1 1
Ras protein signal transduction 0.031 0.024 -10000 0 -10000 0 0
IRS1 0.012 0 -10000 0 -10000 0 0
INS 0 0.001 -10000 0 -10000 0 0
LEP -0.046 0.16 -10000 0 -0.42 29 29
STAT5B -0.049 0.071 -10000 0 -0.23 6 6
STAT5A -0.049 0.071 -10000 0 -0.23 6 6
GRB2 0.012 0 -10000 0 -10000 0 0
PDGFB-D/PDGFRB -0.058 0.098 -10000 0 -0.57 4 4
CSN2 0.008 0.052 -10000 0 -0.48 1 1
PIK3CA 0.012 0 -10000 0 -10000 0 0
LAT -0.012 0.04 -10000 0 -0.29 2 2
YBX1 0.019 0.002 -10000 0 -10000 0 0
LCK -0.012 0.13 -10000 0 -0.7 8 8
SHC1 0.012 0 -10000 0 -10000 0 0
NOX4 -0.38 0.35 -10000 0 -0.7 128 128
Neurotrophic factor-mediated Trk receptor signaling

Figure S62.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S62.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CRKL 0.012 0 -10000 0 -10000 0 0
RAS family/GTP/Tiam1 -0.017 0.077 -10000 0 -0.26 10 10
NT3 (dimer)/TRKC -0.041 0.11 -10000 0 -0.45 4 4
NT3 (dimer)/TRKB -0.088 0.14 -10000 0 -0.36 38 38
SHC/Grb2/SOS1/GAB1/PI3K 0.032 0 -10000 0 -10000 0 0
RAPGEF1 0.012 0 -10000 0 -10000 0 0
BDNF -0.012 0.13 -10000 0 -0.7 8 8
PIK3CA 0.012 0 -10000 0 -10000 0 0
DYNLT1 0.012 0 -10000 0 -10000 0 0
NTRK1 0.005 0.066 -10000 0 -0.7 2 2
NTRK2 -0.081 0.17 -10000 0 -0.35 60 60
NTRK3 -0.066 0.13 -10000 0 -0.3 57 57
NT-4/5 (dimer)/TRKB -0.11 0.17 -10000 0 -0.39 47 47
neuron apoptosis 0.11 0.16 0.37 47 -10000 0 47
SHC 2-3/Grb2 -0.12 0.17 -10000 0 -0.4 47 47
SHC1 0.012 0 -10000 0 -10000 0 0
SHC2 -0.093 0.15 -10000 0 -0.37 40 40
SHC3 -0.12 0.17 -10000 0 -0.4 49 49
STAT3 (dimer) 0.014 0.04 -10000 0 -0.28 4 4
NT3 (dimer)/TRKA -0.04 0.097 -10000 0 -0.41 4 4
RIN/GDP -0.005 0.058 -10000 0 -10000 0 0
GIPC1 0.012 0 -10000 0 -10000 0 0
KRAS 0.012 0 -10000 0 -10000 0 0
DNAJA3 -0.058 0.12 -10000 0 -0.36 7 7
RIN/GTP 0.001 0.002 -10000 0 -10000 0 0
CCND1 0.015 0.08 -10000 0 -0.59 4 4
MAGED1 0.012 0 -10000 0 -10000 0 0
PTPN11 0.012 0 -10000 0 -10000 0 0
RICS 0 0 -10000 0 -10000 0 0
NT-4/5 (dimer) -0.027 0.15 -10000 0 -0.7 11 11
SHC/GRB2/SOS1 0.025 0 -10000 0 -10000 0 0
GRB2 0.012 0 -10000 0 -10000 0 0
NGF (dimer)/TRKA/MATK -0.007 0.081 -10000 0 -0.45 3 3
TRKA/NEDD4-2 0.013 0.05 -10000 0 -0.52 2 2
ELMO1 0.011 0.021 -10000 0 -0.3 1 1
RhoG/GTP/ELMO1/DOCK1 0.016 0.012 -10000 0 -10000 0 0
NGF -0.006 0.072 -10000 0 -0.3 13 13
HRAS 0.012 0 -10000 0 -10000 0 0
DOCK1 0.012 0 -10000 0 -10000 0 0
GAB2 0.012 0 -10000 0 -10000 0 0
RIT2 0.001 0.003 -10000 0 -10000 0 0
RIT1 0.012 0 -10000 0 -10000 0 0
FRS2 0.012 0 -10000 0 -10000 0 0
DNM1 0.012 0 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
CRK 0.012 0 -10000 0 -10000 0 0
SH2B1 (homopentamer) 0 0 -10000 0 -10000 0 0
RhoG/GTP -0.057 0.11 -10000 0 -0.35 7 7
mol:GDP -0.008 0.08 -10000 0 -10000 0 0
NGF (dimer) -0.006 0.072 -10000 0 -0.3 13 13
RhoG/GDP 0.008 0.014 -10000 0 -0.2 1 1
RIT1/GDP 0 0.059 -10000 0 -10000 0 0
TIAM1 -0.013 0.086 -10000 0 -0.3 19 19
PIK3R1 0.012 0 -10000 0 -10000 0 0
BDNF (dimer)/TRKB -0.046 0.13 -10000 0 -0.46 15 15
KIDINS220/CRKL/C3G 0.019 0 -10000 0 -10000 0 0
SHC/RasGAP 0.019 0 -10000 0 -10000 0 0
FRS2 family/SHP2 0.025 0 -10000 0 -10000 0 0
SHC/GRB2/SOS1/GAB1 0.032 0 -10000 0 -10000 0 0
RIT1/GTP 0.009 0 -10000 0 -10000 0 0
NT3 (dimer) 0.004 0.061 -10000 0 -0.38 5 5
RAP1/GDP -0.02 0.034 -10000 0 -10000 0 0
KIDINS220/CRKL 0.012 0 -10000 0 -10000 0 0
BDNF (dimer) -0.012 0.13 -10000 0 -0.7 8 8
ubiquitin-dependent protein catabolic process 0.01 0.059 -10000 0 -0.44 2 2
Schwann cell development -0.025 0.026 -10000 0 -10000 0 0
EHD4 0.012 0 -10000 0 -10000 0 0
FRS2 family/GRB2/SOS1 0.032 0 -10000 0 -10000 0 0
FRS2 family/SHP2/CRK family/C3G/GAB2 0.034 0 -10000 0 -10000 0 0
RAP1B 0.012 0 -10000 0 -10000 0 0
RAP1A 0.012 0 -10000 0 -10000 0 0
CDC42/GTP -0.074 0.11 -10000 0 -0.36 19 19
ABL1 0.012 0 -10000 0 -10000 0 0
SH2B family/GRB2/SOS1 0.019 0 -10000 0 -10000 0 0
Rap1/GTP 0.011 0.057 -10000 0 -10000 0 0
STAT3 0.014 0.039 -10000 0 -0.28 4 4
axon guidance -0.072 0.1 -10000 0 -0.35 19 19
MAPK3 -0.002 0.072 -10000 0 -0.4 3 3
MAPK1 -0.002 0.072 -10000 0 -0.4 3 3
CDC42/GDP 0 0.059 -10000 0 -10000 0 0
NTF3 0.004 0.062 -10000 0 -0.38 5 5
NTF4 -0.028 0.15 -10000 0 -0.7 11 11
NGF (dimer)/TRKA/FAIM 0.01 0.059 -10000 0 -0.45 2 2
PI3K 0.019 0 -10000 0 -10000 0 0
FRS3 0.012 0 -10000 0 -10000 0 0
FAIM 0.012 0 -10000 0 -10000 0 0
GAB1 0.012 0 -10000 0 -10000 0 0
RASGRF1 -0.09 0.14 -10000 0 -0.38 28 28
SOS1 0.012 0 -10000 0 -10000 0 0
MCF2L -0.028 0.093 -10000 0 -0.4 5 5
RGS19 0.012 0 -10000 0 -10000 0 0
CDC42 0.012 0 -10000 0 -10000 0 0
RAS family/GTP 0.005 0.059 -10000 0 -10000 0 0
Rac1/GDP 0 0.059 -10000 0 -10000 0 0
NGF (dimer)/TRKA/GRIT 0.002 0.059 -10000 0 -0.45 2 2
neuron projection morphogenesis -0.053 0.12 -10000 0 -0.39 7 7
NGF (dimer)/TRKA/NEDD4-2 0.01 0.059 -10000 0 -0.45 2 2
MAP2K1 0.031 0 -10000 0 -10000 0 0
NGFR -0.085 0.14 -10000 0 -0.3 72 72
NGF (dimer)/TRKA/GIPC/GAIP 0.019 0.047 -10000 0 -10000 0 0
RAS family/GTP/PI3K 0.026 0 -10000 0 -10000 0 0
FRS2 family/SHP2/GRB2/SOS1 0.037 0 -10000 0 -10000 0 0
NRAS 0.012 0 -10000 0 -10000 0 0
GRB2/SOS1 0.019 0 -10000 0 -10000 0 0
PRKCI 0.012 0 -10000 0 -10000 0 0
ChemicalAbstracts:146-91-8 0 0 -10000 0 -10000 0 0
RAC1 0.012 0 -10000 0 -10000 0 0
PRKCZ 0.012 0 -10000 0 -10000 0 0
MAPKKK cascade -0.048 0.13 -10000 0 -0.53 13 13
RASA1 0.012 0 -10000 0 -10000 0 0
TRKA/c-Abl 0.013 0.05 -10000 0 -0.52 2 2
SQSTM1 0.012 0 -10000 0 -10000 0 0
BDNF (dimer)/TRKB/GIPC -0.033 0.12 -10000 0 -0.42 15 15
NGF (dimer)/TRKA/p62/Atypical PKCs 0.024 0.051 -10000 0 -0.38 2 2
MATK -0.018 0.099 -10000 0 -0.32 21 21
NEDD4L 0.012 0 -10000 0 -10000 0 0
RAS family/GDP -0.017 0.03 -10000 0 -10000 0 0
NGF (dimer)/TRKA -0.078 0.11 -10000 0 -0.23 74 74
Rac1/GTP -0.071 0.087 -10000 0 -0.28 14 14
FRS2 family/SHP2/CRK family 0.037 0 -10000 0 -10000 0 0
Signaling events mediated by PRL

Figure S63.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S63.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CCNE1 -0.003 0.1 -10000 0 -0.7 5 5
mol:Halofuginone 0.005 0 -10000 0 -10000 0 0
ITGA1 0.012 0 -10000 0 -10000 0 0
CDKN1A 0.027 0.012 -10000 0 -10000 0 0
PRL-3/alpha Tubulin -0.023 0.14 -10000 0 -0.52 18 18
mol:Ca2+ -0.082 0.23 0.31 15 -0.53 45 60
AGT -0.12 0.28 -10000 0 -0.7 45 45
CCNA2 0.031 0.026 -10000 0 -0.36 1 1
TUBA1B 0.012 0 -10000 0 -10000 0 0
EGR1 0.017 0.038 -10000 0 -0.52 1 1
CDK2/Cyclin E1 0.029 0.059 -10000 0 -0.36 5 5
MAPK3 -0.023 0.14 -10000 0 -0.52 18 18
PRL-2 /Rab GGTase beta 0.019 0 -10000 0 -10000 0 0
MAPK1 -0.023 0.14 -10000 0 -0.52 18 18
PTP4A1 0.027 0.028 -10000 0 -0.39 1 1
PTP4A3 -0.043 0.19 -10000 0 -0.7 18 18
PTP4A2 0.012 0 -10000 0 -10000 0 0
ITGB1 -0.023 0.14 -10000 0 -0.52 18 18
SRC 0.012 0 -10000 0 -10000 0 0
RAC1 0.012 0.053 -10000 0 -10000 0 0
Rab GGTase beta/Rab GGTase alpha 0.019 0 -10000 0 -10000 0 0
PRL-1/ATF-5 0.032 0.028 -10000 0 -0.36 1 1
RABGGTA 0.012 0 -10000 0 -10000 0 0
BCAR1 0.024 0.083 0.31 18 -10000 0 18
RHOC 0.012 0.053 -10000 0 -10000 0 0
RHOA 0.012 0.053 -10000 0 -10000 0 0
cell motility 0.016 0.054 -10000 0 -10000 0 0
PRL-1/alpha Tubulin 0.032 0.028 -10000 0 -0.36 1 1
PRL-3/alpha1 Integrin -0.023 0.14 -10000 0 -0.52 18 18
ROCK1 0.016 0.054 -10000 0 -10000 0 0
RABGGTB 0.012 0 -10000 0 -10000 0 0
CDK2 0.012 0 -10000 0 -10000 0 0
mitosis 0.027 0.028 -10000 0 -0.39 1 1
ATF5 0.012 0 -10000 0 -10000 0 0
IL12-mediated signaling events

Figure S64.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S64.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IL12/IL12R/TYK2/JAK2/SOCS1 0.01 0.083 -10000 0 -0.31 3 3
TBX21 -0.095 0.32 -10000 0 -1 14 14
B2M 0.011 0.01 -10000 0 -10000 0 0
TYK2 0.011 0.02 -10000 0 -10000 0 0
IL12RB1 -0.003 0.087 -10000 0 -0.42 8 8
GADD45B -0.04 0.23 -10000 0 -0.86 5 5
IL12RB2 0.001 0.086 -10000 0 -0.61 4 4
GADD45G -0.04 0.23 -10000 0 -0.81 6 6
natural killer cell activation -0.002 0.02 -10000 0 -10000 0 0
RELB 0.012 0 -10000 0 -10000 0 0
RELA 0.012 0 -10000 0 -10000 0 0
IL18 0.015 0.007 -10000 0 -10000 0 0
IL2RA 0.001 0.077 -10000 0 -0.43 6 6
IFNG -0.081 0.24 -10000 0 -0.7 30 30
STAT3 (dimer) -0.043 0.23 -10000 0 -0.71 10 10
HLA-DRB5 -0.022 0.14 -10000 0 -0.54 15 15
FASLG -0.097 0.32 -10000 0 -0.96 17 17
NF kappa B2 p52/RelB -0.13 0.22 -10000 0 -0.76 17 17
CD4 0.01 0.029 -10000 0 -0.3 2 2
SOCS1 0.009 0.046 -10000 0 -0.7 1 1
EntrezGene:6955 -0.001 0.012 -10000 0 -10000 0 0
CD3D 0 0.062 -10000 0 -0.3 9 9
CD3E -0.001 0.065 -10000 0 -0.3 10 10
CD3G -0.015 0.09 -10000 0 -0.31 20 20
IL12Rbeta2/JAK2 0.011 0.072 -10000 0 -0.54 3 3
CCL3 -0.095 0.31 -10000 0 -0.9 17 17
CCL4 -0.084 0.3 -10000 0 -0.99 13 13
HLA-A 0.011 0.01 -10000 0 -10000 0 0
IL18/IL18R 0.038 0.054 -10000 0 -10000 0 0
NOS2 -0.1 0.34 -10000 0 -1 18 18
IL12/IL12R/TYK2/JAK2/SPHK2 0.011 0.081 -10000 0 -0.31 3 3
IL1R1 -0.083 0.29 -10000 0 -0.98 11 11
IL4 0.003 0.02 -10000 0 -10000 0 0
JAK2 0.011 0.02 -10000 0 -10000 0 0
EntrezGene:6957 -0.001 0.012 -10000 0 -10000 0 0
TCR/CD3/MHC I/CD8 -0.052 0.27 -10000 0 -0.83 21 21
RAB7A -0.017 0.2 -10000 0 -0.74 4 4
lysosomal transport -0.014 0.2 -10000 0 -0.7 4 4
FOS -0.031 0.2 -10000 0 -0.79 8 8
STAT4 (dimer) -0.033 0.24 -10000 0 -0.79 7 7
STAT5A (dimer) -0.18 0.27 -10000 0 -0.82 25 25
GZMA -0.099 0.33 -10000 0 -0.98 18 18
GZMB -0.16 0.34 -10000 0 -0.88 22 22
HLX 0.012 0 -10000 0 -10000 0 0
LCK -0.094 0.3 -10000 0 -0.82 19 19
TCR/CD3/MHC II/CD4 -0.017 0.15 -10000 0 -0.48 16 16
IL2/IL2R 0.015 0.061 -10000 0 -0.41 3 3
MAPK14 -0.032 0.23 -10000 0 -0.87 5 5
CCR5 -0.044 0.23 -10000 0 -0.82 7 7
IL1B -0.12 0.28 -10000 0 -0.68 44 44
STAT6 -0.011 0.095 -10000 0 -10000 0 0
STAT4 0.011 0.021 -10000 0 -0.3 1 1
STAT3 0.012 0 -10000 0 -10000 0 0
STAT1 0 0.092 -10000 0 -0.7 4 4
NFKB1 0.012 0 -10000 0 -10000 0 0
NFKB2 0.012 0 -10000 0 -10000 0 0
IL12B 0.005 0.052 -10000 0 -0.72 1 1
CD8A -0.007 0.084 -10000 0 -0.35 12 12
CD8B -0.002 0.082 -10000 0 -0.43 7 7
T-helper 1 cell differentiation 0 0 -10000 0 -10000 0 0
natural killer cell mediated cytotoxicity -0.01 0.083 0.31 3 -10000 0 3
IL2RB 0.004 0.062 -10000 0 -0.38 5 5
proteasomal ubiquitin-dependent protein catabolic process -0.028 0.22 -10000 0 -0.75 6 6
IL2RG 0.011 0.021 -10000 0 -0.3 1 1
IL12 0.013 0.051 -10000 0 -0.55 1 1
STAT5A 0.012 0 -10000 0 -10000 0 0
CD247 0.003 0.056 -10000 0 -0.31 7 7
IL2 0.004 0.006 -10000 0 -10000 0 0
SPHK2 0.012 0 -10000 0 -10000 0 0
FRAP1 0 0 -10000 0 -10000 0 0
IL12A 0.01 0.028 -10000 0 -0.3 1 1
IL12/IL12R/TYK2/JAK2 -0.09 0.31 -10000 0 -0.87 17 17
MAP2K3 -0.036 0.23 -10000 0 -0.79 7 7
RIPK2 0.003 0.08 -10000 0 -0.7 3 3
MAP2K6 -0.036 0.23 -10000 0 -0.79 7 7
regulation of dendritic cell antigen processing and presentation 0 0 -10000 0 -10000 0 0
HLA-DRA 0.012 0.021 -10000 0 -0.3 1 1
IL18RAP 0.001 0.065 -10000 0 -0.3 10 10
IL12Rbeta1/TYK2 0.007 0.07 -10000 0 -0.57 2 2
EOMES -0.055 0.28 -10000 0 -1 16 16
STAT1 (dimer) -0.068 0.26 -10000 0 -0.69 19 19
T cell proliferation -0.024 0.19 -10000 0 -0.61 6 6
T-helper 1 cell lineage commitment 0 0 -10000 0 -10000 0 0
IL18R1 0.012 0.031 -10000 0 -0.31 2 2
CD8-positive alpha-beta T cell lineage commitment 0 0 -10000 0 -10000 0 0
NF kappa B1 p50/RelA -0.085 0.15 -10000 0 -0.64 6 6
ATF2 -0.023 0.22 -10000 0 -0.8 5 5
PLK2 and PLK4 events

Figure S65.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S65.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PLK2 -0.015 0.14 -9999 0 -0.7 9 9
PLK4 0.012 0 -9999 0 -10000 0 0
regulation of centriole replication -0.002 0.1 -9999 0 -0.52 9 9
Arf6 signaling events

Figure S66.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S66.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CENTA1/KIF3B 0.017 0 -9999 0 -10000 0 0
ARNO/beta Arrestin1-2 0.007 0.042 -9999 0 -10000 0 0
EGFR 0.012 0 -9999 0 -10000 0 0
EPHA2 -0.003 0.1 -9999 0 -0.7 5 5
USP6 0.012 0 -9999 0 -10000 0 0
IQSEC1 0.012 0 -9999 0 -10000 0 0
EGFR/EGFR/EGF/EGF -0.057 0.15 -9999 0 -0.52 16 16
ARRB2 0.008 0.002 -9999 0 -10000 0 0
mol:GTP 0.012 0.018 -9999 0 -10000 0 0
ARRB1 0.012 0 -9999 0 -10000 0 0
FBXO8 0.012 0 -9999 0 -10000 0 0
TSHR 0.006 0.047 -9999 0 -0.7 1 1
EGF -0.093 0.2 -9999 0 -0.41 57 57
somatostatin receptor activity 0 0 -9999 0 -0.001 6 6
ARAP2 0.012 0 -9999 0 -10000 0 0
mol:GDP -0.055 0.078 -9999 0 -0.22 15 15
mol:PI-3-4-5-P3 0 0 -9999 0 -10000 0 0
ITGA2B -0.013 0.13 -9999 0 -0.7 8 8
ARF6 0.012 0 -9999 0 -10000 0 0
Ephrin A1/EPHA2/NCK1/GIT1 0.021 0.069 -9999 0 -0.4 6 6
ADAP1 0.012 0 -9999 0 -10000 0 0
KIF13B 0.012 0 -9999 0 -10000 0 0
HGF/MET -0.014 0.12 -9999 0 -0.52 12 12
PXN 0.012 0 -9999 0 -10000 0 0
ARF6/GTP -0.044 0.075 -9999 0 -0.21 6 6
EGFR/EGFR/EGF/EGF/ARFGEP100 -0.04 0.13 -9999 0 -0.45 16 16
ADRB2 -0.026 0.1 -9999 0 -0.3 28 28
receptor agonist activity 0 0 -9999 0 0 3 3
actin filament binding 0 0 -9999 0 0 6 6
SRC 0.012 0 -9999 0 -10000 0 0
ITGB3 0.006 0.045 -9999 0 -0.3 5 5
GNAQ 0.012 0 -9999 0 -10000 0 0
EFA6/PI-4-5-P2 0 0 -9999 0 -0.001 1 1
ARF6/GDP 0.002 0.066 -9999 0 -0.26 6 6
ARF6/GDP/GULP/ACAP1 -0.041 0.08 -9999 0 -10000 0 0
alphaIIb/beta3 Integrin/paxillin/GIT1 0.013 0.082 -9999 0 -0.4 8 8
ACAP1 -0.002 0.067 -9999 0 -0.3 11 11
ACAP2 0.012 0 -9999 0 -10000 0 0
LHCGR/beta Arrestin2 0.002 0.005 -9999 0 -10000 0 0
EFNA1 0.009 0.046 -9999 0 -0.7 1 1
HGF 0.002 0.065 -9999 0 -0.37 6 6
CYTH3 0.009 0 -9999 0 -10000 0 0
CYTH2 0.008 0.001 -9999 0 -10000 0 0
NCK1 0.012 0 -9999 0 -10000 0 0
fibronectin binding 0 0 -9999 0 0 1 1
endosomal lumen acidification 0 0 -9999 0 0 4 4
microtubule-based process 0 0 -9999 0 -10000 0 0
GULP1 0.008 0.035 -9999 0 -0.3 3 3
GNAQ/ARNO 0.015 0.003 -9999 0 -10000 0 0
mol:Phosphatidic acid 0 0 -9999 0 -10000 0 0
PIP3-E 0 0 -9999 0 -10000 0 0
MET -0.021 0.15 -9999 0 -0.7 11 11
GNA14 0.011 0.021 -9999 0 -0.3 1 1
GNA15 -0.03 0.17 -9999 0 -0.7 14 14
GIT1 0.012 0 -9999 0 -10000 0 0
mol:PI-4-5-P2 0 0 -9999 0 -0.001 2 2
GNA11 0.012 0 -9999 0 -10000 0 0
LHCGR 0.001 0.004 -9999 0 -10000 0 0
AGTR1 -0.14 0.16 -9999 0 -0.3 110 110
desensitization of G-protein coupled receptor protein signaling pathway 0.002 0.005 -9999 0 -10000 0 0
IPCEF1/ARNO -0.029 0.1 -9999 0 -0.35 16 16
alphaIIb/beta3 Integrin -0.006 0.1 -9999 0 -0.52 8 8
RXR and RAR heterodimerization with other nuclear receptor

Figure S67.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S67.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.018 0.021 -9999 0 -10000 0 0
VDR 0.012 0 -9999 0 -10000 0 0
FAM120B 0.012 0 -9999 0 -10000 0 0
RXRs/LXRs/DNA/9cRA -0.029 0.09 -9999 0 -10000 0 0
RXRs/LXRs/DNA/Oxysterols -0.014 0.082 -9999 0 -10000 0 0
MED1 0.009 0.046 -9999 0 -0.7 1 1
mol:9cRA 0.005 0.003 -9999 0 -10000 0 0
RARs/THRs/DNA/Src-1 -0.017 0.083 -9999 0 -0.33 1 1
RXRs/NUR77 -0.045 0.12 -9999 0 -0.48 8 8
RXRs/PPAR -0.042 0.09 -9999 0 -10000 0 0
NCOR2 0.012 0 -9999 0 -10000 0 0
VDR/VDR/Vit D3 0.009 0 -9999 0 -10000 0 0
RARs/VDR/DNA/Vit D3 0.029 0.01 -9999 0 -10000 0 0
RARA 0.012 0 -9999 0 -10000 0 0
NCOA1 0.012 0 -9999 0 -10000 0 0
VDR/VDR/DNA 0.012 0 -9999 0 -10000 0 0
RARs/RARs/DNA/9cRA 0.025 0.01 -9999 0 -10000 0 0
RARG 0.012 0 -9999 0 -10000 0 0
RPS6KB1 0.025 0.028 -9999 0 -10000 0 0
RARs/THRs/DNA/SMRT -0.017 0.083 -9999 0 -0.33 1 1
THRA 0.006 0.066 -9999 0 -0.7 2 2
mol:Bile acids 0 0 -9999 0 -10000 0 0
VDR/Vit D3/DNA 0.009 0 -9999 0 -10000 0 0
RXRs/PPAR/9cRA/PGJ2/DNA -0.033 0.081 -9999 0 -10000 0 0
NR1H4 -0.14 0.16 -9999 0 -0.3 113 113
RXRs/LXRs/DNA -0.01 0.078 -9999 0 -10000 0 0
NR1H2 0.018 0.002 -9999 0 -10000 0 0
NR1H3 0.018 0.003 -9999 0 -10000 0 0
RXRs/VDR/DNA/Vit D3 -0.028 0.075 -9999 0 -10000 0 0
NR4A1 -0.012 0.13 -9999 0 -0.7 8 8
mol:ATRA 0 0 -9999 0 -10000 0 0
RXRs/FXR/9cRA/MED1 -0.13 0.12 -9999 0 -0.31 48 48
RXRG -0.12 0.15 -9999 0 -0.3 100 100
RXR alpha/CCPG 0.022 0.001 -9999 0 -10000 0 0
RXRA 0.018 0.002 -9999 0 -10000 0 0
RXRB 0.017 0.003 -9999 0 -10000 0 0
THRB -0.066 0.14 -9999 0 -0.3 58 58
PPARG 0.012 0 -9999 0 -10000 0 0
PPARD 0.012 0 -9999 0 -10000 0 0
TNF -0.007 0.081 -9999 0 -0.48 1 1
mol:Oxysterols 0.005 0.002 -9999 0 -10000 0 0
cholesterol transport -0.014 0.082 -9999 0 -10000 0 0
PPARA 0.012 0 -9999 0 -10000 0 0
mol:Vit D3 0 0 -9999 0 -10000 0 0
RARB 0.011 0.021 -9999 0 -0.3 1 1
RXRs/NUR77/BCL2 -0.062 0.1 -9999 0 -0.38 7 7
SREBF1 -0.006 0.076 -9999 0 -10000 0 0
RXRs/RXRs/DNA/9cRA -0.032 0.081 -9999 0 -10000 0 0
ABCA1 -0.006 0.076 -9999 0 -10000 0 0
RARs/THRs -0.006 0.076 -9999 0 -0.38 2 2
RXRs/FXR -0.11 0.11 -9999 0 -10000 0 0
BCL2 0.007 0.041 -9999 0 -0.3 4 4
IL27-mediated signaling events

Figure S68.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S68.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 -0.048 0.1 -10000 0 -10000 0 0
CD4-positive alpha-beta T cell lineage commitment 0 0 -10000 0 -10000 0 0
cytokine production during immune response -0.002 0.11 0.63 2 -10000 0 2
IL27/IL27R/JAK1 0.026 0.14 -10000 0 -0.62 3 3
TBX21 0.027 0.15 -10000 0 -0.58 5 5
IL12B 0.005 0.047 -10000 0 -0.71 1 1
IL12A 0.008 0.014 -10000 0 -0.2 1 1
IL6ST 0.009 0.037 -10000 0 -0.31 3 3
IL27RA/JAK1 0.021 0.039 -10000 0 -0.47 1 1
IL27 -0.029 0.16 -10000 0 -0.7 13 13
TYK2 0.013 0.005 -10000 0 -10000 0 0
T-helper cell lineage commitment -0.15 0.26 -10000 0 -0.53 68 68
T-helper 2 cell differentiation -0.002 0.11 0.63 2 -10000 0 2
T cell proliferation during immune response -0.002 0.11 0.63 2 -10000 0 2
MAPKKK cascade 0.002 0.11 -10000 0 -0.63 2 2
STAT3 0.012 0 -10000 0 -10000 0 0
STAT2 0.012 0 -10000 0 -10000 0 0
STAT1 0.001 0.093 -10000 0 -0.7 4 4
IL12RB1 -0.003 0.082 -10000 0 -0.4 8 8
positive regulation of tyrosine phosphorylation of STAT protein 0 0 -10000 0 -10000 0 0
IL12RB2 0.026 0.16 -10000 0 -0.62 6 6
IL27/IL27R/JAK2/TYK2 0.003 0.11 -10000 0 -0.64 2 2
positive regulation of T cell mediated cytotoxicity 0.002 0.11 -10000 0 -0.63 2 2
STAT1 (dimer) 0.018 0.2 -10000 0 -0.8 4 4
JAK2 0.013 0.006 -10000 0 -10000 0 0
JAK1 0.014 0.002 -10000 0 -10000 0 0
STAT2 (dimer) 0.007 0.1 -10000 0 -0.6 2 2
T cell proliferation -0.044 0.15 -10000 0 -0.57 11 11
IL12/IL12R/TYK2/JAK2 0.007 0.084 -10000 0 -10000 0 0
IL17A -0.16 0.25 -10000 0 -0.53 68 68
mast cell activation -0.002 0.11 0.63 2 -10000 0 2
IFNG -0.002 0.036 -10000 0 -0.09 24 24
T cell differentiation -0.002 0.005 -10000 0 -0.02 6 6
STAT3 (dimer) 0.007 0.1 -10000 0 -0.6 2 2
STAT5A (dimer) 0.007 0.1 -10000 0 -0.6 2 2
STAT4 (dimer) 0.006 0.1 -10000 0 -0.6 2 2
STAT4 0.011 0.021 -10000 0 -0.3 1 1
T cell activation -0.007 0.006 0.078 1 -10000 0 1
IL27R/JAK2/TYK2 0.025 0.055 -10000 0 -0.49 1 1
GATA3 -0.002 0.12 -10000 0 -0.78 4 4
IL18 0.009 0.001 -10000 0 -10000 0 0
positive regulation of mast cell cytokine production 0.007 0.1 -10000 0 -0.59 2 2
IL27/EBI3 -0.023 0.14 -10000 0 -0.52 14 14
IL27RA 0.011 0.04 -10000 0 -0.52 1 1
IL6 -0.1 0.21 -10000 0 -0.68 20 20
STAT5A 0.012 0 -10000 0 -10000 0 0
monocyte differentiation -0.001 0.002 -10000 0 -10000 0 0
IL2 -0.003 0.024 -10000 0 -10000 0 0
IL1B -0.092 0.21 -10000 0 -0.52 44 44
EBI3 -0.004 0.073 -10000 0 -0.3 13 13
TNF 0.007 0.035 -10000 0 -0.53 1 1
S1P3 pathway

Figure S69.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S69.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB 0 0.092 -9999 0 -0.7 4 4
mol:S1P 0.001 0.002 -9999 0 -10000 0 0
S1P1/S1P/Gi -0.053 0.098 -9999 0 -0.3 10 10
GNAO1 -0.13 0.16 -9999 0 -0.3 103 103
S1P/S1P3/G12/G13 0.026 0.003 -9999 0 -10000 0 0
AKT1 0.009 0.04 -9999 0 -10000 0 0
AKT3 -0.006 0.14 -9999 0 -1.1 3 3
mol:GTP 0 0 -9999 0 -10000 0 0
PDGFB-D/PDGFRB 0 0.092 -9999 0 -0.7 4 4
GNAI2 0.014 0.003 -9999 0 -10000 0 0
GNAI3 0.013 0.002 -9999 0 -10000 0 0
GNAI1 0.008 0.041 -9999 0 -0.3 4 4
mol:GDP 0 0 -9999 0 -10000 0 0
S1PR3 0.014 0.003 -9999 0 -10000 0 0
S1PR2 0.012 0 -9999 0 -10000 0 0
EDG1 0 0 -9999 0 -10000 0 0
mol:Ca2+ -0.051 0.11 -9999 0 -0.34 10 10
MAPK3 -0.043 0.1 -9999 0 -0.32 10 10
MAPK1 -0.043 0.1 -9999 0 -0.32 10 10
JAK2 -0.05 0.11 -9999 0 -0.33 12 12
CXCR4 -0.055 0.12 -9999 0 -0.4 10 10
FLT1 0.015 0.002 -9999 0 -10000 0 0
RhoA/GDP 0.009 0 -9999 0 -10000 0 0
Rac1/GDP 0.009 0 -9999 0 -10000 0 0
SRC -0.043 0.1 -9999 0 -0.4 3 3
S1P/S1P3/Gi -0.051 0.11 -9999 0 -0.34 10 10
RAC1 0.012 0 -9999 0 -10000 0 0
RhoA/GTP -0.041 0.099 -9999 0 -0.39 3 3
VEGFA -0.031 0.17 -9999 0 -0.7 15 15
S1P/S1P2/Gi -0.053 0.1 -9999 0 -0.31 10 10
VEGFR1 homodimer/VEGFA homodimer -0.011 0.13 -9999 0 -0.52 15 15
RHOA 0.012 0 -9999 0 -10000 0 0
S1P/S1P3/Gq 0.012 0.058 -9999 0 -10000 0 0
GNAQ 0.012 0 -9999 0 -10000 0 0
GNAZ 0.008 0.041 -9999 0 -0.3 4 4
G12/G13 0.019 0 -9999 0 -10000 0 0
GNA14 0.011 0.021 -9999 0 -0.3 1 1
GNA15 -0.03 0.17 -9999 0 -0.7 14 14
GNA12 0.012 0 -9999 0 -10000 0 0
GNA13 0.012 0 -9999 0 -10000 0 0
GNA11 0.012 0 -9999 0 -10000 0 0
Rac1/GTP -0.041 0.099 -9999 0 -0.39 3 3
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha

Figure S70.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S70.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HIF3A -0.11 0.15 -9999 0 -0.3 88 88
oxygen homeostasis 0 0 -9999 0 -10000 0 0
TCEB2 0.012 0 -9999 0 -10000 0 0
TCEB1 0.012 0 -9999 0 -10000 0 0
HIF1A/p53 0.027 0 -9999 0 -10000 0 0
HIF1A 0.02 0 -9999 0 -10000 0 0
COPS5 0.012 0 -9999 0 -10000 0 0
VHL/Elongin B/Elongin C/RBX1/CUL2 0.037 0 -9999 0 -10000 0 0
FIH (dimer) 0.012 0 -9999 0 -10000 0 0
CDKN2A -0.19 0.32 -9999 0 -0.7 65 65
ARNT/IPAS -0.063 0.1 -9999 0 -10000 0 0
HIF1AN 0.012 0 -9999 0 -10000 0 0
GNB2L1 0.012 0 -9999 0 -10000 0 0
HIF1A/ARNT 0.027 0 -9999 0 -10000 0 0
CUL2 0.012 0 -9999 0 -10000 0 0
OS9 0.012 0 -9999 0 -10000 0 0
RACK1/Elongin B/Elongin C 0.025 0 -9999 0 -10000 0 0
response to hypoxia 0 0 -9999 0 -10000 0 0
HIF1A/Hsp90 0.027 0 -9999 0 -10000 0 0
PHD1-3/OS9 0.032 0 -9999 0 -10000 0 0
HIF1A/RACK1/Elongin B/Elongin C 0.037 0 -9999 0 -10000 0 0
VHL 0.012 0 -9999 0 -10000 0 0
HSP90AA1 0.012 0 -9999 0 -10000 0 0
HIF1A/JAB1 0.027 0 -9999 0 -10000 0 0
EGLN3 0.012 0 -9999 0 -10000 0 0
EGLN2 0.012 0 -9999 0 -10000 0 0
EGLN1 0.012 0 -9999 0 -10000 0 0
TP53 0.012 0 -9999 0 -10000 0 0
VHL/Elongin B/Elongin C/RBX1/CUL2/HIF1A 0.034 0 -9999 0 -10000 0 0
ARNT 0.012 0 -9999 0 -10000 0 0
ARD1A 0 0 -9999 0 -10000 0 0
RBX1 0.012 0 -9999 0 -10000 0 0
HIF1A/p19ARF -0.078 0.17 -9999 0 -0.35 65 65
Regulation of nuclear SMAD2/3 signaling

Figure S71.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S71.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EP300 0.011 0.014 -10000 0 -10000 0 0
HSPA8 0.013 0.003 -10000 0 -10000 0 0
SMAD3/SMAD4/ER alpha 0.02 0.087 -10000 0 -10000 0 0
AKT1 0.001 0.031 -10000 0 -10000 0 0
GSC -0.018 0.14 -10000 0 -0.49 17 17
NKX2-5 -0.015 0.11 -10000 0 -0.69 6 6
muscle cell differentiation 0.011 0.043 -10000 0 -10000 0 0
SMAD2-3/SMAD4/SP1 0.008 0.084 -10000 0 -10000 0 0
SMAD4 0.007 0.033 -10000 0 -10000 0 0
CBFB 0.012 0 -10000 0 -10000 0 0
SAP18 0.009 0.046 -10000 0 -0.7 1 1
Cbp/p300/MSG1 -0.12 0.22 -10000 0 -0.45 70 70
SMAD3/SMAD4/VDR 0.041 0.03 -10000 0 -10000 0 0
MYC -0.009 0.15 -10000 0 -0.66 11 11
CDKN2B -0.18 0.47 -10000 0 -1.2 43 43
AP1 0.043 0.035 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4/SnoN/SIN3/HDAC complex/NCoR1 0.045 0.03 -10000 0 -10000 0 0
SMAD2-3/SMAD4/FOXO1-3a-4/FOXG1 -0.035 0.15 -10000 0 -0.4 17 17
SP3 0.014 0 -10000 0 -10000 0 0
CREB1 0.012 0 -10000 0 -10000 0 0
FOXH1 -0.006 0.092 -10000 0 -0.44 8 8
SMAD3/SMAD4/GR 0.024 0.063 -10000 0 -0.29 1 1
GATA3 0 0.078 -10000 0 -0.52 4 4
SKI/SIN3/HDAC complex/NCoR1 0.04 0.015 -10000 0 -10000 0 0
MEF2C/TIF2 0.01 0.088 -10000 0 -10000 0 0
endothelial cell migration 0.12 0.24 0.51 62 -10000 0 62
MAX 0.02 0.016 -10000 0 -10000 0 0
RBBP7 0.013 0.001 -10000 0 -10000 0 0
RBBP4 0.013 0.001 -10000 0 -10000 0 0
RUNX2 0.012 0 -10000 0 -10000 0 0
RUNX3 0.012 0 -10000 0 -10000 0 0
RUNX1 0.003 0.08 -10000 0 -0.7 3 3
CTBP1 0.012 0 -10000 0 -10000 0 0
NR3C1 0.008 0.065 -10000 0 -0.3 9 9
VDR 0.012 0 -10000 0 -10000 0 0
CDKN1A 0.038 0.058 -10000 0 -10000 0 0
KAT2B 0.012 0.005 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4/FOXH1 0.001 0.078 -10000 0 -0.43 3 3
DCP1A 0.012 0 -10000 0 -10000 0 0
SKI 0.013 0.001 -10000 0 -10000 0 0
SERPINE1 -0.12 0.24 -10000 0 -0.51 58 58
SMAD3/SMAD4/ATF2 0.025 0.037 -10000 0 -10000 0 0
SMAD3/SMAD4/ATF3 0.024 0.048 -10000 0 -0.43 1 1
SAP30 0.013 0.001 -10000 0 -10000 0 0
Cbp/p300/PIAS3 0.026 0.033 -10000 0 -10000 0 0
JUN 0.04 0.035 -10000 0 -10000 0 0
SMAD3/SMAD4/IRF7 0.026 0.038 -10000 0 -10000 0 0
TFE3 0.008 0.017 -10000 0 -10000 0 0
COL1A2 -0.053 0.18 -10000 0 -0.55 26 26
mesenchymal cell differentiation -0.025 0.037 -10000 0 -10000 0 0
DLX1 -0.021 0.14 -10000 0 -0.66 11 11
TCF3 0.012 0 -10000 0 -10000 0 0
FOS 0.017 0.005 -10000 0 -10000 0 0
SMAD3/SMAD4/Max 0.031 0.045 -10000 0 -10000 0 0
Cbp/p300/SNIP1 0.023 0.014 -10000 0 -10000 0 0
ZBTB17 0.021 0.022 -10000 0 -10000 0 0
LAMC1 0.026 0.035 -10000 0 -10000 0 0
TGIF2/HDAC complex/SMAD3/SMAD4 0 0.12 -10000 0 -0.47 12 12
IRF7 0.013 0.001 -10000 0 -10000 0 0
ESR1 -0.013 0.09 -10000 0 -0.3 20 20
HNF4A 0.012 0 -10000 0 -10000 0 0
MEF2C 0.003 0.092 -10000 0 -10000 0 0
SMAD2-3/SMAD4 0.012 0.062 -10000 0 -0.31 1 1
Cbp/p300/Src-1 0.024 0.021 -10000 0 -10000 0 0
IGHV3OR16-13 0 0.011 -10000 0 -10000 0 0
TGIF2/HDAC complex -0.024 0.16 -10000 0 -0.7 12 12
CREBBP 0.012 0.01 -10000 0 -10000 0 0
SKIL 0.012 0 -10000 0 -10000 0 0
HDAC1 0.013 0.001 -10000 0 -10000 0 0
HDAC2 0.013 0.001 -10000 0 -10000 0 0
SNIP1 0.013 0.003 -10000 0 -10000 0 0
GCN5L2 -0.001 0.012 -10000 0 -10000 0 0
SMAD3/SMAD4/TFE3 0.026 0.043 -10000 0 -10000 0 0
MSG1/HSC70 -0.14 0.25 -10000 0 -0.52 70 70
SMAD2 -0.002 0.041 -10000 0 -0.36 1 1
SMAD3 0.015 0.029 -10000 0 -10000 0 0
SMAD3/E2F4-5/DP1/p107/SMAD4 0.025 0.055 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4 0.011 0.022 -10000 0 -10000 0 0
NCOR1 0.013 0.001 -10000 0 -10000 0 0
NCOA2 0.012 0 -10000 0 -10000 0 0
NCOA1 0.012 0 -10000 0 -10000 0 0
MYOD/E2A 0.009 0 -10000 0 -10000 0 0
SMAD2-3/SMAD4/SP1/MIZ-1 0.022 0.085 -10000 0 -10000 0 0
IFNB1 0.028 0.033 -10000 0 -10000 0 0
SMAD3/SMAD4/MEF2C 0.007 0.094 -10000 0 -10000 0 0
CITED1 -0.2 0.33 -10000 0 -0.7 70 70
SMAD2-3/SMAD4/ARC105 0.02 0.056 -10000 0 -10000 0 0
RBL1 0 0.092 -10000 0 -0.7 4 4
SMAD2-3/SMAD4/FOXO1-3a-4/CEBPB -0.04 0.2 -10000 0 -0.46 43 43
RUNX1-3/PEBPB2 0.019 0.053 -10000 0 -0.45 3 3
SMAD7 0.032 0.062 -10000 0 -10000 0 0
MYC/MIZ-1 0.014 0.12 -10000 0 -0.48 11 11
SMAD3/SMAD4 -0.012 0.13 -10000 0 -10000 0 0
IL10 0.014 0.11 -10000 0 -0.46 4 4
PIASy/HDAC complex 0.014 0.011 -10000 0 -10000 0 0
PIAS3 0.012 0.005 -10000 0 -10000 0 0
CDK2 0.012 0.009 -10000 0 -10000 0 0
IL5 0.017 0.098 -10000 0 -0.52 5 5
CDK4 0.013 0.01 -10000 0 -10000 0 0
PIAS4 0.014 0.011 -10000 0 -10000 0 0
ATF3 0.009 0.046 -10000 0 -0.7 1 1
SMAD3/SMAD4/SP1 0.011 0.066 -10000 0 -10000 0 0
FOXG1 -0.086 0.23 -10000 0 -0.7 29 29
FOXO3 0.004 0.039 -10000 0 -10000 0 0
FOXO1 0.004 0.039 -10000 0 -10000 0 0
FOXO4 0.004 0.039 -10000 0 -10000 0 0
heart looping 0.003 0.091 -10000 0 -10000 0 0
CEBPB 0.003 0.049 -10000 0 -0.7 1 1
SMAD3/SMAD4/DLX1 0.003 0.1 -10000 0 -0.45 10 10
MYOD1 0 0 -10000 0 -10000 0 0
SMAD3/SMAD4/HNF4 0.025 0.037 -10000 0 -10000 0 0
SMAD3/SMAD4/GATA3 0.015 0.083 -10000 0 -0.41 3 3
SnoN/SIN3/HDAC complex/NCoR1 0.012 0 -10000 0 -10000 0 0
SMAD3/SMAD4/RUNX1-3/PEBPB2 0.029 0.058 -10000 0 -0.37 3 3
SMAD3/SMAD4/SP1-3 0.024 0.061 -10000 0 -10000 0 0
MED15 0.012 0 -10000 0 -10000 0 0
SP1 0.001 0.042 -10000 0 -10000 0 0
SIN3B 0.013 0.001 -10000 0 -10000 0 0
SIN3A 0.013 0.001 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4/FOXH1/NKX2-5 0.003 0.097 -10000 0 -0.38 9 9
ITGB5 0.034 0.054 -10000 0 -10000 0 0
TGIF/SIN3/HDAC complex/CtBP 0.04 0.011 -10000 0 -10000 0 0
SMAD3/SMAD4/AR -0.009 0.09 -10000 0 -0.45 1 1
AR -0.046 0.12 -10000 0 -0.31 41 41
negative regulation of cell growth 0.031 0.052 -10000 0 -10000 0 0
SMAD3/SMAD4/MYOD 0.018 0.036 -10000 0 -10000 0 0
E2F5 -0.006 0.11 -10000 0 -0.7 6 6
E2F4 0.012 0 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4/FOXH1/SMIF 0.018 0.064 -10000 0 -0.36 3 3
SMAD2-3/SMAD4/FOXO1-3a-4 -0.014 0.14 -10000 0 -0.31 40 40
TFDP1 0.012 0 -10000 0 -10000 0 0
SMAD3/SMAD4/AP1 0.037 0.041 -10000 0 -10000 0 0
SMAD3/SMAD4/RUNX2 0.025 0.037 -10000 0 -10000 0 0
TGIF2 -0.024 0.16 -10000 0 -0.7 12 12
TGIF1 0.012 0 -10000 0 -10000 0 0
ATF2 0.012 0 -10000 0 -10000 0 0
IFN-gamma pathway

Figure S72.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S72.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IFN-gamma/IFN-gammaR/JAK1/JAK1/JAK2/JAK2 -0.011 0.12 -9999 0 -0.33 30 30
positive regulation of NF-kappaB transcription factor activity 0 0 -9999 0 -10000 0 0
CRKL 0.012 0 -9999 0 -10000 0 0
STAT1 (dimer)/Cbp/p300 0.01 0.13 -9999 0 -0.61 4 4
IFN-gammaR/JAK1/JAK1/JAK2/JAK2 0.016 0.029 -9999 0 -10000 0 0
antigen processing and presentation of peptide antigen via MHC class I -0.026 0.054 -9999 0 -0.26 4 4
CaM/Ca2+ -0.008 0.12 -9999 0 -0.33 1 1
RAP1A 0.012 0 -9999 0 -10000 0 0
STAT1 (dimer)/SHP2 -0.013 0.14 -9999 0 -0.68 4 4
AKT1 0.003 0.11 -9999 0 -10000 0 0
MAP2K1 -0.002 0.11 -9999 0 -0.34 1 1
MAP3K11 -0.009 0.12 -9999 0 -0.31 30 30
IFNGR1 0.009 0.013 -9999 0 -10000 0 0
mol:GTP 0 0 -9999 0 -10000 0 0
CaM/Ca2+/CAMKII -0.042 0.14 -9999 0 -0.41 16 16
Rap1/GTP -0.03 0.079 -9999 0 -10000 0 0
CRKL/C3G 0.019 0 -9999 0 -10000 0 0
IFN-gamma/IFN-gammaR/JAK1/JAK1/JAK2/JAK2 /TC-PTP -0.013 0.13 -9999 0 -0.36 30 30
CEBPB 0.02 0.12 -9999 0 -0.52 1 1
STAT3 0.012 0 -9999 0 -10000 0 0
IFN-gamma/IFN-gammaR/JAK1/JAK1/JAK2/JAK2/SOCS1 -0.006 0.12 -9999 0 -10000 0 0
STAT1 -0.015 0.14 -9999 0 -0.43 12 12
CALM1 0.012 0 -9999 0 -10000 0 0
IFN-gamma (dimer) -0.078 0.24 -9999 0 -0.69 30 30
PIK3CA 0.012 0 -9999 0 -10000 0 0
STAT1 (dimer)/PIAS1 -0.007 0.13 -9999 0 -0.64 4 4
CEBPB/PTGES2/Cbp/p300 -0.024 0.058 -9999 0 -10000 0 0
mol:Ca2+ -0.013 0.12 -9999 0 -0.33 30 30
MAPK3 0.011 0.1 -9999 0 -10000 0 0
STAT1 (dimer) -0.034 0.072 -9999 0 -0.36 4 4
MAPK1 0.011 0.1 -9999 0 -10000 0 0
JAK2 0.009 0.013 -9999 0 -10000 0 0
PIK3R1 0.012 0 -9999 0 -10000 0 0
JAK1 0.009 0.013 -9999 0 -10000 0 0
CAMK2D 0.012 0 -9999 0 -10000 0 0
DAPK1 0.021 0.12 -9999 0 -0.51 7 7
SMAD7 0.021 0.047 -9999 0 -10000 0 0
CBL/CRKL/C3G 0.004 0.11 -9999 0 -10000 0 0
PI3K -0.038 0.099 -9999 0 -10000 0 0
IFNG -0.079 0.24 -9999 0 -0.69 30 30
apoptosis 0.014 0.093 -9999 0 -0.41 6 6
CAMK2G 0.012 0 -9999 0 -10000 0 0
STAT3 (dimer) 0.012 0 -9999 0 -10000 0 0
CAMK2A -0.016 0.09 -9999 0 -0.3 21 21
CAMK2B -0.049 0.14 -9999 0 -0.33 41 41
FRAP1 0.002 0.099 -9999 0 -10000 0 0
PRKCD 0.003 0.11 -9999 0 -10000 0 0
RAP1B 0.012 0 -9999 0 -10000 0 0
negative regulation of cell growth -0.026 0.054 -9999 0 -0.26 4 4
PTPN2 0.012 0 -9999 0 -10000 0 0
EP300 0.013 0 -9999 0 -10000 0 0
IRF1 0.02 0.11 -9999 0 -0.45 4 4
STAT1 (dimer)/PIASy -0.009 0.13 -9999 0 -0.64 4 4
SOCS1 0.002 0.036 -9999 0 -0.52 1 1
mol:GDP 0.002 0.1 -9999 0 -10000 0 0
CASP1 0.021 0.047 -9999 0 -10000 0 0
PTGES2 0.012 0 -9999 0 -10000 0 0
IRF9 0.032 0.042 -9999 0 -10000 0 0
mol:PI-3-4-5-P3 -0.037 0.097 -9999 0 -10000 0 0
RAP1/GDP -0.03 0.079 -9999 0 -10000 0 0
CBL -0.01 0.12 -9999 0 -0.31 30 30
MAP3K1 -0.009 0.12 -9999 0 -0.34 1 1
PIAS1 0.012 0 -9999 0 -10000 0 0
PIAS4 0.012 0 -9999 0 -10000 0 0
antigen processing and presentation of peptide antigen via MHC class II -0.026 0.054 -9999 0 -0.26 4 4
PTPN11 -0.016 0.12 -9999 0 -0.33 30 30
CREBBP 0.013 0 -9999 0 -10000 0 0
RAPGEF1 0.012 0 -9999 0 -10000 0 0
Signaling mediated by p38-gamma and p38-delta

Figure S73.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S73.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EEF2K 0.023 0 -9999 0 -10000 0 0
SNTA1 0.012 0 -9999 0 -10000 0 0
response to hypoxia 0 0 -9999 0 -10000 0 0
STMN1 0.023 0 -9999 0 -10000 0 0
MAPK12 0.013 0.067 -9999 0 -0.4 6 6
CCND1 0.011 0.04 -9999 0 -0.22 4 4
p38 gamma/SNTA1 0.019 0.064 -9999 0 -0.37 6 6
MAP2K3 0.012 0 -9999 0 -10000 0 0
PKN1 0.012 0 -9999 0 -10000 0 0
G2/M transition checkpoint 0.013 0.067 -9999 0 -0.4 6 6
MAP2K6 0.019 0 -9999 0 -10000 0 0
MAPT -0.034 0.11 -9999 0 -0.23 53 53
MAPK13 0.019 0 -9999 0 -10000 0 0
hyperosmotic response 0 0 -9999 0 -10000 0 0
ZAK 0.015 0 -9999 0 -10000 0 0
VEGFR1 specific signals

Figure S74.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S74.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR1 homodimer/VEGFB homodimer 0.029 0 -9999 0 -10000 0 0
VEGFR1 homodimer/NRP1 0.019 0 -9999 0 -10000 0 0
mol:DAG 0.014 0.087 -9999 0 -0.4 10 10
VEGFR1 homodimer/NRP1/VEGFR 121 -0.002 0.11 -9999 0 -0.4 15 15
CaM/Ca2+ 0.02 0.082 -9999 0 -0.37 10 10
HIF1A 0.02 0 -9999 0 -10000 0 0
GAB1 0.012 0 -9999 0 -10000 0 0
AKT1 0.032 0.071 -9999 0 -10000 0 0
PLCG1 0.014 0.087 -9999 0 -0.4 10 10
NOS3 0.035 0.071 -9999 0 -10000 0 0
CBL 0.012 0 -9999 0 -10000 0 0
mol:NO 0.035 0.07 -9999 0 -10000 0 0
FLT1 0.026 0 -9999 0 -10000 0 0
PGF -0.018 0.14 -9999 0 -0.7 10 10
VEGFR1 homodimer/NRP2/VEGFR121 0.005 0.11 -9999 0 -0.4 16 16
CALM1 0.012 0 -9999 0 -10000 0 0
PIK3CA 0.012 0 -9999 0 -10000 0 0
eNOS/Hsp90 0.041 0.068 -9999 0 -10000 0 0
endothelial cell proliferation -0.006 0.087 -9999 0 -10000 0 0
mol:Ca2+ 0.014 0.086 -9999 0 -0.39 10 10
MAPK3 0.023 0.077 -9999 0 -0.34 10 10
MAPK1 0.023 0.077 -9999 0 -0.34 10 10
PIK3R1 0.012 0 -9999 0 -10000 0 0
PLGF homodimer -0.018 0.14 -9999 0 -0.7 10 10
PRKACA 0.012 0 -9999 0 -10000 0 0
RP11-342D11.1 0 0 -9999 0 -10000 0 0
CAV1 0.004 0.05 -9999 0 -0.3 6 6
VEGFA homodimer -0.033 0.17 -9999 0 -0.7 15 15
VEGFR1 homodimer/VEGFA homodimer -0.002 0.12 -9999 0 -0.44 15 15
platelet activating factor biosynthetic process 0.027 0.075 -9999 0 -10000 0 0
PI3K 0.023 0.083 -9999 0 -0.37 10 10
PRKCA 0.019 0.081 -9999 0 -0.36 10 10
PRKCB 0.01 0.08 -9999 0 -0.36 10 10
VEGFR1 homodimer/PLGF homodimer 0.008 0.095 -9999 0 -0.44 10 10
VEGFA -0.033 0.17 -9999 0 -0.7 15 15
VEGFB 0.012 0 -9999 0 -10000 0 0
mol:IP3 0.014 0.087 -9999 0 -0.4 10 10
RASA1 0.032 0 -9999 0 -10000 0 0
NRP2 0.009 0.046 -9999 0 -0.7 1 1
VEGFR1 homodimer 0.026 0 -9999 0 -10000 0 0
VEGFB homodimer 0.012 0 -9999 0 -10000 0 0
NCK1 0.012 0 -9999 0 -10000 0 0
eNOS/Caveolin-1 0.039 0.068 -9999 0 -10000 0 0
PTPN11 0.012 0 -9999 0 -10000 0 0
mol:PI-3-4-5-P3 0.022 0.082 -9999 0 -0.37 10 10
mol:L-citrulline 0.035 0.07 -9999 0 -10000 0 0
VEGFR1 homodimer/VEGFA homodimer/CBL/CD2AP 0.014 0.1 -9999 0 -0.37 15 15
VEGFR1 homodimer/VEGFA homodimer/NCK1 0.007 0.11 -9999 0 -0.4 15 15
CD2AP 0.012 0 -9999 0 -10000 0 0
PI3K/GAB1 0.028 0.08 -9999 0 -10000 0 0
PDPK1 0.024 0.078 -9999 0 -10000 0 0
VEGFR1 homodimer/VEGFA homodimer/SHP2 0.007 0.11 -9999 0 -0.4 15 15
mol:NADP 0.035 0.07 -9999 0 -10000 0 0
HSP90AA1 0.012 0 -9999 0 -10000 0 0
ubiquitin-dependent protein catabolic process 0.013 0.1 -9999 0 -0.37 15 15
VEGFR1 homodimer/NRP2 0.027 0.031 -9999 0 -0.44 1 1
PDGFR-beta signaling pathway

Figure S75.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S75.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
S1P1/Sphingosine-1-phosphate -0.029 0.13 -9999 0 -0.34 33 33
PDGFB-D/PDGFRB/SLAP 0.009 0.07 -9999 0 -0.52 4 4
PDGFB-D/PDGFRB/APS/CBL 0.017 0.061 -9999 0 -0.44 4 4
AKT1 0.037 0.045 -9999 0 -10000 0 0
mol:PI-4-5-P2 0 0 -9999 0 -10000 0 0
mol:Sphingosine-1-phosphate -0.033 0.14 -9999 0 -0.35 33 33
PIK3CA 0.012 0 -9999 0 -10000 0 0
FGR -0.009 0.065 -9999 0 -0.42 5 5
mol:Ca2+ -0.002 0.052 -9999 0 -0.3 4 4
MYC -0.009 0.11 -9999 0 -0.43 11 11
SHC1 0.012 0 -9999 0 -10000 0 0
HRAS/GDP 0.023 0.051 -9999 0 -0.36 4 4
LRP1/PDGFRB/PDGFB 0.017 0.061 -9999 0 -0.44 4 4
GRB10 0.012 0 -9999 0 -10000 0 0
PTPN11 0.012 0 -9999 0 -10000 0 0
GO:0007205 -0.002 0.053 -9999 0 -0.31 4 4
PTEN 0.011 0.021 -9999 0 -0.3 1 1
GRB2 0.012 0 -9999 0 -10000 0 0
GRB7 -0.006 0.11 -9999 0 -0.7 6 6
PDGFB-D/PDGFRB/SHP2 0.009 0.07 -9999 0 -0.52 4 4
PDGFB-D/PDGFRB/GRB10 0.009 0.07 -9999 0 -0.52 4 4
cell cycle arrest 0.009 0.07 -9999 0 -0.52 4 4
HRAS 0.012 0 -9999 0 -10000 0 0
HIF1A 0.041 0.041 -9999 0 -10000 0 0
GAB1 -0.014 0.074 -9999 0 -0.37 4 4
mol:GTP 0 0 -9999 0 -10000 0 0
DNM2 -0.013 0.08 -9999 0 -0.38 4 4
PDGFB-D/PDGFRB 0.015 0.063 -9999 0 -0.46 4 4
mol:GDP 0 0 -9999 0 -10000 0 0
PDGFB-D/PDGFRB/LMW-PTP 0.009 0.07 -9999 0 -0.52 4 4
S1P1/Sphingosine-1-phosphate/PDGFB-D/PDGFRB -0.04 0.12 -9999 0 -0.32 33 33
positive regulation of MAPKKK cascade 0.009 0.07 -9999 0 -0.52 4 4
PIK3R1 0.012 0 -9999 0 -10000 0 0
mol:IP3 -0.002 0.053 -9999 0 -0.31 4 4
E5 -0.001 0.001 -9999 0 -10000 0 0
CSK 0.013 0.001 -9999 0 -10000 0 0
PDGFB-D/PDGFRB/GRB7 -0.005 0.11 -9999 0 -0.52 10 10
SHB 0.012 0 -9999 0 -10000 0 0
BLK -0.2 0.22 -9999 0 -0.44 102 102
PTPN2 0.012 0.002 -9999 0 -10000 0 0
PDGFB-D/PDGFRB/SNX15 0.009 0.07 -9999 0 -0.52 4 4
BCAR1 0.012 0 -9999 0 -10000 0 0
VAV2 -0.014 0.08 -9999 0 -0.37 4 4
CBL 0.012 0 -9999 0 -10000 0 0
PDGFB-D/PDGFRB/DEP1 0.009 0.07 -9999 0 -0.52 4 4
LCK -0.014 0.065 -9999 0 -0.33 7 7
PDGFRB -0.001 0.093 -9999 0 -0.7 4 4
ACP1 0.012 0 -9999 0 -10000 0 0
HCK -0.003 0.066 -9999 0 -0.39 6 6
ABL1 -0.018 0.069 -9999 0 -0.37 4 4
PDGFB-D/PDGFRB/CBL -0.017 0.071 -9999 0 -0.34 4 4
PTPN1 0.012 0.002 -9999 0 -10000 0 0
SNX15 0.012 0 -9999 0 -10000 0 0
STAT3 0.012 0 -9999 0 -10000 0 0
STAT1 0 0.092 -9999 0 -0.7 4 4
cell proliferation -0.007 0.1 -9999 0 -0.39 11 11
SLA 0.012 0 -9999 0 -10000 0 0
actin cytoskeleton reorganization 0.032 0.051 -9999 0 -10000 0 0
SRC -0.005 0.05 -9999 0 -0.37 4 4
PI3K -0.006 0.042 -9999 0 -10000 0 0
PDGFB-D/PDGFRB/GRB7/SHC 0.005 0.096 -9999 0 -0.45 10 10
SH2B2 0.012 0 -9999 0 -10000 0 0
PLCgamma1/SPHK1 -0.034 0.14 -9999 0 -0.36 33 33
LYN -0.005 0.05 -9999 0 -0.36 4 4
LRP1 0.012 0 -9999 0 -10000 0 0
SOS1 0.012 0 -9999 0 -10000 0 0
STAT5B 0.012 0 -9999 0 -10000 0 0
STAT5A 0.012 0 -9999 0 -10000 0 0
NCK1-2/p130 Cas 0.029 0.052 -9999 0 -0.36 4 4
SPHK1 -0.088 0.25 -9999 0 -0.7 33 33
EDG1 0 0.003 -9999 0 -10000 0 0
mol:DAG -0.002 0.053 -9999 0 -0.31 4 4
PLCG1 -0.002 0.054 -9999 0 -0.31 4 4
NHERF/PDGFRB 0.017 0.061 -9999 0 -0.44 4 4
YES1 -0.006 0.051 -9999 0 -0.37 4 4
cell migration 0.017 0.061 -9999 0 -0.44 4 4
SHC/Grb2/SOS1 0.029 0.052 -9999 0 -0.36 4 4
SLC9A3R2 0.012 0 -9999 0 -10000 0 0
SLC9A3R1 0.012 0 -9999 0 -10000 0 0
NHERF1-2/PDGFRB/PTEN 0.024 0.057 -9999 0 -0.4 4 4
FYN -0.005 0.05 -9999 0 -0.36 4 4
DOK1 0.018 0.056 -9999 0 -0.4 4 4
HRAS/GTP 0.009 0 -9999 0 -10000 0 0
PDGFB 0.012 0 -9999 0 -10000 0 0
RAC1 -0.009 0.089 -9999 0 -0.37 2 2
PRKCD 0.017 0.057 -9999 0 -0.41 4 4
FER 0.017 0.057 -9999 0 -0.41 4 4
MAPKKK cascade -0.006 0.046 -9999 0 -0.35 4 4
RASA1 0.017 0.057 -9999 0 -0.41 4 4
NCK1 0.012 0 -9999 0 -10000 0 0
NCK2 0.012 0 -9999 0 -10000 0 0
p62DOK/Csk 0.026 0.052 -9999 0 -0.37 4 4
PDGFB-D/PDGFRB/SHB 0.009 0.07 -9999 0 -0.52 4 4
chemotaxis -0.017 0.068 -9999 0 -0.36 4 4
STAT1-3-5/STAT1-3-5 -0.012 0.063 -9999 0 -0.35 8 8
Bovine Papilomavirus E5/PDGFRB -0.001 0.07 -9999 0 -0.53 4 4
PTPRJ 0.012 0 -9999 0 -10000 0 0
Coregulation of Androgen receptor activity

Figure S76.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S76.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NRIP1 -0.002 0.03 -9999 0 -10000 0 0
SVIL -0.003 0.038 -9999 0 -0.3 2 2
ZNF318 0.043 0.062 -9999 0 -10000 0 0
JMJD2C 0.004 0.027 -9999 0 -0.11 10 10
T-DHT/AR/Ubc9 -0.008 0.077 -9999 0 -0.28 4 4
CARM1 0.011 0.004 -9999 0 -10000 0 0
PRDX1 0.015 0.004 -9999 0 -10000 0 0
PELP1 0.018 0.01 -9999 0 -10000 0 0
CTNNB1 0.002 0.021 -9999 0 -10000 0 0
AKT1 0.021 0.017 -9999 0 -10000 0 0
PTK2B 0.003 0.019 -9999 0 -10000 0 0
MED1 0.019 0.048 -9999 0 -0.65 1 1
MAK 0.025 0.13 -9999 0 -0.68 6 6
response to oxidative stress 0.002 0.005 -9999 0 -10000 0 0
HIP1 -0.001 0.026 -9999 0 -10000 0 0
GSN -0.005 0.043 -9999 0 -0.35 2 2
NCOA2 0.011 0.004 -9999 0 -10000 0 0
NCOA6 0 0.026 -9999 0 -10000 0 0
DNA-PK 0.05 0.071 -9999 0 -0.39 2 2
NCOA4 0.011 0.003 -9999 0 -10000 0 0
PIAS3 0.002 0.021 -9999 0 -10000 0 0
cell proliferation 0.017 0.084 -9999 0 -0.34 6 6
XRCC5 0.019 0.014 -9999 0 -10000 0 0
UBE3A -0.008 0.041 -9999 0 -10000 0 0
T-DHT/AR/SNURF -0.022 0.095 -9999 0 -0.35 7 7
FHL2 0.04 0.058 -9999 0 -10000 0 0
RANBP9 0 0.026 -9999 0 -10000 0 0
JMJD1A 0.005 0.025 -9999 0 -0.12 8 8
CDK6 0.011 0.046 -9999 0 -0.68 1 1
TGFB1I1 -0.002 0.033 -9999 0 -0.3 1 1
T-DHT/AR/CyclinD1 -0.025 0.1 -9999 0 -0.5 5 5
XRCC6 0.019 0.014 -9999 0 -10000 0 0
T-DHT/AR 0.004 0.089 -9999 0 -0.32 4 4
CTDSP1 0.008 0.009 -9999 0 -10000 0 0
CTDSP2 0.033 0.042 -9999 0 -10000 0 0
BRCA1 -0.007 0.073 -9999 0 -0.74 2 2
TCF4 0.028 0.031 -9999 0 -10000 0 0
CDKN2A -0.18 0.32 -9999 0 -0.69 65 65
SRF 0.029 0.019 -9999 0 -10000 0 0
NKX3-1 -0.011 0.12 -9999 0 -0.66 7 7
KLK3 -0.24 0.5 -9999 0 -1.2 52 52
TMF1 0.01 0.005 -9999 0 -10000 0 0
HNRNPA1 0.024 0.023 -9999 0 -10000 0 0
AOF2 -0.013 0.027 -9999 0 -0.066 48 48
APPL1 0.038 0.038 -9999 0 -10000 0 0
T-DHT/AR/Caspase 8 0.003 0.083 -9999 0 -0.28 4 4
AR -0.042 0.12 -9999 0 -0.3 41 41
UBA3 0.008 0.009 -9999 0 -10000 0 0
PATZ1 0.024 0.023 -9999 0 -10000 0 0
PAWR 0.01 0.005 -9999 0 -10000 0 0
PRKDC 0.013 0.065 -9999 0 -0.67 2 2
PA2G4 0.026 0.028 -9999 0 -10000 0 0
UBE2I 0.012 0 -9999 0 -10000 0 0
T-DHT/AR/Cyclin D3/CDK11 p58 0.002 0.073 -9999 0 -0.4 1 1
RPS6KA3 -0.002 0.03 -9999 0 -10000 0 0
T-DHT/AR/ARA70 -0.015 0.075 -9999 0 -0.3 3 3
LATS2 0.024 0.022 -9999 0 -10000 0 0
T-DHT/AR/PRX1 0.009 0.08 -9999 0 -0.4 1 1
Cyclin D3/CDK11 p58 0.012 0.005 -9999 0 -10000 0 0
VAV3 -0.037 0.1 -9999 0 -0.31 29 29
KLK2 -0.017 0.12 -9999 0 -0.54 10 10
CASP8 0.017 0.009 -9999 0 -10000 0 0
T-DHT/AR/TIF2/CARM1 -0.008 0.071 -9999 0 -0.39 1 1
TMPRSS2 0.001 0.069 -9999 0 -0.72 1 1
CCND1 -0.006 0.094 -9999 0 -0.71 4 4
PIAS1 -0.008 0.041 -9999 0 -10000 0 0
mol:T-DHT 0.003 0.016 -9999 0 -0.055 13 13
CDC2L1 0.001 0.002 -9999 0 -10000 0 0
PIAS4 -0.018 0.061 -9999 0 -10000 0 0
T-DHT/AR/CDK6 -0.006 0.083 -9999 0 -0.33 4 4
CMTM2 -0.012 0.14 -9999 0 -0.69 9 9
SNURF -0.012 0.087 -9999 0 -0.33 15 15
ZMIZ1 0.015 0.015 -9999 0 -10000 0 0
CCND3 0.014 0.002 -9999 0 -10000 0 0
TGIF1 0.024 0.023 -9999 0 -10000 0 0
FKBP4 -0.003 0.052 -9999 0 -0.7 1 1
PLK1 signaling events

Figure S77.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S77.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
regulation of centriole-centriole cohesion -0.005 0.019 0.19 2 -10000 0 2
BUB1B 0.003 0.046 -10000 0 -0.27 4 4
PLK1 0.008 0.019 -10000 0 -0.094 1 1
PLK1S1 0.009 0.011 -10000 0 -10000 0 0
KIF2A 0.014 0.017 -10000 0 -10000 0 0
regulation of mitotic centrosome separation 0.008 0.019 -10000 0 -0.094 1 1
GOLGA2 0.012 0 -10000 0 -10000 0 0
Hec1/SPC24 0.017 0.049 -10000 0 -0.39 3 3
WEE1 0.006 0.034 -10000 0 -10000 0 0
cytokinesis 0.019 0.036 -10000 0 -0.33 2 2
PP2A-alpha B56 0.024 0.024 -10000 0 -10000 0 0
AURKA 0.006 0.026 -10000 0 -0.14 6 6
PICH/PLK1 -0.043 0.15 -10000 0 -0.33 47 47
CENPE -0.006 0.095 -10000 0 -0.42 11 11
RhoA/GTP 0.009 0 -10000 0 -10000 0 0
positive regulation of microtubule depolymerization 0.014 0.017 -10000 0 -10000 0 0
PPP2CA 0.012 0 -10000 0 -10000 0 0
FZR1 0.012 0 -10000 0 -10000 0 0
TPX2 -0.008 0.049 -10000 0 -0.14 29 29
PAK1 0.012 0.001 -10000 0 -10000 0 0
SPC24 0.003 0.08 -10000 0 -0.7 3 3
FBXW11 0.012 0 -10000 0 -10000 0 0
CLSPN -0.006 0.051 -10000 0 -0.16 22 22
GORASP1 0.012 0 -10000 0 -10000 0 0
metaphase 0 0.001 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
NLP 0.004 0.011 -10000 0 -0.058 2 2
G2 phase of mitotic cell cycle -0.001 0.002 -10000 0 -0.011 6 6
STAG2 0.012 0 -10000 0 -10000 0 0
GRASP65/GM130/RAB1/GTP 0.013 0.018 -10000 0 -10000 0 0
spindle elongation 0.008 0.019 -10000 0 -0.094 1 1
ODF2 0.012 0.002 -10000 0 -10000 0 0
BUB1 -0.006 0.019 -10000 0 -10000 0 0
TPT1 0.009 0.017 -10000 0 -0.2 1 1
CDC25C 0.01 0.017 -10000 0 -0.19 1 1
CDC25B -0.09 0.25 -10000 0 -0.69 34 34
SGOL1 0.005 0.019 -10000 0 -0.19 2 2
RHOA 0.012 0 -10000 0 -10000 0 0
CCNB1/CDK1 -0.048 0.11 -10000 0 -0.31 36 36
CDC14B 0.009 0.001 -10000 0 -10000 0 0
CDC20 0.009 0.046 -10000 0 -0.7 1 1
PLK1/PBIP1 0.01 0.03 -10000 0 -0.4 1 1
mitosis 0 0.006 0.034 6 -0.019 2 8
FBXO5 0.006 0.034 -10000 0 -0.34 1 1
CDC2 -0.001 0.005 -10000 0 -0.014 36 36
NDC80 0.012 0 -10000 0 -10000 0 0
metaphase plate congression 0.01 0.011 -10000 0 -10000 0 0
ERCC6L -0.041 0.14 -10000 0 -0.32 47 47
NLP/gamma Tubulin 0.007 0.012 -10000 0 -10000 0 0
microtubule cytoskeleton organization 0.009 0.017 -10000 0 -0.2 1 1
G2/M transition DNA damage checkpoint -0.001 0.001 -10000 0 -0.01 2 2
PPP1R12A 0.012 0.001 -10000 0 -10000 0 0
interphase -0.001 0.001 -10000 0 -0.01 2 2
PLK1/PRC1-2 0.019 0.043 -10000 0 -0.4 2 2
GRASP65/GM130/RAB1/GTP/PLK1 0.026 0.015 -10000 0 -10000 0 0
RAB1A 0.012 0 -10000 0 -10000 0 0
prophase 0 0 -10000 0 -10000 0 0
Aurora A/BORA 0.007 0.041 -10000 0 -0.38 2 2
mitotic prometaphase 0 0.001 -10000 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0.027 0.011 -10000 0 -10000 0 0
microtubule-based process 0.011 0.044 -10000 0 -0.43 2 2
Golgi organization 0.008 0.019 -10000 0 -0.094 1 1
Cohesin/SA2 0.012 0.016 -10000 0 -10000 0 0
PPP1CB/MYPT1 0.018 0.001 -10000 0 -10000 0 0
KIF20A 0.006 0.066 -10000 0 -0.7 2 2
APC/C/CDC20 0.013 0.034 -10000 0 -0.42 1 1
PPP2R1A 0.012 0 -10000 0 -10000 0 0
chromosome segregation 0.01 0.03 -10000 0 -0.39 1 1
PRC1 0.012 0 -10000 0 -10000 0 0
ECT2 -0.021 0.12 -10000 0 -0.41 19 19
C13orf34 0.008 0.04 -10000 0 -0.39 2 2
NUDC 0.01 0.011 -10000 0 -10000 0 0
regulation of attachment of spindle microtubules to kinetochore 0.003 0.046 -10000 0 -0.26 4 4
spindle assembly 0.009 0.016 -10000 0 -10000 0 0
spindle stabilization 0.009 0.01 -10000 0 -10000 0 0
APC/C/HCDH1 0.016 0.001 -10000 0 -10000 0 0
MKLP2/PLK1 0.011 0.045 -10000 0 -0.43 2 2
CCNB1 0.005 0.065 -10000 0 -0.69 2 2
PPP1CB 0.012 0.001 -10000 0 -10000 0 0
BTRC 0.012 0 -10000 0 -10000 0 0
ROCK2 0.016 0.013 -10000 0 -10000 0 0
TUBG1 0.009 0.011 -10000 0 -10000 0 0
G2/M transition of mitotic cell cycle -0.047 0.11 -10000 0 -0.3 36 36
MLF1IP 0.007 0.036 -10000 0 -0.54 1 1
INCENP 0.012 0.001 -10000 0 -10000 0 0
Role of Calcineurin-dependent NFAT signaling in lymphocytes

Figure S78.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S78.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 0.009 0.046 -10000 0 -0.7 1 1
NFATC1 0.043 0.029 -10000 0 -10000 0 0
NFATC2 0.029 0.024 -10000 0 -10000 0 0
NFATC3 0.02 0.003 -10000 0 -10000 0 0
YWHAE 0.012 0 -10000 0 -10000 0 0
Calcineurin A alpha-beta B1/CABIN1 -0.082 0.11 -10000 0 -0.31 26 26
Exportin 1/Ran/NUP214 0.025 0.002 -10000 0 -10000 0 0
mol:DAG 0 0.001 -10000 0 -10000 0 0
CABIN1/MEF2D/CaM/Ca2+/CAMK IV -0.077 0.089 -10000 0 -0.38 6 6
BCL2/BAX 0.015 0.028 -10000 0 -10000 0 0
CaM/Ca2+/Calcineurin A alpha-beta B1 0.01 0.004 -10000 0 -10000 0 0
CaM/Ca2+ 0.01 0.004 -10000 0 -10000 0 0
BAX 0.012 0 -10000 0 -10000 0 0
MAPK14 0.012 0.001 -10000 0 -10000 0 0
BAD 0.012 0 -10000 0 -10000 0 0
CABIN1/MEF2D -0.072 0.1 -10000 0 -0.29 26 26
Calcineurin A alpha-beta B1/BCL2 0.007 0.041 -10000 0 -0.3 4 4
FKBP8 0.012 0 -10000 0 -10000 0 0
activation-induced cell death of T cells 0.071 0.1 0.29 26 -10000 0 26
KPNB1 0.012 0 -10000 0 -10000 0 0
KPNA2 0.003 0.08 -10000 0 -0.7 3 3
XPO1 0.012 0 -10000 0 -10000 0 0
SFN 0.012 0 -10000 0 -10000 0 0
MAP3K8 0.013 0.002 -10000 0 -10000 0 0
NFAT4/CK1 alpha 0.029 0.006 -10000 0 -10000 0 0
MEF2D/NFAT1/Cbp/p300 0.045 0.064 -10000 0 -0.28 8 8
CABIN1 -0.083 0.11 -10000 0 -0.31 26 26
CALM1 0.013 0.002 -10000 0 -10000 0 0
RAN 0.012 0 -10000 0 -10000 0 0
MAP3K1 0.012 0 -10000 0 -10000 0 0
CAMK4 -0.003 0.067 -10000 0 -0.3 11 11
mol:Ca2+ 0 0.003 -10000 0 -10000 0 0
MAPK3 0.012 0 -10000 0 -10000 0 0
YWHAH 0.012 0 -10000 0 -10000 0 0
Calcineurin A alpha-beta B1/AKAP79/PKA 0.016 0.024 -10000 0 -10000 0 0
YWHAB 0.012 0 -10000 0 -10000 0 0
MAPK8 0.012 0.002 -10000 0 -10000 0 0
MAPK9 0.012 0 -10000 0 -10000 0 0
YWHAG 0.012 0 -10000 0 -10000 0 0
FKBP1A 0.012 0 -10000 0 -10000 0 0
NFAT1-c-4/YWHAQ 0.057 0.028 -10000 0 -10000 0 0
PRKCH 0.012 0 -10000 0 -10000 0 0
CABIN1/Cbp/p300 0.018 0.006 -10000 0 -10000 0 0
CASP3 0.012 0.001 -10000 0 -10000 0 0
PIM1 0.012 0 -10000 0 -10000 0 0
Calcineurin A alpha-beta B1/FKBP12/FK506 0.009 0.002 -10000 0 -10000 0 0
apoptosis -0.002 0.026 -10000 0 -0.4 1 1
14-3-3 family/BAD/CaM/Ca2+/Calcineurin A alpha-beta B1 0.036 0.002 -10000 0 -10000 0 0
PRKCB -0.063 0.13 -10000 0 -0.3 56 56
PRKCE 0.012 0 -10000 0 -10000 0 0
JNK2/NFAT4 0.025 0.003 -10000 0 -10000 0 0
BAD/BCL-XL 0.016 0.035 -10000 0 -0.52 1 1
PRKCD 0.012 0 -10000 0 -10000 0 0
NUP214 0.012 0 -10000 0 -10000 0 0
PRKCZ 0.012 0.002 -10000 0 -10000 0 0
PRKCA 0.012 0 -10000 0 -10000 0 0
PRKCG -0.32 0.35 -10000 0 -0.7 108 108
PRKCQ -0.001 0.094 -10000 0 -0.62 5 5
FKBP38/BCL2 0.015 0.028 -10000 0 -10000 0 0
EP300 0.012 0.004 -10000 0 -10000 0 0
PRKCB1 0 0 -10000 0 -10000 0 0
CSNK2A1 0.012 0 -10000 0 -10000 0 0
NFATc/JNK1 0.048 0.029 -10000 0 -10000 0 0
CaM/Ca2+/FKBP38 0.017 0.004 -10000 0 -10000 0 0
FKBP12/FK506 0.009 0 -10000 0 -10000 0 0
CSNK1A1 0.016 0.005 -10000 0 -10000 0 0
CaM/Ca2+/CAMK IV 0.009 0.038 -10000 0 -10000 0 0
NFATc/ERK1 0.048 0.028 -10000 0 -10000 0 0
CABIN1/YWHAQ/CaM/Ca2+/CAMK IV -0.078 0.088 -10000 0 -0.38 6 6
NR4A1 0.033 0.12 -10000 0 -0.57 8 8
GSK3B 0.012 0.002 -10000 0 -10000 0 0
positive T cell selection 0.02 0.003 -10000 0 -10000 0 0
NFAT1/CK1 alpha 0.027 0.019 -10000 0 -10000 0 0
RCH1/ KPNB1 0.012 0.061 -10000 0 -0.52 3 3
YWHAQ 0.012 0 -10000 0 -10000 0 0
PRKACA 0.012 0.001 -10000 0 -10000 0 0
AKAP5 0.008 0.035 -10000 0 -0.3 3 3
MEF2D 0.012 0.004 -10000 0 -10000 0 0
mol:FK506 0 0 -10000 0 -10000 0 0
YWHAZ 0.012 0 -10000 0 -10000 0 0
NFATc/p38 alpha 0.047 0.029 -10000 0 -10000 0 0
CREBBP 0.012 0.004 -10000 0 -10000 0 0
BCL2 0.007 0.041 -10000 0 -0.3 4 4
Regulation of Telomerase

Figure S79.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S79.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Telomerase catalytic core complex -0.067 0.2 -9999 0 -0.62 19 19
RAD9A 0.012 0 -9999 0 -10000 0 0
AP1 0.016 0.021 -9999 0 -10000 0 0
IFNAR2 0.013 0.005 -9999 0 -10000 0 0
AKT1 0.001 0.042 -9999 0 -10000 0 0
ER alpha/Oestrogen -0.009 0.06 -9999 0 -0.2 20 20
NFX1/SIN3/HDAC complex 0.036 0.018 -9999 0 -10000 0 0
EGF -0.093 0.2 -9999 0 -0.41 57 57
SMG5 0.012 0 -9999 0 -10000 0 0
SMG6 0.012 0 -9999 0 -10000 0 0
SP3/HDAC2 0.019 0.009 -9999 0 -10000 0 0
TERT/c-Abl -0.057 0.19 -9999 0 -0.57 19 19
SAP18 0.009 0.047 -9999 0 -0.7 1 1
MRN complex 0.025 0 -9999 0 -10000 0 0
WT1 -0.3 0.35 -9999 0 -0.7 101 101
WRN 0.012 0 -9999 0 -10000 0 0
SP1 0.013 0.007 -9999 0 -10000 0 0
SP3 0.012 0.003 -9999 0 -10000 0 0
TERF2IP 0.012 0 -9999 0 -10000 0 0
Telomerase/Nucleolin -0.071 0.16 -9999 0 -0.66 5 5
Mad/Max 0.018 0.007 -9999 0 -10000 0 0
TERT -0.069 0.2 -9999 0 -0.63 19 19
CCND1 -0.059 0.19 -9999 0 -0.79 5 5
MAX 0.012 0.003 -9999 0 -10000 0 0
RBBP7 0.012 0.001 -9999 0 -10000 0 0
RBBP4 0.012 0.001 -9999 0 -10000 0 0
TERF2 0.011 0 -9999 0 -10000 0 0
PTGES3 0.012 0 -9999 0 -10000 0 0
SIN3A 0.012 0.001 -9999 0 -10000 0 0
Telomerase/911 0.021 0.04 -9999 0 -10000 0 0
CDKN1B -0.03 0.16 -9999 0 -0.43 30 30
RAD1 0.012 0 -9999 0 -10000 0 0
XRCC5 0.012 0 -9999 0 -10000 0 0
XRCC6 0.012 0 -9999 0 -10000 0 0
SAP30 0.012 0.001 -9999 0 -10000 0 0
TRF2/PARP2 0.018 0 -9999 0 -10000 0 0
UBE3A 0.012 0.003 -9999 0 -10000 0 0
JUN 0.012 0.003 -9999 0 -10000 0 0
E6 0 0.003 -9999 0 -10000 0 0
HPV-16 E6/E6AP 0.009 0.005 -9999 0 -10000 0 0
FOS 0.009 0.029 -9999 0 -0.3 2 2
IFN-gamma/IRF1 -0.044 0.18 -9999 0 -0.51 30 30
PARP2 0.012 0 -9999 0 -10000 0 0
BLM 0.003 0.08 -9999 0 -0.7 3 3
Telomerase -0.008 0.079 -9999 0 -0.39 3 3
IRF1 0.016 0.003 -9999 0 -10000 0 0
ESR1 -0.015 0.088 -9999 0 -0.3 20 20
KU/TER 0.019 0 -9999 0 -10000 0 0
ATM/TRF2 0.019 0 -9999 0 -10000 0 0
ubiquitin-dependent protein catabolic process 0.04 0.021 -9999 0 -10000 0 0
HPV-16 E6/E6AP/NFX1/SIN3/HDAC complex 0.04 0.022 -9999 0 -10000 0 0
HDAC1 0.012 0.001 -9999 0 -10000 0 0
HDAC2 0.012 0.007 -9999 0 -10000 0 0
ATM 0 0 -9999 0 -10000 0 0
SMAD3 0.019 0.004 -9999 0 -10000 0 0
ABL1 0.012 0 -9999 0 -10000 0 0
MXD1 0.012 0.003 -9999 0 -10000 0 0
MRE11A 0.012 0 -9999 0 -10000 0 0
HUS1 0.012 0 -9999 0 -10000 0 0
RPS6KB1 0.012 0 -9999 0 -10000 0 0
TERT/NF kappa B1/14-3-3 -0.041 0.18 -9999 0 -0.65 7 7
NR2F2 0.013 0.007 -9999 0 -10000 0 0
MAPK3 0.012 0.007 -9999 0 -10000 0 0
MAPK1 0.012 0.007 -9999 0 -10000 0 0
TGFB1/TGF beta receptor Type II 0.013 0.002 -9999 0 -10000 0 0
NFKB1 0.012 0 -9999 0 -10000 0 0
HNRNPC 0.012 0 -9999 0 -10000 0 0
DNA damage response signal transduction by p53 class mediator resulting in induction of apoptosis 0 0 -9999 0 -10000 0 0
NBN 0.012 0 -9999 0 -10000 0 0
EGFR 0.012 0.002 -9999 0 -10000 0 0
mol:Oestrogen 0 0.002 -9999 0 -10000 0 0
EGF/EGFR -0.058 0.15 -9999 0 -0.52 16 16
MYC -0.022 0.15 -9999 0 -0.7 11 11
IL2 0.004 0.01 -9999 0 -10000 0 0
KU 0.019 0 -9999 0 -10000 0 0
RAD50 0.012 0 -9999 0 -10000 0 0
HSP90AA1 0.012 0 -9999 0 -10000 0 0
TGFB1 0.013 0.002 -9999 0 -10000 0 0
TRF2/BLM 0.012 0.057 -9999 0 -0.49 3 3
FRAP1 0 0 -9999 0 -10000 0 0
KU/TERT -0.052 0.19 -9999 0 -0.64 10 10
SP1/HDAC2 0.02 0.012 -9999 0 -10000 0 0
PINX1 0.012 0 -9999 0 -10000 0 0
Telomerase/EST1A -0.071 0.16 -9999 0 -0.6 8 8
Smad3/Myc 0.001 0.1 -9999 0 -0.45 11 11
911 complex 0.025 0 -9999 0 -10000 0 0
IFNG -0.076 0.24 -9999 0 -0.69 30 30
Telomerase/PinX1 -0.071 0.16 -9999 0 -0.66 5 5
Telomerase/AKT1/mTOR/p70S6K 0.006 0.057 -9999 0 -10000 0 0
SIN3B 0.012 0.001 -9999 0 -10000 0 0
YWHAE 0.012 0 -9999 0 -10000 0 0
Telomerase/EST1B -0.071 0.16 -9999 0 -0.6 8 8
response to DNA damage stimulus 0.003 0 -9999 0 -10000 0 0
MRN complex/TRF2/Rap1 0.036 0 -9999 0 -10000 0 0
TRF2/WRN 0.018 0 -9999 0 -10000 0 0
Telomerase/hnRNP C1/C2 -0.071 0.16 -9999 0 -0.6 8 8
E2F1 0 0.094 -9999 0 -0.71 4 4
ZNFX1 0.012 0.001 -9999 0 -10000 0 0
PIF1 -0.03 0.17 -9999 0 -0.7 14 14
NCL 0.012 0 -9999 0 -10000 0 0
DKC1 0.003 0.08 -9999 0 -0.7 3 3
telomeric DNA binding 0 0 -9999 0 -10000 0 0
Regulation of Androgen receptor activity

Figure S80.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S80.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.017 0.004 -9999 0 -10000 0 0
SMARCC1 0.005 0.009 -9999 0 -10000 0 0
REL 0.016 0.008 -9999 0 -10000 0 0
HDAC7 0.02 0.07 -9999 0 -10000 0 0
JUN 0.01 0.005 -9999 0 -10000 0 0
EP300 0.012 0.001 -9999 0 -10000 0 0
KAT2B 0.012 0.001 -9999 0 -10000 0 0
KAT5 0.013 0.001 -9999 0 -10000 0 0
MAPK14 0.016 0.012 -9999 0 -10000 0 0
FOXO1 0.012 0.001 -9999 0 -10000 0 0
T-DHT/AR 0.019 0.076 -9999 0 -10000 0 0
MAP2K6 0.011 0.006 -9999 0 -10000 0 0
BRM/BAF57 0.013 0.013 -9999 0 -10000 0 0
MAP2K4 0.01 0.021 -9999 0 -0.3 1 1
SMARCA2 0.009 0.007 -9999 0 -10000 0 0
PDE9A -0.12 0.34 -9999 0 -0.88 38 38
NCOA2 0.012 0.002 -9999 0 -10000 0 0
CEBPA 0.01 0.029 -9999 0 -0.3 2 2
EHMT2 0.01 0.005 -9999 0 -10000 0 0
cell proliferation 0.024 0.092 -9999 0 -0.39 1 1
NR0B1 0.002 0.046 -9999 0 -0.7 1 1
EGR1 0.005 0.051 -9999 0 -0.5 2 2
RXRs/9cRA -0.053 0.078 -9999 0 -10000 0 0
AR/RACK1/Src 0.016 0.048 -9999 0 -10000 0 0
AR/GR -0.009 0.083 -9999 0 -0.32 5 5
GNB2L1 0.013 0.001 -9999 0 -10000 0 0
PKN1 0.012 0.001 -9999 0 -10000 0 0
RCHY1 0.012 0 -9999 0 -10000 0 0
epidermal growth factor receptor activity -0.001 0.002 -9999 0 -10000 0 0
MAPK8 0.015 0.018 -9999 0 -10000 0 0
T-DHT/AR/TIF2/CARM1 0.023 0.044 -9999 0 -10000 0 0
SRC 0.025 0.025 -9999 0 -10000 0 0
NR3C1 0 0.06 -9999 0 -0.3 9 9
KLK3 -0.24 0.44 -9999 0 -1 53 53
APPBP2 0.012 0.005 -9999 0 -10000 0 0
TRIM24 0.01 0.007 -9999 0 -10000 0 0
T-DHT/AR/TIP60 0.017 0.04 -9999 0 -10000 0 0
TMPRSS2 -0.002 0.089 -9999 0 -1 1 1
RXRG -0.13 0.15 -9999 0 -0.3 100 100
mol:9cRA -0.001 0.003 -9999 0 -10000 0 0
RXRA 0.012 0.001 -9999 0 -10000 0 0
RXRB 0.012 0.001 -9999 0 -10000 0 0
CARM1 0.012 0.002 -9999 0 -10000 0 0
NR2C2 0.012 0.001 -9999 0 -10000 0 0
KLK2 0.013 0.11 -9999 0 -0.46 10 10
AR -0.012 0.082 -9999 0 -0.23 6 6
SENP1 0.012 0.002 -9999 0 -10000 0 0
HSP90AA1 0.012 0 -9999 0 -10000 0 0
MDM2 0.018 0.013 -9999 0 -10000 0 0
SRY 0.006 0.013 -9999 0 -10000 0 0
GATA2 0.004 0.05 -9999 0 -0.3 6 6
MYST2 0.013 0.002 -9999 0 -10000 0 0
HOXB13 -0.009 0.071 -9999 0 -0.31 12 12
T-DHT/AR/RACK1/Src 0.021 0.042 -9999 0 -10000 0 0
positive regulation of transcription 0.004 0.05 -9999 0 -0.3 6 6
DNAJA1 0.012 0.005 -9999 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0.026 0.004 -9999 0 -10000 0 0
NCOA1 0.013 0.007 -9999 0 -10000 0 0
SPDEF -0.058 0.13 -9999 0 -0.3 51 51
T-DHT/AR/TIF2 0.025 0.034 -9999 0 -10000 0 0
T-DHT/AR/Hsp90 0.016 0.041 -9999 0 -10000 0 0
GSK3B 0.012 0.003 -9999 0 -10000 0 0
NR2C1 0.014 0.003 -9999 0 -10000 0 0
mol:T-DHT 0.021 0.026 -9999 0 -10000 0 0
SIRT1 0.012 0.001 -9999 0 -10000 0 0
ZMIZ2 0.018 0.013 -9999 0 -10000 0 0
POU2F1 0.02 0.025 -9999 0 -10000 0 0
T-DHT/AR/DAX-1 0.01 0.047 -9999 0 -0.35 1 1
CREBBP 0.012 0.001 -9999 0 -10000 0 0
SMARCE1 0.009 0.007 -9999 0 -10000 0 0
Aurora B signaling

Figure S81.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S81.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Condensin I complex 0.028 0.028 -9999 0 -10000 0 0
STMN1 0.023 0.003 -9999 0 -10000 0 0
Aurora B/RasGAP/Survivin 0.034 0.031 -9999 0 -0.42 1 1
Chromosomal passenger complex/Cul3 protein complex 0.012 0.058 -9999 0 -10000 0 0
BIRC5 0.012 0.046 -9999 0 -0.68 1 1
DES -0.37 0.22 -9999 0 -0.5 169 169
Aurora C/Aurora B/INCENP 0.034 0.006 -9999 0 -10000 0 0
Aurora B/TACC1 0.022 0.004 -9999 0 -10000 0 0
Aurora B/PP2A 0.025 0.004 -9999 0 -10000 0 0
mol:GTP 0 0 -9999 0 -10000 0 0
CBX5 0.015 0.002 -9999 0 -10000 0 0
mitotic metaphase/anaphase transition 0 0.001 -9999 0 -10000 0 0
NDC80 0.023 0.003 -9999 0 -10000 0 0
Cul3 protein complex -0.002 0.077 -9999 0 -0.45 3 3
KIF2C 0.024 0.015 -9999 0 -10000 0 0
PEBP1 0.014 0.001 -9999 0 -10000 0 0
KIF20A 0.006 0.066 -9999 0 -0.7 2 2
mol:GDP 0 0 -9999 0 -10000 0 0
Aurora B/RasGAP 0.025 0.004 -9999 0 -10000 0 0
SEPT1 0.011 0.021 -9999 0 -0.3 1 1
SMC2 0.012 0 -9999 0 -10000 0 0
SMC4 0.012 0 -9999 0 -10000 0 0
NSUN2/NPM1/Nucleolin 0.008 0.016 -9999 0 -10000 0 0
PSMA3 0.012 0 -9999 0 -10000 0 0
G2/M transition of mitotic cell cycle 0 0.002 -9999 0 -10000 0 0
H3F3B 0.018 0.002 -9999 0 -10000 0 0
AURKB 0.021 0.006 -9999 0 -10000 0 0
AURKC 0.012 0.002 -9999 0 -10000 0 0
CDCA8 0.012 0.046 -9999 0 -0.68 1 1
cytokinesis 0.006 0.04 -9999 0 -0.36 1 1
Aurora B/Septin1 0.037 0.038 -9999 0 -0.32 1 1
AURKA -0.006 0.11 -9999 0 -0.7 6 6
INCENP 0.015 0.002 -9999 0 -10000 0 0
KLHL13 -0.033 0.13 -9999 0 -0.34 30 30
BUB1 0.009 0.047 -9999 0 -0.7 1 1
hSgo1/Aurora B/Survivin 0.029 0.05 -9999 0 -0.4 3 3
EVI5 0.014 0.001 -9999 0 -10000 0 0
RhoA/GTP 0.007 0.043 -9999 0 -0.38 2 2
SGOL1 0.006 0.066 -9999 0 -0.7 2 2
CENPA 0.024 0.039 -9999 0 -0.28 2 2
NCAPG 0.006 0.066 -9999 0 -0.7 2 2
Aurora B/HC8 Proteasome 0.025 0.004 -9999 0 -10000 0 0
NCAPD2 0.012 0 -9999 0 -10000 0 0
Aurora B/PP1-gamma 0.025 0.004 -9999 0 -10000 0 0
RHOA 0.012 0 -9999 0 -10000 0 0
NCAPH 0.006 0.066 -9999 0 -0.7 2 2
NPM1 0.005 0.009 -9999 0 -10000 0 0
RASA1 0.012 0 -9999 0 -10000 0 0
KLHL9 0.012 0 -9999 0 -10000 0 0
mitotic prometaphase 0.001 0.001 -9999 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0.025 0.004 -9999 0 -10000 0 0
PPP1CC 0.012 0 -9999 0 -10000 0 0
Centraspindlin 0.044 0.049 -9999 0 -0.42 2 2
RhoA/GDP 0.009 0 -9999 0 -10000 0 0
NSUN2 0.005 0.009 -9999 0 -10000 0 0
MYLK -0.063 0.11 -9999 0 -0.22 77 77
KIF23 0.008 0.066 -9999 0 -0.69 2 2
VIM 0.023 0.003 -9999 0 -10000 0 0
RACGAP1 0.014 0.001 -9999 0 -10000 0 0
mitosis 0 0 -9999 0 -10000 0 0
NCL 0.005 0.009 -9999 0 -10000 0 0
Chromosomal passenger complex 0.035 0.029 -9999 0 -0.24 1 1
Chromosomal passenger complex/EVI5 0.075 0.048 -9999 0 -0.34 2 2
TACC1 0.012 0 -9999 0 -10000 0 0
PPP2R5D 0.012 0 -9999 0 -10000 0 0
CUL3 0.012 0 -9999 0 -10000 0 0
response to DNA damage stimulus 0 0 -9999 0 -10000 0 0
Paxillin-independent events mediated by a4b1 and a4b7

Figure S82.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S82.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 0.018 0.044 -9999 0 -0.37 1 1
CRKL 0.012 0 -9999 0 -10000 0 0
Rac1/GDP 0.009 0 -9999 0 -10000 0 0
DOCK1 0.012 0 -9999 0 -10000 0 0
ITGA4 0.008 0.035 -9999 0 -0.3 3 3
alpha4/beta7 Integrin/MAdCAM1 -0.062 0.092 -9999 0 -0.42 1 1
EPO 0.005 0.047 -9999 0 -0.7 1 1
alpha4/beta7 Integrin 0.009 0.047 -9999 0 -0.38 1 1
mol:GTP 0 0 -9999 0 -10000 0 0
CRK 0.012 0 -9999 0 -10000 0 0
alpha4/beta1 Integrin 0.016 0.024 -9999 0 -10000 0 0
EPO/EPOR (dimer) 0.013 0.035 -9999 0 -0.52 1 1
lamellipodium assembly 0.031 0.001 -9999 0 -10000 0 0
PIK3CA 0.012 0 -9999 0 -10000 0 0
PI3K 0.019 0 -9999 0 -10000 0 0
ARF6 0.012 0 -9999 0 -10000 0 0
JAK2 0.024 0.027 -9999 0 -0.25 1 1
PXN 0.012 0 -9999 0 -10000 0 0
PIK3R1 0.012 0 -9999 0 -10000 0 0
MADCAM1 -0.16 0.16 -9999 0 -0.3 124 124
cell adhesion -0.063 0.091 -9999 0 -0.42 1 1
CRKL/CBL 0.019 0 -9999 0 -10000 0 0
ITGB1 0.012 0 -9999 0 -10000 0 0
SRC 0.024 0.027 -9999 0 -10000 0 0
ITGB7 0.003 0.054 -9999 0 -0.3 7 7
RAC1 0.012 0 -9999 0 -10000 0 0
alpha4/beta1 Integrin/VCAM1 0.022 0.03 -9999 0 -0.32 1 1
p130Cas/Crk/Dock1 0.04 0.023 -9999 0 -10000 0 0
VCAM1 0.01 0.029 -9999 0 -0.3 2 2
RHOA 0.012 0 -9999 0 -10000 0 0
alpha4/beta1 Integrin/Paxillin/GIT1 0.03 0.018 -9999 0 -10000 0 0
BCAR1 0.028 0.025 -9999 0 -10000 0 0
EPOR 0.012 0 -9999 0 -10000 0 0
mol:GDP 0 0 -9999 0 -10000 0 0
CBL 0.012 0 -9999 0 -10000 0 0
GIT1 0.012 0 -9999 0 -10000 0 0
Rac1/GTP 0.031 0.001 -9999 0 -10000 0 0
FAS signaling pathway (CD95)

Figure S83.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S83.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SPTAN1 0.006 0.032 -10000 0 -10000 0 0
RFC1 0.006 0.032 -10000 0 -10000 0 0
PRKDC 0.003 0.051 -10000 0 -0.43 2 2
RIPK1 0.013 0.002 -10000 0 -10000 0 0
CASP7 0.017 0.031 -10000 0 -10000 0 0
FASLG/FAS/FADD/FAF1 0.015 0.058 0.2 8 -0.23 2 10
MAP2K4 0.024 0.072 -10000 0 -10000 0 0
mol:ceramide 0.02 0.06 -10000 0 -10000 0 0
GSN 0.005 0.035 -10000 0 -10000 0 0
FASLG/FAS/FADD/FAF1/Caspase 8 0.023 0.058 -10000 0 -0.24 2 2
FAS 0.012 0.004 -10000 0 -10000 0 0
BID 0.011 0.046 0.26 4 -0.46 1 5
MAP3K1 0.025 0.047 -10000 0 -10000 0 0
MAP3K7 0.012 0.002 -10000 0 -10000 0 0
RB1 0.006 0.032 -10000 0 -10000 0 0
CFLAR 0.013 0.002 -10000 0 -10000 0 0
HGF/MET -0.027 0.15 -10000 0 -0.46 22 22
ARHGDIB 0.006 0.032 -10000 0 -10000 0 0
FADD 0.012 0.004 -10000 0 -10000 0 0
actin filament polymerization -0.005 0.035 -10000 0 -10000 0 0
NFKB1 -0.013 0.042 -10000 0 -10000 0 0
MAPK8 0.022 0.099 -10000 0 -0.38 5 5
DFFA 0.006 0.032 -10000 0 -10000 0 0
DNA fragmentation during apoptosis 0.006 0.032 -10000 0 -10000 0 0
FAS/FADD/MET 0.002 0.1 -10000 0 -0.44 11 11
CFLAR/RIP1 0.016 0.005 -10000 0 -10000 0 0
FAIM3 0.004 0.062 -10000 0 -0.38 5 5
FAF1 0.012 0.005 -10000 0 -10000 0 0
PARP1 0.006 0.032 -10000 0 -10000 0 0
DFFB 0.006 0.032 -10000 0 -10000 0 0
CHUK -0.011 0.036 -10000 0 -10000 0 0
FASLG -0.003 0.084 -10000 0 -0.39 9 9
FAS/FADD 0.018 0.007 -10000 0 -10000 0 0
HGF 0.003 0.065 -10000 0 -0.37 6 6
LMNA 0.017 0.028 -10000 0 -10000 0 0
CASP6 0.006 0.032 -10000 0 -10000 0 0
CASP10 0.012 0.004 -10000 0 -10000 0 0
CASP3 0.007 0.036 0.19 7 -10000 0 7
PTPN13 -0.025 0.15 -10000 0 -0.56 15 15
CASP8 0.006 0.043 0.3 5 -10000 0 5
IL6 -0.024 0.2 -10000 0 -0.64 20 20
MET -0.021 0.15 -10000 0 -0.7 11 11
ICAD/CAD 0.006 0.03 -10000 0 -10000 0 0
FASLG/FAS/FADD/FAF1/Caspase 10 0.02 0.06 -10000 0 -10000 0 0
activation of caspase activity by cytochrome c 0.011 0.046 0.26 4 -0.46 1 5
PAK2 0.006 0.032 -10000 0 -10000 0 0
BCL2 0.007 0.041 -10000 0 -0.3 4 4
Signaling events mediated by VEGFR1 and VEGFR2

Figure S84.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S84.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
alphaV beta3 Integrin 0.014 0.031 -9999 0 -10000 0 0
AKT1 0.055 0.061 -9999 0 -10000 0 0
PTK2B 0.018 0.097 -9999 0 -10000 0 0
VEGFR2 homodimer/Frs2 0.032 0 -9999 0 -10000 0 0
CAV1 0.004 0.05 -9999 0 -0.3 6 6
CALM1 0.012 0 -9999 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/Frs2 0.012 0.11 -9999 0 -0.39 15 15
endothelial cell proliferation 0.038 0.079 -9999 0 -10000 0 0
mol:Ca2+ 0.02 0.098 -9999 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/IQGAP1/Rac 0.02 0.1 -9999 0 -0.36 15 15
RP11-342D11.1 0.012 0.097 -9999 0 -0.36 15 15
CDH5 0.012 0 -9999 0 -10000 0 0
VEGFA homodimer 0.005 0.11 -9999 0 -0.4 15 15
SHC1 0.012 0 -9999 0 -10000 0 0
SHC2 -0.004 0.1 -9999 0 -0.63 6 6
HRAS/GDP -0.019 0.073 -9999 0 -10000 0 0
SH2D2A 0.009 0.046 -9999 0 -0.7 1 1
VEGFR2 homodimer/VEGFA homodimer/SHP1/eNOS 0.047 0.074 -9999 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/TsAd 0.01 0.11 -9999 0 -0.39 16 16
VEGFR1 homodimer 0.012 0 -9999 0 -10000 0 0
SHC/GRB2/SOS1 -0.021 0.08 -9999 0 -10000 0 0
GRB10 0.02 0.098 -9999 0 -10000 0 0
PTPN11 0.012 0 -9999 0 -10000 0 0
GRB2 0.012 0 -9999 0 -10000 0 0
PAK1 0.012 0 -9999 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/IQGAP1/Cadherin/beta catenin 0.025 0.097 -9999 0 -0.35 15 15
HRAS 0.012 0 -9999 0 -10000 0 0
VEGF/Rho/ROCK1/Integrin Complex 0.028 0.051 -9999 0 -10000 0 0
HIF1A 0.012 0 -9999 0 -10000 0 0
FRS2 0.012 0 -9999 0 -10000 0 0
oxygen and reactive oxygen species metabolic process 0.018 0.1 -9999 0 -0.36 15 15
mol:GTP 0 0 -9999 0 -10000 0 0
FLT4 0.011 0.021 -9999 0 -0.3 1 1
Nck/Pak 0.019 0 -9999 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/Fyn 0.012 0.11 -9999 0 -0.39 15 15
mol:GDP -0.02 0.078 -9999 0 -10000 0 0
mol:NADP 0.044 0.068 -9999 0 -10000 0 0
eNOS/Hsp90 0.048 0.065 -9999 0 -10000 0 0
PIK3R1 0.012 0 -9999 0 -10000 0 0
mol:IP3 0.02 0.099 -9999 0 -10000 0 0
HIF1A/ARNT 0.019 0 -9999 0 -10000 0 0
SHB 0.012 0 -9999 0 -10000 0 0
VEGFA -0.031 0.17 -9999 0 -0.69 15 15
VEGFC 0.01 0.029 -9999 0 -0.3 2 2
FAK1/Vinculin 0.038 0.078 -9999 0 -10000 0 0
mol:Ca ++ 0 0 -9999 0 -10000 0 0
RHOA 0.012 0 -9999 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/alphaV beta3 Integrin 0.016 0.1 -9999 0 -0.36 15 15
PTPN6 0.012 0 -9999 0 -10000 0 0
EPAS1 0.021 0 -9999 0 -10000 0 0
mol:L-citrulline 0.044 0.068 -9999 0 -10000 0 0
ITGAV 0.012 0 -9999 0 -10000 0 0
PIK3CA 0.012 0 -9999 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/Frs2/GRB2 0.02 0.1 -9999 0 -0.36 15 15
VEGFR2 homodimer/VEGFA homodimer 0.017 0.11 -9999 0 -0.39 15 15
VEGFR2/3 heterodimer 0.031 0.012 -9999 0 -10000 0 0
VEGFB 0.012 0 -9999 0 -10000 0 0
MAPK11 0.023 0.093 -9999 0 -10000 0 0
VEGFR2 homodimer 0.03 0.001 -9999 0 -10000 0 0
FLT1 0.012 0 -9999 0 -10000 0 0
NEDD4 0.014 0 -9999 0 -10000 0 0
MAPK3 0.012 0.096 -9999 0 -0.39 5 5
MAPK1 0.012 0.096 -9999 0 -0.39 5 5
VEGFA145/NRP2 -0.017 0.14 -9999 0 -0.52 16 16
VEGFR1/2 heterodimer 0.032 0 -9999 0 -10000 0 0
KDR 0.03 0.001 -9999 0 -10000 0 0
VEGFA165/NRP1/VEGFR2 homodimer 0.021 0.1 -9999 0 -10000 0 0
SRC 0.012 0 -9999 0 -10000 0 0
platelet activating factor biosynthetic process 0.009 0.098 -9999 0 -0.39 5 5
PI3K 0.045 0.076 -9999 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/NCK1 0.012 0.11 -9999 0 -0.39 15 15
FES 0.02 0.1 -9999 0 -10000 0 0
GAB1 0.035 0.076 -9999 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/Src 0.012 0.11 -9999 0 -0.39 15 15
CTNNB1 0.012 0 -9999 0 -10000 0 0
SOS1 0.012 0 -9999 0 -10000 0 0
ARNT 0.012 0 -9999 0 -10000 0 0
eNOS/Caveolin-1 0.046 0.067 -9999 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/Yes 0.012 0.11 -9999 0 -0.39 15 15
PI3K/GAB1 0.058 0.061 -9999 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/Frs2/Nck/Pak 0.025 0.097 -9999 0 -10000 0 0
PRKACA 0.012 0 -9999 0 -10000 0 0
VEGFR2/3 heterodimer/VEGFC homodimer 0.035 0.018 -9999 0 -10000 0 0
HSP90AA1 0.012 0 -9999 0 -10000 0 0
CDC42 0.02 0.1 -9999 0 -10000 0 0
actin cytoskeleton reorganization 0.01 0.11 -9999 0 -0.39 16 16
PTK2 0.032 0.082 -9999 0 -10000 0 0
EDG1 0.012 0.097 -9999 0 -0.36 15 15
mol:DAG 0.02 0.099 -9999 0 -10000 0 0
CaM/Ca2+ 0.024 0.091 -9999 0 -10000 0 0
MAP2K3 0.025 0.095 -9999 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/GRB10/NEDD4 0.024 0.1 -